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ABSTRACT
The overall objectives of this thesis were the isolation and expression of cDNA 
sequences coding for mammalian SHMT. A probe was developed using the available 
amino acid sequence of the rabbit cytosolic SHMT (Martini et al. , 1987) as a basis 
for designing primers, which were then used to amplify a region of the sequences 
coding for rabbit cytosolic SHMT (chapter 3). This amplified region was 
subsequently used to screen a rabbit liver cDNA library. The screening proved 
successful, with the isolation of sixty-seven clones potentially coding for SHMT. 
Further analysis of one of these clones, pUS1203, has provided the nucleotide 
sequence of the complete coding sequences for cytosolic SHMT (chapter 4). 
Contained within this clone were the 5’ and 3’ UTRs of 155 and 653 nucleotides 
respectively.
The complete SHMT cDNA was cloned into the expression vector pUSlOOO, 
to generate pUS1202, where transcription of the SHMT cDNA was driven by the 
human cytomegalovirus promoter. Expression of this recombinant SHMT in COS-1 
cells was achieved (chapter 5). Site specific mutagenesis to remove an upstream ATG 
codon within the 5’ UTR was found to dramatically increase the levels of SHMT 
activity, when the mutated SHMT cDNA (pUS1208) was transfected into COS-1 
cells. The level of ^ HMT activity in the cells transfected with pUS1208 was 100-fold 
higher than the activity found in cells transfected with pUSlOOO and 50-fold higher 
than in cells transfected with pUS1202.
Subsequent screening of a human breast cancer cell line cDNA library with 
the complete rabbit SHMT cDNA insert in pUS1203, identified 20 possible clones 
containing SHMT sequence (chapter 6). Sequence analysis of the largest of these, 
pUS1206, revealed that it contained 930bp of SHMT coding sequences, 890bp of 3’ 
UTR and 850bp of an intron located 5’ to the coding sequences. Comparison of the 
human and rabbit SHMT cDNAs reveals a high degree of constraint for the coding 
sequences that extends to a region of the 3’ UTR (chapter 7).
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CHAPTER 1
INTRODUCTION
The biochemistry of the amino acid serine has been studied extensively and the 
enzymes involved in the different metabolic pathways of serine have been elucidated. 
The subject of this study, serine hydroxymethyltransferase, SHMT (EC 2.1.2.1), has 
been studied at the biochemical level, and the properties, substrates and reactions of 
the enzyme have been well documented (Schirch, 1982 for review). At the genetic 
level, surprisingly little is known about this enzyme. Studies to date have been 
largely confined to procaryotes and only more recently the lower eucaryote, N. 
crassa. This is surprising because, as the enzyme functions in directing serine 
towards the synthesis of nucleotide precursors, one might have expected that with the 
extensive studies being carried out on different aspects of cancer, any features 
involved in cell proliferation would have been investigated. Biochemical evidence on 
the levels of enzymic activity of serine hydroxymethyltransferase in neoplastic and 
rapidly proliferating cells (see later) points to it as a potential target for enzyme 
directed anticancer therapy. To this end, the present project has involved the 
isolation of cDNA coding for mammalian SHMT as a prelude to the long term goal 
of eventually carrying out enzyme/drug interaction studies on the purified recombinant 
human protein. Thus the isolation of cDNAs for both human and rabbit SHMT, and 
expression studies using the rabbit clone, are reported in this thesis.
In addition to the involvement of SHMT in cancer cells, another biomedical 
aspect of interest in SHMT is the tentative link with schizophrenic and psychotic 
patients (see later). Abnormal levels of activity of the enzyme have been reported in 
the central nervous system of both these classes of patients. A product of the reaction 
catalysed by SHMT is glycine, an excitatory and inhibitory neurotransmitter, and this 
provides a rational for the pathology of these diseases.
1.1 BIOSYNTHESIS OF SERINE
Serine is categorised as one of the non-essential amino acids, insofar as animals 
possess the necessary biosynthetic enzymes to synthesise serine. Under certain 
conditions however it has been suggested that some of these so-called non-essential
1
amino acids become essential, the body not being able to synthesise them at an 
adequate rate to satisfy demand. That this is the case for serine was first suggested 
by Eagle (1959), who reported that the requirement for non-essential amino acids in 
a cell culture medium supporting rapid cell proliferation could be replaced by a single 
amino acid, serine.
There has been some confusion surrounding the pathway of biosynthesis of 
serine. Up until 1969 the existence of two pathways for serine synthesis was 
suggested. The first of these was a pathway involving phosphorylated intermediates 
and became known as the "phosphorylated pathway". The second proposed pathway, 
which was later proven to be a pathway for gluconeogenesis from serine rather than 
a pathway of serine synthesis, was a non-phosphorylated pathway (for discussion see 
Snell, 1986). The confirmed pathway for the biosynthesis of the amino acid serine 
starts at the glycolytic intermediate, 3-phosphoglycerate, which is oxidised using 
NAD'*' to form 3-phosphohydroxypyruvate (figure 1.1). Transfer of the amino group 
from glutamate by phosphoserine aminotransferase to replace the keto group of 
phosphohydroxypyruvate results in the formation of phosphoserine. The final step 
in this short biosynthetic pathway is removal of the phosphate group to form free 
serine. This final irreversible step is catalysed by a specific phosphatase, 
phosphoserine phosphatase, and it is the irreversibility of this step that leads to a 
requirement for an alternative pathway for regeneration of glucose from serine. No 
kinase has been isolated from tissue that is capable of phosphorylating free serine, 
unlike the situation where serine already present in proteins can be readily 
phosphorylated by a number of serine-specific protein kinases. The lack of such a 
kinase leads to the requirement for a pathway of non-phosphorylated intermediates to 
synthesise glucose from serine.
The point of control in the mammalian pathway of serine synthesis is not as 
might be expected exerted on 3-phosphoglycerate dehydrogenase, the first enzyme in 
the pathway, as is the case for bacteria and plants (Umbarger & Umbarger, 1962; 
Pizer, 1963; Slaughter & Davies, 1968). Rather the product, serine, acts as a non­
competitive inhibitor of phosphoserine phosphatase and thus control is exerted at the
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Figure 1.1: Pathway of serine biosynthesis.
final step in the pathway. Under normal conditions there is significant inhibition of 
phosphoserine phosphatase by serine and the enzyme is also repressed by feeding a 
high protein diet (Snell, 1984). Flux through the pathway is rather insensitive to 
levels of 3-phosphoglycerate and it is the demand for serine that regulates its synthesis 
rather than the availability of substrates.
Adaptive changes in the enzymes of serine biosynthesis in both rabbit and rat 
liver have been reported in response to dietary and hormonal influences. 
Phosphoglycerate dehydrogenase activity is inversely related to dietary protein intake 
in both rats and rabbit (Fallon, 1967; Cheung et ah , 1969). In rat the activity of both 
the phosphoserine aminotransferase and phosphoserine phosphatase are increased in 
response to a protein free diet (Hayashi et ah, 1975), while in rabbit although the 
activities of these two enzymes are decreased by a high protein diet, they are 
indifferent to a protein free diet (Cheung et ah , 1969). Following treatment of rats 
with glucocorticoid the activity of the three enzymes of serine synthesis were 
decreased (Snell, 1984).
1.2 SERINE UTILISATION
Once synthesised serine can be used in a number of different metabolic pathways 
(figure 1,2). Like all amino acids serine shares the universal role of providing a 
building block for protein synthesis. The hydroxyl side chain of serine contributes 
to the hydrophil icity of proteins when in exposed regions of the protein. Serine, like 
threonine and tyrosine has another important role in proteins in that the hydroxyl 
group can be readily phosphorylated by protein kinases to form a phosphoserine 
residue within the protein. Sometimes this is a means of "exporting" phosphate, as 
is the case for casein. In other cases phosphorylation/dephosphorylation of specific 
serine or threonine residues in a protein can be a form of activation/inactivation of 
regulatory enzymes.
Serine
P rotein
synthesis
m ethylene
THF
glycine
synthesis
cysteine
synthesis
phospholipid
synthesis
g lu con eogen esis
Figure 1.2: Metabolic uses of serine
Serine is also involved in the synthesis of two other non-essential amino acids, 
glycine and cysteine. The formation of glycine is a one step reaction catalysed by the 
enzyme SHMT, which catalyses the transfer of the methyl group from serine to 
tetrahydrofolate (THF) thus forming methylenetetrahydrofolate and glycine. The 
synthesis of cysteine requires two amino acids, methionine which furnishes the 
sulphur atom and serine which provides the carbon skeleton. The methionine is 
carried in the form of S-adenosylmethionine. The highly reactive methyl group of 
methionine reacts with a methyl group acceptor. This is followed by hydrolysis 
yielding homocysteine, which reacts with serine to yield cystathionine. The final step 
involves cleavage by cystathionine gamma lyase to remove ammonia and release 
cysteine.
Serine contributes to the formation of the plasma membrane by its involvement 
in the synthesis of phospholipids. For example the percentage of incorporation of 
tritiated serine into phospholipids in glioma cells in culture is reported to be 5 %. The 
incorporation of exogenous serine into phospholipids is dependent on the utilisation 
of serine for competing metabolic pathways (Xu et al,, 1991). Serine directly 
provides the hydroxyl group in the phosphoglyceride, phosphatidyl serine and this in 
turn can be used in the synthesis of two other major phosphoglycerides, phosphatidyl 
ethanolamine and phosphatidyl choline. Another form of phospholipid found in 
membranes, particularly in the nervous system, is sphingomyelin, which is derived 
from sphingosine rather than glycerol as is the case for the other phospholipids in the 
plasma membrane. Serine contributes to the formation of sphingosine at the first step 
in its synthesis by condensation with palmitoyl CoA to form dehydrosphinganine, 
which is then converted to sphingosine.
Another biosynthetic role of serine is its utilisation for gluconeogenesis which 
can proceed via two different pathways, initiated either by serine aminotransferase, 
or by serine dehydratase (figure 1.3). In the first of these, serine aminotransferase 
initiates the pathway by a transamination step resulting in the formation of 
hydroxypyruvate which is subsequently used for gluconeogenesis. Serine dehydratase 
on the other hand directly deaminates serine to form pyruvate, which can be used in
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Figure 1.3: Major pathways of hepatic serine metabolism
gluconeogenesis, energy generation or lipogenesis. The pathway involving 
hydroxypyruvate had been considered to be a second pathway of serine synthesis 
rather than of serine utilisation. That this was not the case was proposed 
independently by Rowsell and co-workers (1969) and Lardy and co-workers (1969) 
who investigated the response of the enzymes involved in this pathway to various 
dietary and hormonal influences, and found the response to be more suitable to a role 
in gluconeogenesis rather than serine synthesis.
In general, the adaptive response of these two initiating enzymes of serine 
utilisation for gluconeognesis is the opposite of the response seen for the enzymes of 
serine synthesis. The activities of both enzymes increase with increased protein 
feeding. However in response to a protein free diet, serine dehydratase activity 
decreases while the activity of serine aminotransferase remains the same. Serine 
dehydratase activity was found to be induced by fasting young normally fed rats or, 
in diabetic rats, both situations where gluconeogenesis would be active.
Examination of the tissue distribution of these enzyme activities reveal 
confinement to those tissues which have a gluconeogenic role, coincident with the 
function of these enzymes. Serine dehydratase activity is largely confined to rat liver 
with lower levels found in the kidney, heart and brain. It has been suggested that 
activity found in tissues other than the liver could be related to the presence of L- 
homoserine dehydratase-cystathionase, which has weak serine dehydratase activity 
(Snell, 1984). The tissue distribution of serine aminotransferase is similar to that of 
serine dehydratase, with the highest activity found in liver and a lower level found 
in kidney. In the case of rat liver serine dehydratase, this nutritional control and 
tissue specific expression has been shown to be associated with alteration of DNase 
I hypersensitivity at specific sites in the 5’ flanking region of the gene (Ogawa et al. , 
1991).
The necessity of having two separate and different pathways for 
gluconeogenesis from serine is not clear. The different subcellular locations of the 
enzymes, serine aminotransferase in the mitochondria and serine dehydratase in the
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cytosol, may resolve the question. It has been suggested that the cytosolic location 
of serine dehydratase combined with the observed induction of enzyme activity during 
periods of fasting and diabetes supports a role for this enzyme in gluconeogenesis 
from serine imported from extracellular fluid (Snell, 1984; 1986). The mitochondrial 
location of serine aminotransferase on the other hand may suggest that this enzyme 
can channel carbon to glucose synthesis from serine that has been generated from the 
intramitochondrial metabolism of certain other amino acids, glycine and 
hydroxyproline. Additional support for this role of serine aminotransferase is the 
relatively higher levels of activity found in meat-eating carnivorous animals over 
herbivorous animals. Collagen, which is rich in glycine and hydroxyproline is likely 
to be prevalent in the diet of carnivores (Snell, 1984; 1986).
1.3 PROPERTIES AND REACTIONS OF SHMT
Unlike the two enzymes previously discussed, serine aminotransferase and serine 
dehydratase, SHMT is ubiquitous, being found in all tissues. The physiological role 
of SHMT is the interconversion of serine and glycine resulting in the generation of 
one-carbon units in the form of 5 ,10-methylene tetrahydrofolate (figure 1.4). It is the 
major source of one-carbon units in the cell and as such has a unique and essential 
role to play in folate and nucleotide metabolism. The first evidence of its occurrence 
in the cell was provided by Shemin (1946) and since then it has been purified in a 
homogenous form first from rabbit liver (1963) and shown to require both pyridoxal 
5’ phosphate (PLP) and tetrahydrofolate (THF) as coenzymes.
In addition to the presumed physiological activity of the enzyme, SHMT also 
catalyses transamination, decarboxylation and racemization reactions with several 
amino acids (Shostak & Schirch, 1988; Palekar et al. , 1973). Investigations into the 
stability of SHMT following the addition of different ligands have suggested the 
enzyme exists in an equilibrium between an open and closed form. Binding of the 
amino acid serine, the physiological substrate, to the open form, shifts the equilibrium 
towards the more stable closed form. Schirch and co-workers (1991) have suggested
SHMT
L - Serine + THF glycine +5,10 methylene THF
Figure 1,4: Physiological reaction catalysed by SHMT
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that this closed form of the enzyme functions to block off the side reactions as well 
as enhance catalytic activity by aligning catalytic groups at the active site. In the 
open form, substrate analogs such as alanine can bind but do not stabilise the enzyme 
in the closed form, and it is proposed that it is in the open form that the side 
reactions of transamination, decarboxylation and racemization can occur (Schirch et 
al., 1991). Such a mechanism has also been suggested and confirmed for aspartate 
aminotransferase (AAT) another PLP dependent enzyme (Amone et ah, 1985; 
Jansonius et ah, 1985).
SHMT requires both PLP and THF to carry out the interconversion of serine 
and glycine. PLP is the metabolically active form of vitamin Bg and acts as a 
coenzyme for enzymes catalysing a number of different reactions of amino acid 
metabolism including decarboxylation to amines, racemization, transamination and 
other elimination and replacement reactions of the side chains. It is found tightly 
bound to purified SHMT via formation of an internal aldimine with a lysine residue 
in the protein. Binding of the substrate amino acid results in formation of an external 
aldimine with the bound amino acid. Examination of amino acid sequences of PLP 
dependent transaminases and decarboxylases reveals complete conservation of the 
lysine residue as part of a tetrapeptide involved in binding PLP accross a wide range 
of species (Smith et ah, 1991).
The function of THF as a coenzyme relies on its ability to act as a carrier for 
one-carbon units (Chen & Schirch 1973). It is specifically required for the 
interconversion of serine and glycine but not for the non-specific reactions (Schirch, 
1982). It has been suggested that the THF can bind to the enzyme in either open or 
closed form but that binding of THF to the serine/enzyme complex stabilises the 
enzyme in the closed form (Schirch et al. , 1991). The purified enzyme is found free 
of bound THF. Recent studies using phenylglyoxylate modified SHMT from sheep 
liver have identified two arginine residues required for interaction with THF (Usha 
et ah, 1992). Comparison of the amino acid sequences of the peptides containing 
these two arginine residues to the published amino acid sequence of rabbit cytosolic 
SHMT (Martini et ah , 1987) demonstrate they are equivalent to arg-269 and arg-462
11
of the rabbit protein.
Both cytosolic and mitochondrial forms of the enzyme exist. The cytosolic 
form is the most extensively studied and has been purified homogenously from many 
mammalian livers. The first purification was from rabbit liver in 1963 and since then 
from the liver of rat (Palekar et a t ,  1973), cow (Jones & Priest, 1976) and sheep 
(Ulevitch & Kallen, 1977). More recently the enzyme has been purified from the 
murine leukaemic cell line, L1210 (Strong et ah , 1990). The mitochondrial form of 
the enzyme was first purified from rat liver (Palekar et ah , 1973) using a method 
involving isolation of the mitochondria prior to purification of the enzyme, and 
subsequently in larger amounts from rabbit liver (Schirch & Peterson, 1980) when the 
mitochondrial isozyme was purified by virtue of it having a different affinity for 
DEAE-cellulose than the cytosolic form. In all cases examined so far the enzyme 
exists as a tetramer with each subunit containing a bound PLP molecule. The largest 
size reported to date is the cytosolic enzyme purified from rat liver tissue at 61kDa 
(Palekar et al. , 1973), followed by the enzyme from sheep and L1210 cells at 56kDa 
(Ulevitch & Kallen, 1977; Strong et ah, 1990). The rabbit enzyme is the smallest 
at 53kDa (Schirch & Peterson, 1980).
In rabbit liver tissue where both the cytosolic and mitochondrial enzyme have 
been most extensively studied, both enzymes have a similar size of 53kDa per 
subunit. Both isozymes have a similar affinity for serine and THF, and differ only in 
their affinities for glycine with the mitochondrial enzyme binding glycine 
approximately four times stronger than the cytosolic enzyme (Schirch & Peterson, 
1980). The individual role of each isozyme is not fully understood and will be more 
extensively discussed later.
fîabbi bThe protein sequence of both the^cytosolic and mitochondrial SHMT have been 
published (Martini et ah, 1987; Martini et ah, 1989) and are to date the only 
mammalian protein sequences available. These two enzymes share a 61.9% identity. 
Comparison of these sequences with the protein sequence derived from the nucleotide 
sequence of the bacterial counterpart of SHMT, from E. coli (Plamann et ah, 1983)
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and B. japonicum (Rossbach & Hennecke, 1991) and the lower eucaryote N. crassa 
(McClung et al., 1992) suggests a high dgreee of evolutionary constraint on certain 
regions of the protein.
1.4 CONTROL OF SHMT
The mechanism of the control of SHMT has been a matter of controversy for some 
time, with a number of conflicting results adding to the confusion. The SHMT 
enzyme can be considered a branch point of metabolism, the reaction it catalyses 
yields products that are used in different metabolic pathways. The glycine produced 
is used as a precursor for purine synthesis providing the C-4, C-5 and N-7 of the 
purine ring. The N5, NlO-methylenetetrahydrofolate produced is used as a methyl 
donor for methionine synthesis, méthylation of dUMP to dTMP and acts as a 
precursor for other folate derivatives that are used in purine synthesis. Thus the 
control of SHMT is likely to be a complex matter involving an interaction of 
regulatory factors. Most of the studies on the control of SHMT have been carried 
out on E. coli, S. typhimurium and S. cerevisiae.
The involvement of purines in the regulation of SHMT has been established 
for both E. coli and S. typhimurium. Taylor and co-workers have observed a slight 
repression of SHMT by purines. The addition of guanine to growth medium resulted 
in a two-fold decrease in level of SHMT (Taylor et ah, 1966). Growth of a S. 
typhimurium purine auxotroph on limiting amounts of guanine or inosine resulted in 
a five- to seven-fold increase in enzyme activity (Stauffer et ah, 1974). Folate 
metabolism also appears to be involved in the control of SHMT. The addition of 
trimethoprim to growth medium caused a two- to four-fold increase in SHMT activity 
in S. typhimurium (Stauffer et al., 1974). Trimethoprim is an inhibitor of DHFR 
activity and thus would upset folate metabolism causing an accumulation of 
dihydrofolate and a decrease in tetrahydrofolate and it’s derivatives. Work carried 
out on chronic lymphocytic leukocytes (CLL) cells has demonstrated that in 
eucaryotes, the incorporation of serine into DNA is also controlled of the level of
13
nucleotides. Thorndike and co-workers (1979) reported that the addition of 
thymidine, adenosine or guanine to CLL cells cultured with PHA 48 hours prior to 
the addition of 3- '^^C-serine depressed serine incorporation into DNA.
The reported effects of methionine on SHMT in E. coli have been 
contradictory. Mansouri and co-workers reported a two- to eighteen-fold increase in 
SHMT activity in a met E mutant of E. coli and proposed that methionine acted as 
a repressor of SHMT (Mansouri et ah, 1972). Meedle and Pizer observed an 
increase in SHMT levels in a met K mutant of E. coli and suggested that it was S- 
adenosylmethionine (SAM) and not methionine that acted to control SHMT (Meedle 
& Pizer, 1974). Studies carried out later on a number of different met mutants of E. 
coli indicate that it is the requirement of methionine for méthylation reactions rather 
than for protein synthesis that controls the synthesis of SHMT (Dev & Harvey, 1984). 
Methionine limited growth of a met A mutant, defective in homocysteine synthesis, 
had no effect on SHMT, whereas methionine limited growth of a met E mutant which 
is unable to methylate homocysteine has an increased level of SHMT (Dev & Harvey,
1984).
In S. typhimurium a form of cumulative repression of SHMT has been 
proposed where the addition of a combination of serine, glycine, methionine, adenine, 
guanine and thymidine to glucose minimal medium resulted in a six-fold decrease in 
activity of SHMT to 15% of the level found in cells growm on minimal medium 
(Stauffer et ah, 1974). The individual effect of these compounds added in isolation 
ranged from a decrease to 75% for serine to 58% for guanine. Further studies with 
a met K mutant of S. typhimurium also implicated SAM in the regulation of SHMT 
(Stauffer et ah, 1977). In yeast however, methionine was shown to have no effect 
on SHMT, instead it has been suggested that glycine plays an important role in 
regulating SHMT (Botsford & Parks, 1969).
A potentially interesting mode of controlling SHMT has been suggested by 
Stover and Schirch (1990) who have demonstrated that SHMT can catalyse the 
conversion of N5, NlO-methenylTHF to N5-formylTHF. Since N5-formylTHF is an
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inhibitor of SHMT (Stover & Schirch, 1991), it is possible that the enzyme can 
synthesise an effective inhibitor of it’s main reaction.
The recent isolation of the for gene coding for cytoplasmic SHMT in N. 
crassa (McClung et ah, 1992) has facilitated the use of molecular studies in 
examining SHMT regulation. The addition of glycine (lOmM) and formate (lOmM) 
to the growth medium of N. crassa resulted in a 2.8- and 2-fold increase in for 
mRNA respectively. The increased SHMT activity observed in N. crassa following 
administration of glycine (Burton & Metzenberg, 1975; Cossins et ah, 1975) reflects 
this increased mRNA level. Supplementation of growth medium with formate did not 
result in an increased activity of SHMT (Burton & Metzenberg, 1975; Cossins et ah , 
1975), although McClung and co-workers (1992) reported increased mRNA levels 
under the same conditions. The observed response in mRNA levels to alterations in 
growth medium was dependent on the presence of a functional cpc-1 gene, the 
product of which is the principle regulatory protein of the cross pathway control 
system. The discrepancy between increased for mRNA levels and decreased activity 
of SHMT in N. crassa grown in medium supplemented with formate implies that 
although there is a response at the RNA level to the nutritional status of the cell, 
there are other controlling factors. The cross pathway control system which operates 
in N. crassa, responds to starvation for any of several amino acids by inducing the 
genes of biosynthesis of all amino acids (Hinnesbusch, 1988). The addition of 
formate to the growth medium could, by altering the nutritional status of the cell, 
result in such a global induction of genes regulated by the cross pathway control 
system. The cpc-1 gene product is a DNA binding protein that acts as a 
transcriptional activator of amino acid biosynthetic genes in N. crassa (Paluh et ah, 
1988; Paluh & Yanofsky, 1991). The sequence recognised by the CPC-1 protein, 
TGACTCA (Ebbole et ah, 1991), is found within the first intron of the for gene. 
The response of the for gene to the nutritional status of the cell and it’s dependency 
on the presence of a functional CPC-1 protein suggests that the gene coding for 
cytoplasmic SHMT in N. crassa, is at least partially under the control of the cross 
pathway control system.
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1.5 ROLE OF SHMT IN METABOLISM
The synthesis of glycine and subsequent generation of N5, NlO-methyleneTHF, 
catalysed by SHMT is a branch point in the metabolism of "one-carbon" units. 
Catabolism of serine through this pathway is reported to be a major source of "one- 
carbon" units for the folate pool of the cell (Schirch, 1982). In addition the resulting 
glycine can also be degraded in the mitochondria to yield ammonia, CO2 and N5, 
NlO-methyleneTHF by the glycine-cleavage system (Kikuchi, 1973).
Both products of the SHMT catalysed reaction have an important role in 
nucleotide synthesis. The glycine produced directly provides the carbon atom at 
position 4 and 5 and the nitrogen atom at position 7 of the purine ring in a reaction 
catalysed by phosphoribosylglycinamide synthetase (GAR synthetase) (see figure 1.5). 
The involvement of N5, NlO-methyleneTHF in purine synthesis is more indirect, 
acting as a precursor for 10-formylTHF. The interconversion of N5, NlO- 
methyleneTHF and 10-formylTHF is central to the utilisation of "one-carbon" units, 
and is catalysed by a trifunctional enzyme complex in mammals, Cl-THFsynthase 
(see figure 1.6). This complex has the enzymatic activities of N5, NlO- 
methyleneTHF dehydrogenase and N5, NlO-methenylTHF cyclohydrolase which 
catalyse the interconversion of N5, NlO-methyleneTHF, N5, NlO-methenylTHF and 
10-formylTHF. The third enzyme activity is that of 10-formylTHF synthetase which 
incorporates metabolically produced formate into the one-carbon pool via THF. The 
10-formylTHF derived from N5, NlO-methyleneTHF donates the carbon at position 
2 and 8 at two different stages of purine synthesis (figure 1.7). The first step occurs 
early in the synthesis of purines following incorporation of glycine, and is the 
transformylation of GAR to formylGAR (FGAR). The second step, also a 
transformylation, provides the carbon at position 2 in a reaction catalysed by 
phosphoribosylaminoimadazolecarboxamide (AICAR) formyltransferase (EC 2.12.3).
N5, NlO-methyleneTHF has a more direct involvement in pyrimidine 
synthesis. In a reaction catalysed by thymidylate synthase, N5, NlO-methyleneTHF 
acts as both a methyl donor and a reductant for the méthylation of dUMP to dTMP, 
thus providing the carbon at position 5 (see figure 1.8). This is the sole pathway for
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de novo biosynthesis of dTMP. The resulting dihydrofolate is subsequently reduced 
to THF by the enzyme dihydrofolate reductase (DHFR).
Apart from the involvement of folate derivatives of N5, NlO-methyleneTHF 
in nucleotide synthesis, the 10-formylTHF also donates a formyl group to the 
methionine of formylmethionine tRNA (tRNA™^ .^ tRNA™  ^is used as the initiator 
codon for translation in bacteria and eucaryotic organelles. The initiation of 
translation in the cytoplasm of eucaryotes does not require formylation of initiator 
tRNA™^ . The enzyme responsible for formylation of tRNA™^  is methionyl-tRNA- 
formyltransferase (EC 2.1.2.9), and is found in all procaryotes and eucaryotic 
organelles, but not in eucaryotic cytoplasm (Caskey et <2/., 1967).
Serine functions as a precursor of glycine in the central nervous system 
(CNS). Here in addition to the significant role of glycine in the metabolism of 
proteins, nucleotides and "one-carbon" units, it also functions as a neurotransmitter. 
That glycine functions as an inhibitory neurotransmitter was first suggested by 
Aprison and Werman (1965) in the spinal cord of the cat. Subsequently numerous 
reports have substantiated this claim, studied the mechanism of this inhibition and 
more recently expanded the role of glycine in neurotransmission. An initial report 
by Johnson and Ascher (1987) of the ability of glycine to function as an excitatory 
neurotransmitter as well as an inhibitory one, by activation of the NMDA receptor, 
has been confirmed (Bowery, 1987). Although three potential precursors exist in the 
CNS for glycine synthesis, serine, threonine and glyoxylate, serine seems to be the 
major precursor in the reaction catalysed by SHMT. Shank and Aprison followed the 
fate of [3- '^^C]serine and found the labelling pattern of glycine to be consistent with 
this view (Shank & Aprison, 1970). Subsequent investigations into the regional 
distribution of SHMT activity and glycine content within the rat CNS revealed a good 
correlation, with activity highest in the spinal cord and medulla pons and decreasing 
in the cerebellum, midbrain and telencephalon (Daly & Aprison, 1974). This 
correlation between SHMT activity and glycine content has been confirmed and 
extended to include retinal tissue (Dasgupta & Narayanaswami, 1982). Unlike rat 
liver, where both mitochondrial and cytosolic isozymes of SHMT exist (Ogawa &
21
Fujioka, 1981) SHMT activity in rat CNS is almost exclusively mitochondrial, 
accounting for 96-99% of total activity (Daly & Aprison, 1974).
1.6 SHMT IN CANCER CELLS
The role of SHMT in providing precursors for nucleotide synthesis points to it as an 
important enzyme in proliferating cells. Channelling of serine towards nucleotide 
synthesis by SHMT would lead to an increased requirement for serine in rapidly 
growing cells. Cells grown in culture have been shown to require serine for growth 
(Eagle, 1959). Extensive studies on the enzyme activities of serine metabolism in 
different cells and tissues have suggested a selective channelling of serine towards 
nucleotide synthesis by SHMT in tissues undergoing rapid growth.
(i) SHMT in rapidlv proliferating cells
Initial studies on serine metabolism in rapidly growing cells were carried out on 
human blood peripheral lymphocytes. DNA synthesis was stimulated by the additiom 
of the mitogen, phytohaemagglutinin (PHA), and the activity of SHMT monitored. 
Thorndike and co-workers (1979) first reported an eight-fold increase in SHMT in 
PHA stimulated cells compared to control unstimulated cells. Eichler and co-workers 
(1981) confirmed this observed increase of SHMT activity in mitogen stimulated 
lymphocytes and demonstrated a parallel increase in the incorporation of [S- '^^C]serine 
into DNA. In the 72 hours following PHA stimulation of human lymphocytes, 55% 
of [3-^ "*C]serine was used in the synthesis of purine and pyrimidine nucleotides. 
Incorporation of glycine synthesised from [carboxyl- '^*C] serine into purines was 
estimated to be 40% (Rowe et al. , 1985). The increased levels of SHMT activity and 
increased incorporation of serine into nucleotides is consistent with the idea that 
SHMT plays a significant role in providing carbon for nucleotide synthesis in cells 
undergoing rapid proliferation. Examination of serine biosynthesis in PHA-stimulated 
human lymphocytes has expanded this concept, suggesting that there is a coordinate
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control on the pathways for serine synthesis and serine utilisation for nucleotide 
synthesis. Snell and Barnett (1988) reported an increase in serine synthesis from 
glucose that was accompanied by an increase in nucleotide synthesis from serine in 
PHA treated human lymphocytes.
(ii) Serine metabolism in rat liver during neonatal development 
One of the most significant roles of serine in cellular metabolism during foetal and 
postnatal development may be the provision of precursors for nucleotide synthesis via 
SHMT, to help satisfy the increased demand for DNA synthesis that occurs at this 
time. An increased incorporation of from [3-^ "‘C] serine into DNA was reported 
for human foetal liver compared to adult liver (Sturman et al. , 1975), thus implicating 
SHMT in the provision of an increased supply of nucleotides for DNA synthesis. 
More extensive studies have since been carried out on rat liver at various stages of 
development from foetus to adult. The proposed metabolic channelling of serine in 
PHA-stimulated lymphocytes holds true for rat liver at the foetal and perinatal periods 
of development. However, within the liver there is an added competition for serine, 
for gluconeogenesis or energy generation via the enzymes serine dehydratase and 
serine aminotransferase.
The three enzymes of serine biosynthesis have been assayed in rat liver during 
neonatal development. Phosphoserine aminotransferase was shown to peak in the 
perinatal period before declining to adult levels (Snell, 1980). Previous 
developmental studies had shown increased phosphoglycerate dehydrogenase and 
phosphoserine phosphatase activities in rat liver during this period (Johnson et al. , 
1964; Jamdar & Greengard, 1969). Thus the rapidly developing rat liver has an 
increased capacity to synthesise serine de novo from glucose.
The utilisation of serine in the developing liver is controlled by the enzymic 
activities present. Serine dehydratase has an activity in foetal liver only 1 % of the 
adult liver value and thus plays a negligible role until weaning when the activity 
increases to twice the adult level (Snell, 1980). Serine aminotransferase on the other
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hand is present in foetal liver at 30% of adult liver values and increases to twice this 
value during the suckling period when it plays a significant role in directing serine 
towards hepatic gluconeogenesis (Snell, 1980). The developmental pattern of SHMT 
suggests a significant role during the foetal-perinatal period, when activity peaks to 
a value approximately half the level found in adult liver (Snell, 1980). This peak in 
SHMT activity parallels the increased levels of the enzymes of serine synthesis and 
may indicate coupling of serine biosynthesis and nucleotide synthesis from serine 
during this period. An observed increase in DNA synthesis and thymidine 
incorporation into DNA in perinatal rat liver (Yeoh & Oliver, 1971, 1972) supports 
the involvement of SHMT in providing increased levels of precursors for nucleotide 
synthesis.
(iii) SHMT in cancer cells
The increased capacity of rapidly growing rat liver cells at particular stages in
development to synthesise serine and preferentially use the synthesised serine for 
nucleotide synthesis suggests an ability of proliferating cells to channel serine towards 
this function at times of increased DNA synthesis. This theory is supported by the 
increased SHMT activity and increased serine incorporation into DNA in mitogen 
stimulated human lymphocytes (Eichler et aZ., 1981; Thorndike et ah, 1979; Snell 
& Barnett, 1988). Tumourigenic tissues have a requirement for increased DNA 
synthesis to satisfy the high rate of cell divison. A metabolic reorientation of serine 
metabolism in cancer cells, to favour nucleotide synthesis as seen in foetal and 
perinatal rat liver, would identify SHMT as a potential target for enzyme directed 
anticancer therapy.
Studies carried out on tumour cells confirm that serine metabolism is altered
in tumours compared to normal tissue from same organ. In hepatomas the
preferential utilisation of serine for nucleotide precursor synthesis is brought about 
by deleting the enzyme activities that compete with SHMT for serine, whilst 
selectively retaining the activity of SHMT (Snell, 1988). In the range of hepatomas 
examined, serine aminotransferase and serine dehydratase activity were absent, while
24
levels of SHMT were between 20% and 90% the adult liver value (Snell, 1985). 
Coupled to the preferential use of serine in hepatomas, is an increased capacity for 
serine biosynthesis. The activity of the first enzyme of serine biosynthesis, 3- 
phosphoglycerate dehydrogenase, is increased in hepatomas (Davis et ah , 1970) to 
a level dependent on the rate of growth of tumour (Snell & Weber, 1986). The 
slowly growing tumour, hepatoma 20, has an eleven-fold increase in activity, whereas 
the faster growing tumour, hepatoma 3924A, has a seventyfive-fold increase in 
activity compared to normal liver values. The remaining two enzymes of the pathway 
are also increased in hepatomas (Snell, 1985; Knox et ah, 1969). Such a selective 
maintenance of the enzymes of serine synthesis and of SHMT in tumours with the 
cellular loss of alternative enzymes of serine utilisation would confer a growth 
advantage to tumour cells over non-neoplastic cells in the same tissue.
In tumours of non-hepatic origin, the reorientation of serine metabolism takes 
place by increasing the activity of SHMT above the levels found in normal tissues. 
SHMT activity was increased five-fold in a rat sarcoma compared to the level found 
in normal skeletal muscle (Snell et a l,  1988). A marked increase in 3- 
phosphoglycerate dehydrogenase (32-fold) in the sarcoma confirms the pattern 
previously shown for rat hepatomas (Snell & Weber, 1986) of an increased capacity 
for serine synthesis. The same pattern has been shown in human neoplasms. 3- 
phosphoglycerate dehydrogenase activity is ten-fold higher and SHMT five fold 
higher in human colon carcinomas compared to normal colon tissue (Snell et ah, 
1988). The apparent generality of this phenomenum suggests the importance of serine 
in the commitment of a cell to proliferation.
(iv) Potential of SHMT as an anticancer target
Confirmation that the reorientation of serine metabolism seen in rat hepatomas also 
exists in rat sarcomas and human colon carcinomas reinforces the generality of the 
hypothesis of preferential serine utilisation for nucleotide synthesis in cancer cells and 
has implications for new strategies in anticancer chemotherapy. The preferential use 
of serine for nucleotide synthesis directed by SHMT points to it as a potential target
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for enzyme directed chemotherapy. Furthermore the positive correlation of SHMT 
activity with tumour growth rate in both Friend leukaemia and Pliss rat 
lymphosarcoma supports this view (Bukin et a l,  1980).
SHMT is one of a trio of enzymes used in the pathway for thymidylate 
synthesis and it is noteworthy that each of the other two enzymes of this cycle, 
dihydrofolate reductase (DHFR) and thymidylate synthase (TS), have proved to be 
important targets for clinically used chemotherapeutic agents. Methotrexate (MTX) 
was synthesised as a structural analogue of folate (Seeger et al. , 1949) and has been 
in clinical use for the past 40 years. It is a potent inhibitor of DHFR (Werkheiser, 
1961). More recent studies on the mechanism of MTX action suggest that the 
primary site of inhibition is amidophosphoribosyl transferase (EC 2.4.2.14) (Sant et 
ah, 1992), which catalyses the first step of the pathway shown in figure 1.7. 
Thymidylate synthase, the other enzyme of the cycle, is the target of the drug, 5- 
fluorouracil. There is a need for further targets in this area due to the developing 
resistance of populations of human tumour cells to these and other clinically used 
drugs. An additional advantage that a drug targetted to SHMT would have, is that 
as well as blocking the synthesis of the pyrimidine thymidylate, it would also affect 
purine synthesis, since the glycine produced in the SHMT catalysed reaction is used 
for purine synthesis and 10-formylTHF derived from 5, 10-methyleneTHF is used as 
a "one-carbon" donor for two steps of purine synthesis (see figure 1.8).
Types of inhibitors that could be used to inhibit SHMT include antifolate 
analogues because of the enzymic requirement for a folate cofactor, and serine 
antimetabolites. A precedent for using amino acid antimetabolites for anticancer 
therapy is the development of acivicin, a glutamine analogue, which has been used 
in clinical trials (Weber, 1983; Weber et ah, 1984). The absolute requirement of 
SHMT for the co-enzyme PLP could also be exploited by using vitamin Bg 
antimetabolites. Two such antimetabolites, D-cycloserine and 4-vinylpyridoxal have 
previously been shown to be inhibitors of SHMT in vivo (Bukin et ah, 1979).
The use of amino acid antimetabolites as inhibitory agents has recieved
26
relatively little attention. Cyclohexylserine was shown to inhibit nucleotide synthesis 
in human leukaemic cells and it was suggested the inhibition was via action on SHMT 
(Pazmino et ah, 1973). The use of D-fluoroalanine as an inhibitor of SHMT was 
explored because of the unique ability of SHMT to catalyse transamination of the D- 
isomer of alanine. Although it was found to irreversibly inhibit SHMT, the affinity 
of D-fluoroalanine for SHMT was too low for the inhibitor to be used effectively in 
vivo (Wang et ah, 1981). However, the study has opened the possibility of 
developing analogues of D-amino acids as specific inhibitors.
The use of antifolates as inhibitors in chemotherapy has been exploited because 
of the involvement of folates in nucleotide synthesis. Baker’s antifol II NSC 127755, 
a triazine antifolate was specifically synthesised to inhibit DHFR (Corbett et ah, 
1982) and exhibited antitumour activity against transplantable colon adenocarcinomas 
and Dunning murine ovarian tumour (Corbett et ah, 1982). Administration of NSC 
127755 at lO'^M to a mouse myeloma cell line in culture resulted in a 56% inhibition 
of SHMT activity and a 61 % inhibition in the incorporation of [6-^H]dUTP into DNA 
(Snell & Riches, 1989). A naturally occurring inhibitor of SHMT has been isolated 
from Mungbean seedlings. Although it has yet to be fully characterised, the inhibitor 
is heat stable and resistant to both RNases and proteinases (Vijaya et ah, 1991).
The use of an inhibitor of SHMT clinically in isolation would be unlikely to 
obtain a full remission. The contribution of the salvage pathway to nucleotide 
synthesis must be taken into account. The enzymes of the salvage pathway are 
reported to be higher in breast cancer tissue than in normal surrounding tissue thus 
indicating that the pathway is active (Camici et ah, 1990). Moreover the inhibition 
of de novo synthesis of nucleotides by antitumour agents has been reported to lead to 
higher salvage activity (Natsumeda et ah, 1989) and thus for treatment to be effective 
both these pathways must be targetted.
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1.7 SHMT IN SCHIZOPHRENIA
The discovery of the duality of glycine in acting as an excitatory as well as an 
inhibitory neurotransmitter may have important implications in the development of 
antipsychotic drugs. There is virtually no active transport of glycine across the 
blood-brain barrier (Smith et al. , 1987) and the main source of glycine in the CNS 
is cleavage of serine by SHMT (Shank & Aprison, 1970). Thus SHMT has an 
important role in the provision of neurotransmitters and may be crucial to correct 
functioning of the CNS.
A decreased level of SHMT has been reported in tissue isolated from the brain 
of schizophrenic and psychotic patients compared to control subjects (Waziri et al. , 
1984; Waziri & Mott, 1986). Furthermore, treament of schizophrenics with glycine 
was reported to have beneficial effects (Waziri, 1988; Rosse et al., 1989). The 
administration of serine to patients recovering from a psychotic attack, appears to 
induce psychotic symptoms similar to those observed during the spontaneous 
psychosis of these patients (Pepplinkhuizen et al., 1980; Bruinvels & Pepplinkhuizen,
1985). The observed effects of these amino acids on patients further implicate SHMT 
in psychotic disorders. The involvement of SHMT in schizophrenics has been 
expanded by more detailed studies of the enzyme in schizophrenics. An abnormal 
activity of SHMT was detected in the temporal lobe of schizophrenic patients, where 
the enzyme had a significantly higher Km (1.6-fold) than in normal subjects. The 
Km of the enzyme was not significantly higher in the frontal lobe of controls, thus 
indicating a specific localised change (Waziri et al., 1990). Morphological 
examinations and magnetic resonance imaging has indicated localised structural 
differences to the temporal lobe of schizophrenics. Regions of the temporal lobe have 
diminished groups of neurons, particularly in the left hemisphere (Roberts, 1990). 
A similar localised loss of glutamate receptors has also been reported (Kerwin et al., 
1988) again predominantly in the left hemisphere.
Serum taken from patients suffering a psychotic attack was found to alter the 
amino acid metabolism of fibroblasts when added to the culture medium. The effect 
was a specific reduction in the levels of serine, methionine and taurine.
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Concommitant with this was an observed increase in SHMT and cystathionine-B- 
synthase (Fekkes et a l,  1991). Serum taken from healthy controls and from 
recovered patients had no effect, suggesting that the factor responsible was either 
absent or inactive.
The involvement of SHMT, if any, in schizophrenia may be in the provision 
of glycine to modulate the NMDA subtype receptor of glutamate. In support of this 
view are reports of abnormal glutamate and dopamine processes in the temporal lobe 
of schizophrenics (Deakin et al., 1989; Reynolds, 1983). Alternatively, it has been 
proposed that formaldehyde present could condense with biogenic amines forming 
psychotogenic compounds such as B-carboline and isoquinoline (Bruivels et al., 
1980). Increased levels of formaldehyde could result from dissociation of N5, NlO- 
methyleneTHF produced in the SHMT-catalysed reaction. Whether SHMT and 
glycine are directly involved in the pathophysiology of schizophrenia remains to be 
seen. However if they do prove to be directly involved this opens a new area for the 
development of antipsychotic drugs.
1.8 COMPARTMENTALISATION OF SHMT
Reduced folates such as THF cannot pass into the mitochondrial matrix, whereas folic 
acid and the slightly more reduced form DHF can readily be taken up by the 
mitochondria (Cybulski & Fisher, 1981). The amino acids, serine and glycine can 
also be transported into the mitochondria (Cybulski & Fisher, 1976). Because the 
reduced folates cannot be transported into the mitochondria, it has generally been 
believed that independent synthesis of activated "one-carbon" units occurs in each 
compartment. Inconsistent with this has been the isolation of a number of different 
mutants of both yeast and CHO cells that indicate an interdependence of the 
mitochondrial and cytoplasmic systems.
A glycine-requiring mutant of CHO cells, totally deficient in mitochondrial 
SHMT activity, but retaining full cytosolic activity has been isolated (Kao & Puck,
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1968). Revertants of the strain obtained by ethyl methane sulfonate treatment, were 
found to have restored mitochondrial activity to 50% of the level found in the wild 
type cell (Chasin et ah, 1974). Growth of the mutant in the presence or absence of 
serine had no effect on glycine levels, whereas in the presence of serine-supplemented 
medium the wild type had an increased level of glycine (Pfender & Pizer, 1980) 
further implicating mitochondrial SHMT in satisfying the requirement for glycine. 
Similarly a yeast mutant, tmp3, which lacks mitochondrial SHMT, DHFR and TS, 
yet retains the cytosolic activities of these enzymes, has a requirement for 
thymidylate, methionine, histidine and adenine (Zelikson & Luzzati, 1977).
The interdependence of cytosolic and mitochondrial "one-carbon" metabolism 
is further exemplified in a yeast mutant lacking cytosolic 10-formylTHF synthetase. 
This mutant is unable to synthesise 10-formylTHF from available formate, and is 
impaired in its ability to synthesise purines using serine as a source of "one-carbon 
units", even though the pathway of synthesis of 10-formylTHF from serine should be 
intact (McKenzie & Jones, 1977). Other mutants lacking the cytosolic enzymes, 5, 
10-methyleneTHF dehydrogenase and 5, 10-methenylTHF cyclohydrolase, and so 
unable to synthesise 10-formylTHF from serine, retain the ability to synthesise 
purines from serine (McKenzie & Jones, 1977). The isolation of these two mutants 
suggest the involvement of both cytosolic and mitochondrial pathways of one-carbon 
metabolism in the utilisation of serine for purine synthesis.
A model proposed for the generation of "one-carbon units" relies on 
significant participation of mitochondrial enzymes (Barlowe & Appling, 1988). The 
model proposes that serine enters the mitochondria where it is converted to glycine 
and N5, NlO-methyleneTHF by mitochondrial SHMT (see figure 1.9). The N5, 
NlO-methyleneTHF can be converted to 10-formylTHF and finally to formate by the 
mitochondrial complex, C l-THF synthase. Formate synthesised in this way, exits the 
mitochondria to the cytoplasm where it is reactivated into the one-carbon pool by 
cytosolic 10-formylTHF synthetase. In support of this hypothesis, the presence of the 
enzymes necessary for these pathways has been demonstrated in their respective 
compartments, and it has been shown that intact mitochondria can generate formate
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Cytoplasm
folate
THF
SHMT < serineglycine
SjlOmethyleneTHF
CITHF synthase
5,10methenylTHF
CITHF synthase
10-formylTHF
CITHF synthase
formate
r
Mitochondria
folate
THF
serine
glycine > SHMT
5,10methylene THF
CITHFsynthase
5,10 methenyl THF
CITHF synthase
10-formylTHF
CITHF synthase
formate
Figure 1.9: Proposed model for intercompartmental folate metabolism
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from serine and that formate exits the mitochondria to the cytoplasm (Barlowe & 
Appling, 1988).
The subsequent isolation of a yeast mutant with a deletion at the MIS 1 locus, 
which encodes mitochondrial Cl-THF synthase, that continues to grow normally in 
the absence of purines and can therefore presumably synthesise purines itself, argues 
against the absolute requirement of the mitochondrial pathways as suggested by 
Barlowe and Appling (1988) (Shannon & Rabinowitz, 1988). Similarly, yeast 
harboring a point mutation in the ADE 3 gene, that inactivates the 10-formylTHF 
synthetase activity of cytoplasmic Cl-THF synthase, can grow without requiring an 
external supply of purines (Barlowe & Appling, 1990), unlike the adeS mutation 
described by McKenzie and Jones (1977), which was a deletion mutation. The 
isolation of these two mutants suggest a pathway for the synthesis of activated "one- 
carbon units" that is independent of a mitochondrial involvement.
The model proposed by Barlowe and Appling (1988) places emphasis on the 
mitochondrial isozyme of SHMT. It fails to suggest a metabolic role for cytosolic 
SHMT in the synthesis of activated "one carbon units". However, the isolation of 
a /o r mutant of N. crassa (Harrold & Fling, 1952) that requires formate for growth 
contradicts the proposed model. This mutant lacks cytosolic SHMT, yet retains 
activity of the mitochondrial isozyme (Cossins et ah, 1976; Cossins & Pang, 1980), 
thus suggesting that the activated "one-carbon units" in N. crassa at least, are 
synthesised through the cytosolic pathway. The growth limitation can be alleviated 
by supplying formate because the 10-formylTHF synthetase assimilates formate into 
the one-carbon pool by conversion to 10-formylTHF.
1.9 AIMS OF THESIS
The biochemical evidence presented, implicates serine hydroxymethyltransferase as 
being a potentially important target for anticancer therapy. Evidence is now also 
mounting that suggests the enzyme is important in certain psychological disorders.
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To complement the biochemical studies that have been carried out on SHMT and 
further explore the role of the enzyme in cancers and its potential as a target for 
anticancer therapy, it is important to isolate the cDNA coding for mammalian SHMT 
and to study the molecular basis of the regulation of the enzyme. To date no work, 
other than the work presented in this thesis has been published citing studies on 
mammalian SHMT at the genetic level. The aim of this thesis was therefore to 
isolate mammalian SHMT coding sequences and express recombinant SHMT in 
animal cells growing in culture. To do this the known protein sequence of the rabbit 
cytosolic SHMT (Martini et al. , 1987) was taken as a starting point from which to 
develop a probe that would isolate coding sequences for rabbit SHMT. Attempts 
were made to optimise expression of the isolated SHMT cDNA in COS-1 cells. 
Finally the cloned rabbit SHMT cDNA was used as a probe to isolate human SHMT 
cDNA from a cDNA library made using RNA from a breast cancer cell line.
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CHAPTER 2
MATERIALS AND METHODS
2.1. MAMMALIAN CELL LINES I
2.1.1 COS-1
African Green Monkey kidney CV-1 cells transformed with SV40 DNA containing 
a 6bp deletion in the origin of replication (ORI) which prevents replication of the 
viral DNA (Gluzman, 1981). Obtained from Celltech Ltd. (Slough, UK).
2.1.2 MOLT-4
A suspension culture derived from the peripheral blood of a male with acute 
lymphoblastic leukaemia (Minowada et ah, 1972). Obtained from M. Bolton 
(University of Surrey).
2.1.3 HeLa
A culture derived from human cervix carcinoma (Scherer et ah , 1953). Obtained 
from D. Simpson (University of Surrey).
2.1.4 ZR-75-1
A culture derived from a human breast carcinoma in a Caucasian female (Engel & 
Young, 1978; Engel et ah, 1978). Obtained from D. Reynolds (University of 
Surrey).
2.2. BACTERIAL CELL STRAINS
2.2.1 ESCHERICHIA COLI strain JM109: recA', endAl, gyrA96, thi, hsdR17, 
supE44, relAl, lambda , A(lac proAB)[F, troD36, proAB, lacP, AM75] (Yanisch- 
Perron et ah. 1985). Obtained from Pharmacia Ltd. (Uppsala, Sweden).
2.2.2 ESCHERICHIA COLI strain DHSa ™: recA', F , endAI, gyrA96, thi-1, 
hsdR17(r^m^^), supE44, relAl. Obtained from BRL Inc. (Paisley, Scotland).
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2.2.3 ESCHERICHIA COLI strain C600 hfl: hflA 150 [chr::TnlO] (Huynh et ah , 
1985; Young & Davis, 1983). Obtained from Clontech (Cambridge Bioscience).
2.2.4 ESCHERICHIA COLI strain JMÜO: ipsL (stf), thr, leu, thi-1, lacY, galK, 
galT, ara, tonA, tsx, dam, dan, supE44, A(lac, proAB), [F’ traD36, proAB, 
lacPAMlS], Obtained from Stratagene (Cambridge, Yanisch-Peron et ah, 1985).
2.2.5 ESCHERICHIA COLI strain XLl-Blue: A(mcrA)182, A(mcrCB-hsdSMR- 
mrr)172, endAl, supE44, thi-1, recA, gyrA96, relAl, lac, lambda', proAB, lacP, 
ZAM15, TniO(tetO]. Obtained from Stratagene (Cambridge).
2.3 VECTORS 
Plasmids
2.3.1 pUC13 (Yanisch-Perron et ah , 1985)
2.3.2 pUClS (Yanisch-Perron et ah, 1985)
2.3.3 pCR™n Obtained from Invitrogen
2.3.4 pUSlOOO (Jackson et ah , 1992)
Plasmid pUSlOOO is derived from a vector, pEEbgpt, obtained from Celltech Ltd. 
(Slough, UK). It contains an SV40 origin of replication supplied by the SV40 early 
promoter region driving transcription of xanthine-guanine phosphoribosyl transferase 
gene (gpt) from pSV2gpt (Whittle et ah , 1987). The plasmid was modified to contain 
the strong promoter/enhancer transcriptional control element from the human 
cytomegalovirus (HCMV) on a 600bp fragment with Hindlll linkers inserted into the 
unique Hindlll site upstream of the EcoRI site of pEE6gpt (T. Jones & P.O. Sanders, 
pers. commun.).
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Bacteriophage
2.3.4 M13mpl8 (Yanisch-Perron et a l , 1985)
2.3.5 M13mpl9 (Yanisch-Perron et a l , 1985)
2.3.6 lambda-gtlO (Hyunh et ah , 1985)
2.4 MEDIA 
Cell culture media.
All tissue culture reagents were obtained from Gibco BRL (Paisley, Scotland).
2.4.1 DMEM
Dulbecco’s modified Eagle’s basal medium (DMEM) supplemented with 2mM 
glutamine, 0.15% sodium bicarbonate and 10% (v/v) heat inactivated foetal calf 
serum (PCS).
2.4.2 RPMI1640
RPMI1640 supplemented with 2mM glutamine, 0.15% sodium bicarbonate and 10% 
(v/v) PCS.
2.4.3 met MEM
Modified essential medium (MEM) supplemented with 2mM glutamine and 0.22% 
sodium bicarbonate but without methionine (Eagle, 1959).
Microbial growth media.
Media and solutions were sterilised by autoclaving at 121®C (15 p.s.i) for 15 minutes 
or by filtration through a 0.2jum PlowPore D filter.
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2.4.4 Luria-Bertani (LB) medium (broth)
Bacto tryptone lOg
Bacto yeast extract 5g
NaCl 5g
Made up to 1000ml with water and to pH 7.5 with 5M NaOH.
Autoclaved.
2.4.5 Luria-Bertani medium (agar)
Made as for broth with the addition of 15g/L Bactoagar. 
Autoclaved.
2.4.6 50x salts
MgS04.7H20 lOg
Citric acid lOOg
K2HPO4 500g
NaNH4(HPO4).4H20 175g
Made up to 1000ml with water and autoclaved.
2.4.7 Minimal medium
Bacto agar 7.5g
Glucose l.Og
Made up to 500ml with water and autoclaved. 50x salts (10ml)
were added after autoclaving.
2.4.8 2x TY medium (broth)
Bacto tryptone 16g
Bacto yeast extract lOg
NaCl 5g
Made up to 1000ml with water and autoclaved.
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2.4.9 2x TY medium (agar)
As for 2x TY broth with the addition of 15g/L Bactoagar.
2.4.10 H-Top agar
Bacto tryptone lOg
NaCl 18g
Agar 8g
Made up to 1000ml with water and autoclaved.
2.4.11 Top agarose
Bacto tryptone l.Og
Bacto yeast extract 0.5g
NaCl 0.5g
MgSO .^VH^O 25g
Agarose l.Og
Made up to 100ml with water and autoclaved.
2.4.12 SOC
Bacto tryptone 2g
Bacto yeast extract 0.5g
NaCl 1ml (IM)
KCl 0.25ml (IM)
MgCl2 1ml (2M)
MgS04 1ml (2M)
Glucose 1ml (2M)
SOC was prepared in the absence of the magnesium salts and 
glucose, to a volume 100ml pH 7.0. After autoclaving, filter 
sterilized magnesium salts and glucose were added prior to use.
2.4.13 Antibiotics
Ampicillin stock solution (lOOmg/ml) was made and added to LB or LB agar to a 
final concentration of lOOjUg/ml.
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2.5 BUFFERS AND SOLUTIONS
2.5.1 Solutions used for RNA Extractions
(i) Lysis buffer
Tris-HCl pH 7.5 0.2M
NaCl 0.14M
MgClz 2.0mM
Nonidet P40, (NP40) 0.5% (v/v)
Lysis buffer was prepared as a sterile solution by autoclaving in the absence of NP-40 
and stored at -20°C. NP-40 was added prior to use.
(ii) TSE.
Tris-HCl pH 8.5 lOmM
EDTA 5mM
SDS 0.5% (w/v)
2.5.2 Solutions used for DNA extractions
2.5.2.1 Solutions for Plasmid Extraction from Bacteria
Alkaline lysis extraction
(i) Solution I.
Glucose 50mM
EDTA pH 8.0 lOmM
Tris-HCl pH 8.0 25mM
(ii) Solution II.
NaOH 0.2M
SDS 1.0% (w/v)
(iii) Solution III.
Potassium acetate (3M potassium 5M acetate)
Prepared as follows:
60ml 5M potassium acetate
11.5ml glacial acetic acid 
28.5ml water
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Caesium chloride extraction 
(vi) Sucrose solution.
Sucrose 25 % (w/v)
Tris-HCl pH 8.0 0.05M
(v) Brij-Doc solution.
Brij 58 1% (w/v)
Sodium deoxycholate 0.4% (w/v)
Made in Ix TE pH 8.0
(vi) Isopropanol saturated with Caesium chloride (CsCl)
CsCl (10g) was dissolved in STE (10ml). Isopropanol (100ml) 
was added and the mixture allowed to settle overnight.
2.S.2.2 Solutions used for the extraction of phage DNA
(i) lambda diluent
NaCl 5.8g
MgSO .^VH^O 2.0g
IM Tris.HCl pH 7.5 50ml
2% gelatin (w/v) 5.0ml
Made up to 1000ml with water and autoclaved.
(ii) SM
NaCl 5.8g
MgS04.7H20 2.0g
IM Tris.HCl pH7.5 5.0ml
2% (w/v) gelatin 5.0ml
Made up to 1000ml with water and autoclaved.
(iii) PEG/Salt/lambda diluent
20% Polyethylene glycol (PEG6000)
2.0M NaCl in lambda diluent
(iv) Buffered phenol
Phenol (BRL) was melted at 55-68°C before being equilibrated 
with IM Tris-HCl buffer pH 8.0 (1:1). 8-Hydroxyquiniline was 
then added to a final concentration of 0.1%.
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2.5.2.3 Solution for the extraction of genomic DNA
(i) lysis buffer
SDS (1%) in EDTA (50mM)
2.5.2.4 Solutions used for phenol/chlorofoim extraction
(i) Phenol/chloroform
Phenol/chloroform was prepared as a 1 : l(v:v) mixture, saturated 
with IM Tris.HCl (pH 8.0) and stored in the presence of the 
antioxidant 8-hydroxyquiniline (0.1% w/v).
2.5.3 Solutions used for electrophoresis
2.5.3.1 Solutions for DNA agarose-gel electrophoresis.
(i) Ix TAB (Tris-acetate)
Tris-acetate 40mM
EDTA ImM
pH to 8.0 with glacial acetic acid.
(ii) DNA loading buffer, (6x).
Bromophenol blue 0.25% (w/v)
Xylene cyanol 0.25% (w/v)
Sucrose 40% (w/v)
Made up in water
2.5.3.2 Solutions used for RNA agarose gel electrophoresis
(i) lOx Gel-running buffer
MOPS 0.5M
EDTA O.OIM
(ii) buffer A
Gel running buffer 0.3x
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(iii) dyes
Buffer A 0.3x
xylene cyanol 0.015%
bromocresol green 0.015%
sucrose 0.8%
Made up in water
(iv) RNA loading buffer
formamide 35 %
dyes 50%
Made in formaldehyde (1.75M)
(v) formaldehyde/formamide
formamide 73%
Made in formaldehyde (3.2M)
2,5.3.3 Solutions for Acrylamide-gel Electrophoresis
(i) Ix TBE (Tris-borate)
Tris-borate 89mM
Boric acid 89mM
EDTA 2mM
(ii) lOx tank buffer
Tris 0.5M
Glycine 0.55M
SDS 1.0% (w/v)
(iii) 4x resolving buffer
Tris-HCl pH 8.8 1.5M
SDS 0.4% (w/v)
(iv) 4x stacking buffer
Tris-HCl pH 6.8 0.5M
SDS 0.4% (w/v)
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(v) 3x SDS-PAGE loading dyes 
SDS
Glycerol
2-mercaptoethanol 
Bromophenol blue 
Made in stacking buffer (1.2x)
(vi) fix
methanol 
acetic acid 
water
6% (w/v)
30% (v/v) 
15% (v/v) 
0.001% (w/v)
30%
10%
60%
2.5.4 Solutions used for hybridisations
(i) Denaturing solution
NaCl 1.5M
NaOH 0.5M
(ii) Neutralising solution
NaCl 1.5M
Tris.HCl pH 7.0 l.OM
(iii) 20x SSC
NaCl 3.0M
Tri-sodium citrate 0.3M
final pH 7.0
(iv) Phosphate buffer (0.2M) pH 6.5
Na^HPO  ^ (0.2M) 18.75ml
NaHzPO^ (0.2M) 31.25ml
Made up to 50ml with water
(v) 50x Denhardt’s solution
Ficoll 5g
Polyvinylpyrrolidone 5g
BSA 5g
Made up to 500ml with water
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(vi) DNA Prehybridisation/hybridisation solution
SSC 6x
SDS 0.1% (w/v)
Denhardt’s solution 5x
EDTA 5mM
Phosphate buffer (pH 6.5) 25mM
Denatured Herring testis DNA 20^g/ml
(vii) RNA prehybridisation/hybridisation solution
Deionised formamide 50% (v/v)
SSC 5x
Denhardt’s solution 5x
Phosphate buffer (pH 6.5) 25mM
Denatured Herring testis DNA 20/ug/ml
2.5.6 Enzyme Buffers
(i) lOx Kinase buffer
Tris-HCl (pH 7.6)
MgCl2
DTT
Spermidine
EDTA
0.5M
O.IM
50mM
50mM
ImM
(ii) lOx Calf intestinal alkaline phosphatase buffer 
React 3 (BRL)
Tris.HCl (pH 8.0) 50mM
MgClg lOmM
NaCl ImM
(iii) Restriction buffers were obtained from the manufacturers with the
enzymes.
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(iv) lOx Nick translation buffer.
Tris-HCl pH 7.2
M g S 0 4
DTT
BSA
500mM
lOOmM
ImM
500jng/ml
2.5.7 Solutions for COS-1 Cell Transfections
(i) Transfection cocktail
DNA Ifxg
DEAE dextran (lOmg/ml PBS) 20jul
PBS 380jul
(ii) Transfection media
DMEM supplemented with DMSG (10% v/v) or chloroquine 
(80juM, filter sterilized)
(iii) RIPA lysis buffer
NaCl 150mM
NP 40 1%
DOC 0.5%
SDS 0.1%
Tris pH 8.0 50mM
2.5.8 Solutions used for the assay of SHMT activity
(i) Tetrahydrofolate
lOmM THE was made up in 60mM 2-mercaptoethanol under 
Ng. The THF was stored at -20®C in the dark and used within 
2-3 weeks.
(ii) Radiolabelled serine mix
L-[3-''*C] serine (50/Æi/ml) 100^1
serine (1.4mM) 900/nl
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2.5.9 General Buffers and Solutions
(i) TE Buffer
Tris-HCl pH8.0 
EDTA pH 8.0
(ii) STE
NaCl
Tris
EDTA pH 7.5
lOmM
ImM
lOOmM
lOmM
ImM
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2.6 RNA EXTRACTIONS
Precautions were taken to prevent ribonuclease degradation of RNA by soaking all 
plasticware overnight in 0.1% DEPC and rinsing with sterile DEPC treated water. 
In the RNAzol™ methods, the RNAzol™ contains guanidinium thiocyanate which is 
an inhibitor of RNases. The vanadyl ribonuclease complex used in the extraction of 
cytoplasmic RNA is also a potent RNase inhibitor.
2.6.1 Extraction of RNA from rabbit liver tissue using RNAzol^
Total RNA was extracted from rabbit liver tissue using RNAzol™ (Biogenesis Ltd., 
Bournemouth), which is a modification of the method of Chomzynski and Sacchi 
(1987). Tissue samples (approx. Ig) were cut immediately from the liver of a freshly 
killed rabbit into liquid nitrogen. The sample (Ig) was transferred to a glass-Teflon 
homogeniser, homogenised with RNAzoF^ (20ml) and then transferred to a 50ml 
oakridge tube. Chloroform (2ml) was added and the samples were shaken vigorously 
before placing on ice for 15 minutes. After centrifugation at 12000g for 15 minutes 
(4°C); the aqueous phase was removed to a fresh tube and an equal volume of 
isopropanol was added. The RNA was precipitated by incubating at -20°C for 45 
minutes and centrifuging at 12000g (4°C) for 15 minutes. The supernatant was 
removed and the RNA pellet was washed twice by vortexing with 75 % ethanol and 
centrifuging at 12000g (4°C) for 8 minutes to pellet the RNA. The pellet was dried 
under vacuum for 5 minutes, resuspended in HgO (1ml) and stored at -70®C.
2.6.2 Extraction of RNA from COS-1 cells using RNAzolB™
Transfected COS-1 cells were lysed directly in the tissue culture flask by the addition 
of RNAzolB™ (2ml). The RNA was solubilised by passing the lysate a few times 
through the pipette before transferring to an eppendorf tube. Chloroform (0.2ml) was 
added, the mixture was shaken and incubated on ice for 5 minutes before 
centrifugation at 12000g for 15 minutes (4°C). The aqueous layer was transferred to 
a fresh tube and the RNA precipitated by the addition of an equal volume of 
isopropanol (4°C, 15 minutes) before centrifuging at 12000g for 15 minutes (4°C). 
The RNA pellet was washed with 75% ethanol, dried and resuspended in 20/Ltl H2O.
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2.6.3 Extraction of cytoplasmic RNA from MOLT-4 cells in culture
RNA was extracted from cells using a method based on that of Favaloro et al. (1980). 
Cells (2x10^) were pelleted by centrifugation at 80g (4®C) for 5 minutes, washed with 
cold PBS and recentrifuged at 80g for 5 minutes (4®C). The cells were lysed by 
adding vanadyl ribonucleoside complex (VRC, 0.5ml) directly onto the cells and 
resuspending the pellet in lysis buffer (Section 2.5.1, 4.5ml). The lysate was 
centrifuged at 1630g for 3 minutes to sediment the nuclei. The supernatant which 
contains the cytoplasm was transferred to a 50ml oakridge tube containing TSE 
(Section 2.5.1, 5ml), H2O (10ml) and phenol/chloroform (1:1 v/v, 15ml), and mixed 
for 50 minutes on a rotating wheel at room temperature before centrifuging at 1630g 
for 10 minutes. The aqueous layer was removed to a fresh tube and an equal volume 
of phenol/chloroform was added. The sample was mixed for 10 minutes on the 
rotating wheel and centrifuged as before. The aqueous layer was then transferred to 
a fresh tube and the RNA was precipitated by adding 2 volumes of cold ethanol, 
incubating overnight at -20®C, and centrifuging at 12000g (4°C) for 15 minutes. The 
pellet was washed with 70% ethanol and dried under vacuum. The RNA was 
resuspended in 100pi H2O and stored at -70°C.
2.7 DNA EXTRACTIONS
2.7.1 Extraction and Purification of Plasmid DNA
(i) Alkaline Lysis Method.
Small scale preparations of plasmid DNA were prepared using a method based on that 
of Bimboim and Doly (1979). Overnight cultures (1.5ml) of bacteria, grown in LB 
broth containing ampicillin (100/Ltg/ml) were centrifuged and the cell pellets were 
resuspended in 150 pi of ice-cold solution I (Section 2.5.2.1) and incubated at room 
temperature for 5 minutes. Solution II (freshly made. Section 2.5.2.1, 300jitl) was 
added, mixed by inversion and incubated for 5 minutes on ice. Solution III (225/itl, 
ice-cold. Section 2.5.2.1) was then added and mixed by vortexing, before incubating 
on ice for a further 5 minutes. The chromosomal DNA and proteins were then 
pelleted by centrifugation (lOOOOg, 5-10 minutes) leaving the plasmid DNA in the 
supernatant. The supernatant was transferred to a fresh tube and extracted with
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phenol/chloroform (section 2.7.5). The aqueous phase was then transferred to a 
fresh tube and plasmid DNA was precipitated by adding two volumes of ethanol 
(room temperature) and incubating at room temperature (5 minutes) before 
centrifuging at lOOOOg for 5 minutes. The DNA was washed with 70% ethanol, dried 
under vacuum and resuspended in HgO (20)^ 1).
(ii) Cleared Lysate Method
An exponentially growing bacterial culture (1.5ml) was innoculated into 150ml of 
prewarmed (37°C) LB broth containing ampicillin (lOO/xg/ml). This culture was 
grown overnight at 37°C and the cells were harvested by centrifugation (6000g, 10 
minutes, 4°C) and resuspended in ice-cold sucrose solution (section 2.5.2.1, 2.6ml). 
Lysozyme (0.5ml 20mg/ml in 0.25M EDTA pH 8.0) was added and the cells were 
placed on ice for 10 minutes. Ice-cold EDTA (0.25MpH 8.0, 2.6ml) was added, the 
solutions mixed and returned to ice for a further 5 minutes before adding Brij-Doc 
solution (Section 2.5.2.1, 4ml). Cells were lysed by pipetting up and down 2-4 times 
and then returned to ice for 30 minutes. Cell debris and most of the chromosomal 
DNA were removed by centrifugation (15000g, 4°C, 45 minutes). The supernatant 
(7ml) was removed and added to CsCl (6.65g) and ethidium bromide (210jul, 1.5% 
w/v) and mixed gently until the CsCl had dissolved. The lysate was transferred to 
a Beckman Quick Seal polyallomer ultracentrifugation tube and centrifuged at 
45000rpm (18°C) for 24 hours in a Beckman L8 ultracentrifuge. The plasmid band 
was visualized under u.v, light (300nm) and recovered by puncturing the tube with 
a 19G disposable needle and drawing the band into a 1ml syringe. Ethidium bromide 
was removed from the solution by several extractions with isopropanol saturated with 
caesium chloride (Section 2.5.2.1). Plasmid DNA was precipitated using an equal 
volume of isopropanol and one tenth volume 3M sodium acetate. The precipitated 
DNA was recovered by centrifugation (lOOOOg, 15 minutes, 4°C) and resuspended in 
200/xl of sterile water.
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2.7.2 Extraction and purification of phage DNA
(i) Extraction of M13 double stranded DNA
A growing culture from phage stock was prepared as described in section 2.7.2(ii). 
The culture was then grown overnight, instead of the 6 hour growth for extraction of 
single stranded DNA. Double stranded DNA was extracted using the method 
described in section 2.7. l(i) for the extraction of plasmid DNA.
(ii) Extraction of M13 single stranded DNA
An overnight culture OÎJM109 grown in 2xTY broth was innoculated into fresh 2xTY 
broth (1:100). This diluted culture was dispensed into 1.5 ml aliquots and each was 
innoculated with 50pl of phage stock and grown for 6 hours at 37°C shaking. The 
cells were removed by centrifuging at lOOOOg for 2-3 minutes. The phage were 
precipitated by mixing the supernatant (1.5ml) with 20% PEG6000, 2.5M NaCl in 
lambda diluent (200fd), and incubating at room temperature for 15 minutes. The 
phage were then pelleted by centrifuging at lOOOOg for 10 minutes (4°C). TE (100^1, 
pH 8.0) and phenol saturated with TE (50^1) were added and the solution was 
vortexed for 15 seconds and left at room temperature for 15 minutes. The aqueous 
layer was removed after centrifugation (lOOOOg, 3 minutes) and ethanol precipitated 
(Section 2.7.6). Following centrifugation (15000g, 15 minutes, 4°C), the pellet was 
washed with 70% ethanol, resuspended in 30^1 HjO and stored at -20°C.
(iii) Purification of Lambda-gtlO DNA.
Purified lambda phage stocks were plated to give confluent lysis (Section 2.10). The 
plates were then shaken for 2 hours at room temperature with 5 ml lambda diluent 
(Section 2.5.2.2) and 2 drops chloroform. The lambda diluent containing the phage 
was harvested and spun for 10 minutes at 9000rpm (4°C) to pellet debris. The 
supernatant was removed to a fresh tube and RNase (final concentration ipg/m\) and 
DNase (final concentration 2U/ml) treated at 37°C for 30 minutes before adding an 
equal volume of 20% PEG6000, 2M NaCl in lambda diluent, and incubating on ice 
for 1 hour. The phage were recovered by centrifuging at lOOOOrpm for 20 minutes 
(4°C). The phage pellet was resuspended in lambda diluent (0.5ml). After the
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addition of SDS (5pl, 10%) and EDTA (5jul, 0,5M pH 8.0) the solution was 
incubated at 68“C for 15 minutes before phenol/chloroform extracting the aqueous 
layer twice. The DNA was precipitated with two volumes of ethanol, resuspended 
in lOOpl TE and reprecipitated with ammonium acetate as described (Section 2.7.6). 
The DNA was washed, resuspended in 50^1 TE and stored at -4®C.
2.7.3 Extraction and Purification of Genomic DNA from Mammalian Cells.
Genomic DNA was extracted from the nuclei of mammalian cells from which RNA 
had been previously extracted (Section 2.6.3). The pellet containing the nuclei was 
retained after centrifugation of the lysed cells. The nuclei were then lysed by adding 
10ml lysis buffer (Section 2.5.2.3) and pipetting up and down a 10ml plastic pipette 
5 times. Samples were incubated at 37°C for 1 hour with DNase free RNase 
(50/fg/ml, BRL Ltd.), and then at 55°C for 4 hours with Proteinase K (50jng/ml, 
Sigma Ltd.). A phenol/chloroform extraction was performed by gently inverting on 
a rotating wheel for 1 to 2 hours. After centrifuging (1630g, 15 minutes) the aqueous 
layer was removed and a second phenol/chloroform extraction was performed before 
extracting once with chloroform. The DNA was precipitated by incubating with two 
volumes of ice-cold ethanol.
2.7.4 Extraction of DNA from agarose gels
DNA was electrophoresed through agarose gels as described in section 2.8. l(i). The 
fragment(s) of interest were recovered from agarose gels by a particular method 
depending on the size of DNA to be purified. Fragments of DNA that were less than 
500bp in size were purified using NA 45 paper (Schleicher and Schuell, Anderman, 
Kingston-upon-Thames) or GlassMAX™ (BRL, Paisley), whereas fragments of DNA 
larger than this were purified using Geneclean™ (Stratatech Scientific, Luton).
(i) Geneclean™ method
This method uses a silica matrix to bind the DNA and is based on the method of 
Vogelstein and Gillespie (1979). The DNA to be purified was electrophoresed 
through a TAE agarose gel as previously described and a gel slice containing the 
required DNA fragment was excised from the gel and weighed. Sodium iodide (2-3
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volumes) was added to the agarose and the mixture was incubated at 55®C until the 
agarose gel slice had melted. "Glassmilk" suspension was then added to the DNA 
solution (5jitl per 5pg DNA), mixed thoroughly and incubated on ice for 5 minutes 
to allow binding of the DNA to the silica matrix. The silica matrix was pelleted by 
centrifugation (lOOOOg, 5 seconds) and the sodium iodide supernatant discarded. The 
pellet was washed by resuspension in 400pl ice cold "NEW" buffer and the silica 
matrix sedimented by centrifugation (lOOOOg, 5 seconds). The supernatant was 
discarded and the washing procedure repeated twice more before resuspending the 
pellet in 5-lOpl of TE buffer. The suspension was incubated at 55°C for 3-4 minutes 
and pelleted by centrifugation (lOOOOg, lOseconds). The supernatant containing the 
DNA was recovered. The recovered DNA was stored at -20°C.
(ii) NA 45 paper method
Following staining of the gel with ethidium bromide in IxTAE buffer, the fragments 
of interest were visualised under u.v light and incisions were made in front of and 
behind the DNA band. Strips of NA 45 paper were inserted into the incisions and 
electrophoresis was continued until the DNA adsorbed on to the paper. The DNA 
was then eluted by incubating the paper at 70°C for 2 hours in an arginine/salt 
solution (50mM arginine, IM NaCl; 400jul). The ethidium bromide was removed by 
mixing with an equal volume of isoamyl alcohol saturated with water and allowing 
the phases to settle. The upper alcohol phase was discarded and the extraction 
repeated until all traces of ethidium bromide were gone. The DNA was recovered 
from the lower aqueous phase by ethanol precipitation.
(iii) GlassMAX™
This method of isolating DNA, like Geneclean™, is based on the method of 
Vogelstein and Gillespie (1979). The system operates on the same principle as 
Geneclean^^, that in the presence of Nal, DNA will bind to silica. The silica is 
present as a membrane in a column through which bound DNA is passed. The DNA 
sample was electrophoresed through a TAE agarose gel and the required band was 
excised and weighed. Nal (0.45ml/0.1 g agarose) was added and the gel melted at 
55°C. The DNA/Nal solution was then passed through the silica column by
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centrifuging at 13000g for 20 seconds. The column was washed with 400/tl of "wash 
solution" by centrifuging for 20 seconds at 13000g. This procedure was repeated 
three times before eluting the DNA by adding 40pl of TE (65-70°C) and centrifuging 
at 13000g for 20 seconds.
2.7.5 Extraction of solutions of nucleic acid with phenol/chloroform
Phenol/chloroform extractions were performed by adding an equal volume of 
phenol/chloroform (section 2.5.2.4) to the aqueous DNA solution and vortexing for 
5-10 seconds to mix. The aqueous and organic phases were separated by 
centrifugation (lOOOOg, 3 minutes) and the aqueous phase transferred to a fresh tube. 
The extraction procedure was repeated until the interface between the phases became 
clear. A final extraction was performed using an equal volume of chloroform. The 
nucleic acid was then ethanol precipitated (Section 2.7.6).
2.7.6 Ethanol Precipitation of Nucleic Acid.
DNA was precipitated using one of two methods.
Method A: Addition of 0.1 volume of 3M sodium acetate pH 5.2 followed by 2-3 
volumes of ethanol.
Method B: Addition of 0.5 volume of 7.5M ammonium acetate followed by the 
addition of 2.5-3.0 volumes of ethanol.
After the addition of ethanol the solutions were mixed and incubated at -20^C for 1 
hour, -70°C for 30 minutes or on a dry ice/ethanol bath for 10 minutes. Precipitated 
DNA was collected by centrifugation (lOOOOg, 5-30 minutes). The DNA pellet was 
washed in 70% (v/v) ethanol and dried under vacuum prior to resuspending in TE or 
sterile water. RNA was precipitated by the addition of 2.5 volumes of ethanol and 
0.1 volumes 3M sodium acetate. Precipitates were cooled to -70°C overnight and 
recovered by centrifugation as described for DNA.
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2.7.7 Quantitation of Nucleic Acid in Aqueous Solution.
The concentration and purity of nucleic acid in aqueous solutions was estimated by 
measuring the u.v. absorbance of the solution over the wavelength range of 
250-300nm. Pure solutions of DNA and RNA have an absorbance peak at 260nm 
and a 260nm/280nm ratio of 2.0 and 1.8 respectively (Sambrook et aL, 1989). The 
concentration of nucleic acid was calculated using an absorbance value of 1 at 260nm 
to be equivalent to 50jng/ml for double stranded DNA and 40/xg/ml for single 
stranded nucleic acid. When estimating the concentration of oligonucleotides made 
using an Applied Biosystems DNA synthesizer (section 2.7.8), a concentration of 
33jug/ml was used to calculate DNA concentration in accordance with the 
manufacturer’s recomendations.
2.7.8 Oligonucleotide synthesis
Oligonucleotides were chemically synthesized using an "Applied Biosystems" DNA
; ■ • ’■ y  1*1 S •synthesizer model 381A, using phosphoramidite chemistryBeaucage & Carruthersi)The
oligonucleotides were extracted from the columns on which they were synthesised
using 18M ammonium hydroxide, and deprotected at 55°C for 12 hours in 18M
ammonium hydroxide. The oligonucleotides were then ethanol precipitated and
resuspended in TE buffer. The concentration of the oligonucleotide was calculated
spectrophotometrically to give a typical yield of 40pg.
2.8 ELECTROPHORESIS
2.8.1 Agarose-gel Electrophoresis
(i) DNA Electrophoresis.
Agarose gel electrophoresis was performed at 100 V for a time dependant on the gel 
dimensions and the agarose concentration. The concentration of agarose used 
depended on the size of the DNA to be separated, with higher concentrations (2%) 
being used to sepaiate fragments of DNA less than 500bp in size. Gels were cast and 
run in IxTAE buffer (section 2.5.3.1) with samples loaded in Ixloading solution
54
(section 2.5.3.1). After electrophoresis, gels were stained with ethidium bromide 
(0.5/ig/ml) for 20 minutes, destained in HgO for 10 minutes and the DNA bands were 
visualized under u.v. light.
(ii) RNA Electrophoresis.
RNA was electrophoresed through denaturing agarose gels (2.2M formaldehyde). 
Gels (1.5%) were prepared by dissolving the agarose (1.5g) in 72 ml of sterile water 
and allowing the molten agarose to cool to 55°C before adding lOxMOPS (section 
2.5.3.2, 10ml) and formaldehyde (18ml). The solutions were mixed and the gel was 
immediately poured. RNA samples (l-20jitg in a volume of 4.5jttl) were denatured 
by incubating at 70°C for 10 minutes with 11.6^1 formamide/formaldehyde solution 
(section 2.5.3.2) and 4 A pi Buffer A (section 2.5.3.2). The samples were then cooled 
on ice for 3 minutes before adding RNA loading dye (2pl, section 2.5.3.2) and 
electrophoresing at lOOV. The gels were stained in ethidium bromide (5jug/ml, 10 
minutes) for viewing under uv light and destained overnight at 4°C.
2,8.2 Polyacrylamide-gel electrophoresis
(i) Preparation of DNA sequencing gel and electrophoresis conditions 
Urea (31.5g) was dissolved with acrylamide (9.3ml 40% acrylamide [19:1] 
bisacrylamide, NBL, Cramlington) and lOx TBE (7.5ml, section 2.5.3.3) in a total 
volume of 75ml. Ammonium persulphate (420jnl, 10%) and TEMED (75/d, Sigma, 
Dorset) were then added and the solution mixed before pouring it between glass plates 
(31cm X 38.5cm x 0.4mm) previously coated with either dimethyl dichlorosilane 
(repellant) or gamma-methacryloxypropyl-trimethoxy silane (adhesive). The gel was 
pre-electrophoresed for 15-30 minutes, followed by 75W constant power in IxTBE 
electrophoresis buffer after loading the DNA samples.
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(ii) SDS-Polyacrylamide-gel Electrophoresis.
A 9% resolving gel (48ml) was prepared from stock solutions as follows, 
water 21.6ml
30% acrylamide mix 14.4ml
4x resolving buffer (2.5.3.3) 12.0ml
10% Ammonium persulphate 0.30ml
TEMED 0.02ml
Ammonium persulphate and TEMED were added immediately before the gel was 
poured. The gel was allowed to set for 1 hour under an overlay of butanol saturated 
with water. After the gel had set, the overlay was poured off. A stacking gel (24ml) 
was also prepared from stock solutions as follows,
water 13.9ml
30% acrylamide mix 4.0ml
4x stacking buffer (2.5.3.3) 6.0ml
10% Ammonium persulphate 0.2ml
TEMED 0.01ml
The stacking gel was poured directly on top of the resolving gel and the comb 
inserted into the gel solution. After the stacking gel had set the comb was removed 
under buffer and the wells were washed with electrophoresis buffer. The samples 
were mixed with one third volume of 3x gel loading dye (section 2.5.3.3) and boiled 
for 5 minutes before loading. The gel was electrophoresed in Ix tank buffer (section 
2.5.3.3) at 150 V until the dye had run through the stacking gel, and at 200 V 
through the resolving gel. After electrophoresis, the proteins were fixed in the gel 
by precipitation in 30% methanol/10% acetic acid for 1 hour. After fixing, the gel 
was immersed in ENHANCE™ solution for 1 hour before washing with HgO for 30 
minutes and drying (80°C, 90 minutes) under vacuum. The gel was then exposed to 
Fuji-RX film at -70°C.
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SEQUENCING
For each sequencing reaction, a single annealing reaction was setup, consisting of DNA (l^ig), reaction buffer (2pl) 
and primer (Ifti). The reaction was made up to 10|xl with water, heated at 65^C for 2 minutes before allowing to cool 
slowly to 35^C when tlie reaction was placed on ice. For each annealing reaction four tubes were s ^  up, each one 
containing 2 . 5 ( jl1 of one of the termination mixes ddATP, ddCTP, ddGTP or ddTTP, and incubated at 37®C. The 
labelling reaction was then canied out as follows.
annealed reaction 10|xl
DTT (O.IM) 1.0[xl
Diluted labelling mix 2.0|xl
(1:4 mjx:water; 5x mix 7.5|aM 
dGTP, dCTP and dTTP)
H-35S]dATP 1.0^1
Diluted sequenase 2 . 0 | J l1
The mixture was incubated at room temperature for 3 minutes before transfetiing 3.5|il of the labelling mixture to each 
of the termination tubes and continuing their incubation at 37^C for a further 5 minutes. The stop mix: (95% 
formamide, 20mM EDTA, 0.05% Bromophenol Blue, 0.05% Xylene Cyanol FF) was then added (4/tl) and the 
reactions stored at -20^C for up to one week.
2.9 SEQUENCING
2.9.1 DNA Sequencing
Sequencing reactions were carried out on 1-2 ng of template DNA using a Cambridge 
BioScience Sequenase™ kit as described by the manufacturers. The kit is based on 
the dideoxy chain termination method of Sanger et al. , (1977) and includes all the 
buffers, solutions and enzyme required for the addition of deoxynucleotides (and their 
dideoxy derivatives) to the 3’ end of a growing DNA chain.
2.9.2 Preparation of Single Stranded M13 Template DNA
Single stranded DNA was extracted from phage as described (section 2.7.2(ii)) and 
the concentration determined by electrophoresis of DNA on an agarose gel. The 
DNA prepared can be used directly in the sequencing reactions (Ijitg).
2.9.3 Pteparation of double stranded pUC Template DNA.
Plasmid DNA was extracted as described (section 2.7.l(i)). The concentration was 
determined by gel electrophoresis and 2-3^g of DNA was subsequently used in the 
sequencing reactions. The DNA was denatured by incubating DNA with 0.2M 
NaOH/2mM EDTA (Lim & Pene, 1988) at 37®C for 30 minutes before ethanol 
precipitating using a dry ice/ethanol bath (section 2.7.6). The denatured DNA (2fig) 
was used immediately in the sequencing reactions.
2.9.4 Preparation of DNA Sequencing-gel and Electrophoresis Conditions.
Acrylamide gels (5%) were made and electrophoresed under the conditions described 
(section 2.8.2(i)). After electrophoresis, the DNA was fixed in the gel by immersion 
in 10% methanol/10% acetic acid for 20 minutes, then rinsed throughly for 5 minutes 
under running water to remove the urea, before drying in a hot air oven at 80°C for 
1 hour. The gel was then placed in direct contact with Fuji-RX film in an X-ray 
cassette and kept in the dark for 16-18 hours.
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2.10 RECOMBINANT LAMBDA PHAGE LIBRARY
2.10.1 Preparation of Phage Plating Cells
An individual colony was picked from a freshly grown LB agar plate and used to 
innoculate LB media (10ml) containing 0.2% maltose. The culture was grown 
overnight at 37°C.
2.10.2 Titration of recombinant lambda phage library
Libraries were titrated by making serial dilutions in SM buffer (section 2.5.9), 
incubating at 37°C for 20 minutes with 300fû plating cells and plating on LB agar 
plates by adding top agarose containing MgSO^ (lOmM, section 2.4.10). Plates were 
incubated overnight at 37°C.
2.10.3 Plating library
The library was plated for screening, by incubating the appropiate number of phage 
to give 100,000 plaques per plate (530cm^) at 37°C for 20-30 minutes with the 
overnight culture (500jitl) and SM buffer (300jitl, 2.5.9). Top agarose containing 
MgSO^ (lOmM) was added and the mixture was poured onto LB agar plates. The 
plates were incubated at 37°C for 8-14 hours.
2.10.4 Purification of plaques
After identification of positive plaques by hybridisation, a plug of agar was removed 
from the plate in the region of the positive signal using the wide end of a sterile 
pasteur pipette. This was put into 1ml SM, 2 drops chloroform and left at 4°C 
overnight. The phage from this stock were replated and rescreened, and positive 
plaques were again identified and picked. Repeated replating and rescreening was 
carried out until an individual plaque could be picked.
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2.11 HYBRIDISATIONS
All hybridisation were performed using Hybond-N^^ nylon membrane (Amersham).
2.11.1 Southern Transfer of DNA,
Southern transfer was performed according to the method of Southern, (1975) as 
described in Sambrook et al. , (1989). DNA was electrophoresed through an agarose 
gel as described (section 2.8. l(i)). The DNA was denatured by soaking the gel in 
several volumes of denaturing solution (section 2.5.4) for 45 minutes, and in 
neutralising solution (section 2.5.4) for 30 minutes. The gel was then rinsed in 
2xSSC and blotted overnight with 20xSSC. After blotting, the membrane was 
air-dried and the DNA fixed to the membrane by baking at 80°C for 2 hours.
2.11.2 Northern Transfer of RNA.
RNA samples were electrophoresed through a 1.5% denaturing agarose gel as 
described (2.8. l(i)). The gel was blotted directly with 20xSSC as described for 
DNA.
2.11.2(1) RNA Dot Blot
RNA (IjLil) was denatured at 70°C in three volumes formaldehyde/formamide (section 
2.5.3.2) and one volume Buffer A (section 2.5.3.2) for 5 minutes before adding an 
equal volume of 20xSSC (section 2.5.4). The solution was then dotted onto nylon 
allowing each dot to dry before the next application. The filter was baked at 80^C 
for 2 hours and hybridised as described in section 2.11.5.
2.11.3 Plaque Lifts
Replica filters of plaques on a plate were prepared by direct contact with the plate 
surface. The first membrane remained in contact for 1 minute and the duplicate for 
2 minutes. The membrane was then placed, plaque side uppermost, on to 3-MM 
filter paper soaked in denaturing solution for 5 minutes, neutralising solution for 5 
minutes and finally rinsed in 2xSSC. The membrane was air-dried and the DNA 
fixed to the nylon by baking at 80°C for 2 hours.
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RADIOLABELLING PROBE
DNA to be labelled (30iig) was first denatured by boiling for 5 minutes and cooling 
immediately on ice. Priming solution (5jjl1, random hexanucleotides) and labelling solution 
(10|ri, dATP, dTTP and dGTP in Tris. MgCl2 and 2-mercaptoethanol) were added. 
[o -^32P]dCTP (50|xCi) was added, followed by the addition of 2p,l Klenow (lU/|xl) and the 
labelling was carried out at 37^0 for 30 minutes. The probe was again denatured by 
boiling and cooling on ice prior to addition to the hybridisation reaction.
2.11.4 DNA Hybridisations
Hybridisations (and prehybridisations) were carried out in Hybaid^^ bottles at 65°C. 
Prehybridisations were performed in hybridisation solution (section 2.5.4) at 65°C for 
1 hour. After prehybridisation, denatured, radiolabelled probe DNA (section 2.11.6) 
was added directly to the hybridisation solution and hybridisation was continued under 
the same conditions, for 16-24 hours. The membranes were washed with SSC in the 
presence 0.1% SDS. The concentration of SSC and the washing temperature 
depended on the specificity of the probe DNA for its target. After washing, the 
membrane was wrapped in Saran-wrap™ and autoradiographed with Fuji-X-ray film 
in the presence of an intensifing screen at -70°C.
2.11.5 RNA Hybridisations
RNA hybridisations were performed at 45°C in the presence of 50% formamide 
(section 2.5.4) as described above for DNA.
2.11.6 Preparation of ^^ P labelled DNA Probes.
Radiolabelling of DNA probes was carried out using an Amersham Multiprime DNA 
labelling system, based on the method of Feinberg and Vogelstein (1983). Probe 
DNA was isolated from agarose gels using Geneclean™ (section 2.7.4(i)). DNA 
(30ng) was denatured by boiling for 4 minutes followed by rapid cooling on ice. The 
denatured DNA was used directly in the labelling reaction as described by the 
manufacturers. A standard reaction, using [a-^^P] dCTP with a specific activity of 
3000Ci/mmol, results in probes with an average length of 200 nucleotides with a 
specific activity of 1.8x10^  dpm/jtig.
2.11.7 Stripping blots
Filters were incubated at 45°C for 45 minutes in 0.4M NaOH and then in 0. IxSSC, 
0.1% SDS, 0.2M Tris pH 7.5 for 30 minutes. The filters were autoradiographed 
before reprobing.
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2.12 Transfection of COS cells
2.12.1 DEAE-Dextran Mediated Transfection of COS-1 Cells.
COS-1 cells were obtained from Celltech Ltd and cultured in DMEM (section 
2.17.1(1)). Exogenous DNA was introduced into COS-1 cells using a DEAE dextran 
transfection method (Lopata et ah, 1984). Semiconfluent monolayers of cells were 
prepared for transfection by seeding at 7.5 x 10^cells/75mm tissue culture flask 12-16 
hours prior to transfection. For each transfection the DNA (l^g, CsCl gradient 
purified, 2.7.1(ii)) was prepared as individual transfection cocktails (section 2.5.7). 
At 12-16 hours post seeding, culture medium was aspirated off and the cells were 
washed in warm (37®C) sterile PBS. The transfection cocktail was evenly applied 
over the cell monolayer surface and the cells incubated, with occasional gentle 
shaking at 37°C for 30 minutes. DMEM containing 80^M chloroquine (section 2.5.7) 
was added to the cells, and incubation continued at 37°C for a further 3 hours. The 
medium was removed by aspiration and replaced with DMEM (2ml), containing 10% 
DMSO (section 2.5.7). After 2.5 minutes, the DMSO medium was aspirated off and 
replaced with 8ml of fresh, warmed (37°C) DMEM for 72 hours. Cells required for 
the assay of protein activity were harvested following treatment with trypsin (section 
2.17.1(i)), sonicated in the presence of Triton X-100 and stored on ice for use in the 
SHMT assay (section 2.18.1). Cells for RNA extraction were harvested using 
RNAzolB™ (section 2.6.2). For the analysis of proteins by SDS-PAGE the cells 
were first radiolabelled using f^Sjmethionine. The medium was aspirated off, and 
cells washed with Eagle’s medium (Eagle, 1959) without methionine. 
methionine (80juCi) was added with Eagle’s medium and cells incubated for 4 hours. 
The cells were then harvested using RIPA buffer (section 2.5.7) and stored at -70°C 
for PAGE (section 2.8.2(ii)).
2.13 ENZYMES
2.13.1 Restriction Enzyme Digestions
Restriction enzymes were obtained from BRL and Boehringer and digestions 
performed according to the manufacturer’s instructions and with the buffers provided 
by the manufacturer unless stated. Small scale analysis was performed using
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approximately Ijwg of DNA and 1-5 units of enzyme in a volume of 20jul. RNase was 
included in digestions where required, to a final concentration of 0.05 mg/ml. 
Digestion of genomic DNA was performed in a volume of lOOfil with 50 units of 
enzyme. The digestion products were ethanol precipitated (section 2.7.6) and 
resuspended in a smaller volume prior to electrophoresis.
2.13.2 Dephosphorylation of DNA.
Dephosphorylation of vector DNA was performed using calf intestinal alkaline 
phosphatase (CIP). The reaction was carried out at 37°C in Ix react 3 buffer (BRL, 
section 2.5.6) for 1 hour with 1 Unit of enzyme per nmol of 5’ ends. CIP was 
inactivated at 70°C for 10 minutes and phenol/chloroform extracted (section 2.7.5). 
The dephosphorylated vector was then recovered by ethanol precipitation.
2.13.3 DNA ligations
DNA ligations were performed using T4 DNA ligase according to the manufacturers 
instructions. Generally, ligations were carried out using lOOng of a dephosphorylated 
vector at an insert:vector molar ends ratio of 2:1. Cohesive end ligations were 
incubated at 16°C and blunt end ligations at 10°C. Ligation products were either 
diluted or used directly to transform competent cells.
2.13.4 Filling 3'recessed ends
The 3’ recessed ends of restriction enzyme digested DNA and purified PCR products 
were filled in using the large fragment of T4 DNA polymerase. The DNA was 
incubated at room temperature for 45 minutes with 2mM dNTPs and 6U of enzyme 
in Ix nick translation buffer (section 2.5.6). The DNA was then purified by 
phenol/chloroform extraction (2.7.5) followed by ethanol precipitation.
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2.13.5 Phosphorylation of DNA
The following reaction mix was set up in a total volume of 40^1:
Dephosphorylated DNA.
2/tl kinase buffer (lOX, section 2.5.6)
2fjil ATP (2mM)
2{jlI T4 polynucleotide kinase (5U/jul)
The reaction mixture was incubated at 37°C for 1 hour and then stopped by addition 
of 0.5M EDTA (2ftl). It was extracted once with phenol/chloroform, and the DNA 
was ethanol precipitated.
2.14 Transformation of Eschetichia coli
2.14.1 Transfonmation of DHSol cells with plasmid DNA
Competent DHSol cells were obtained from BRL. Ligations were incubated with 20^1 
cells on ice for 40-60 minutes before heat shocking at 42°C for 45 seconds, and 
returning to ice for 2 minutes. SOC (80/d, section 2.4.11) was added and the cells 
were shaken at 37^C for 60 minutes before plating on LB agar plates containing 
ampicillin (100/xg/ml). For plasmids where blue/white colour selection operated, X- 
gal (40/tl, 20mg/ml) and IPTG (4/tl, 200mg/ml) were added before plating. The 
plates were then incubated overnight at 37°C.
2.14.2 Transformation of DH5a cells with RF M13 DNA
Transformations were carried out as for plasmids (section 2.14.1) except the cells 
were shaken at 37®C for 10-15 minutes before plating. The competent cells were 
plated with X-gal (40/tI, 20mg/ml), IPTG (4/tl, 200mg/ml) and 200^1 of exponentially 
growing JM109 cells (in 2xTY) in 4ml Htop agar (section 2.4.9) onto 2xTY plates.
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A m p l i f i c a t i o n  o f  DNA u s i n g  PCR
double s tranded  DNA 9<ioC o lig o n u c leo tid es
single stran d ed  DNA
46oC
oligonucleotides have annealed to  ta rg e t DNA
72oC
DNAsynthesis ex tends from annealed oligonucleotides
R epeated cycles of denaturing, annealing and extending the DNA 
re su lts  in exponential am plification of the  ta rg e t DNA
Amplification of ta rg e t  DNA was carried  out using o ligonucleotides com plem entary to  the ends 
of the ta rg e t DNA sequence to  prime syn thesis of the DNA by Tag polym erase. Double stranded 
DNA was firs t denatured a t Q4oC The o ligonucleotides are annealed a t 46oC and DNA synthesis 
carried out a t 72oC. Successive rounds of d en atu ring , annealing and extending the DNA are 
carried out
2.15 Polymerase Chain Reaction
2.15.1 PCR from RNA: Production of a cDNA
Total RNA (Ijug), extracted from rabbit liver tissue using RNAzol™ (Biogenesis Ltd., 
Bournemouth) was reverse transcribed by Rous-associated virus 2 reverse 
transcriptase using 600ng of oligo 3 (Chapter 3, figure 3.4) to prime cDNA 
synthesis. The reaction was carried out at 42°C in 50mM-KCl, lOmM-Tris-HCl pH, 
8.3, l.SmM-MgClz, and 0.01 % (w/v) gelatine in a total volume of 50/tl. The RNA- 
DNA hybrid product was denatured by boiling for 6 minutes and then cooling on ice. 
Oligo 1 (600ng) (Chapter 3, figure 3.4) and 2.5U of Taq polymerase were then 
added, and 25 successive rounds of dénaturation (1 minute at 94°C), annealing (1 
minute at 46°C) and extension (1 minute at 72®C) of the DNA were carried out. The 
products of the PCR reaction were then electrophoresed on an agarose gel as 
described.
2.15.2 PCR from DNA
DNA (lOOng) was amplified using Taq polymerase (2.5U) by cycling through 25-30 
rounds of denaturating at 94°C, annealing at the appropiate temperature and extending 
at 72®C in 50mM-KCl, lOmM Tris-HCl pH 8.3, 1.5mM MgCl^, 0.01% (w/v) 
gelatine and 1.25mM dNTPs in a total volume of 50/tl. The specific oligonucleotides 
used to prime amplification were added before dénaturation. The reaction was carried 
out under a layer of paraffin oil.
2.16 STOCKS
2.16.1 Preparation of Bacteriophage Stocks.
(i) Lambda-gtlO.
A single plaque was picked from an LB agar plate into sterile SM buffer using a 
sterile glass pasteur pipette. Phage were stored, over chloroform, at 4°C.
(ii) M13mpl8.
Exponentially growing JM109 were innoculated with phage picked from a plaque 
using a sterile pasteur pipette and the culture grown, with vigorous shaking at 37°C 
for 6-7 hours. A phage stock was prepared from this culture by removing the cells
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by centrifugation (lOOOOg, 5 minutes). The supernatant, containing viable phage 
particles, was transferred to a fresh sterile tube and stored at 4“C.
2.16.2 Preparation of bacterial stocks
Escheiichia coli cultures were maintained on LB agar plates, with antibiotics if 
appropriate, and subcultured every 6 to 8 weeks. For the long term storage of 
bacteria they were frozen at -70‘^C in LB-broth containing 15 % glycerol.
2.17 ANIMAL CELL CULTURE TECHNIQUES
2.17.1 CELL CULTURE.
(i) Anchorage dependent cells (COS-1).
COS-1 cells were grown as monolayers in tissue culture flasks in DMEM (section 
2.4.1) with heat inactivated foetal calf serum (FCS, 10% v/v) at 37°C (5% CO2). 
Cells were subcultured when the growth was confluent by treating with trypsin and 
diluting the cells to a suitable density. The media was aspirated off and the cells 
were washed with PBS. The cells were then incubated with trypsin/EDTA at 37°C 
until the cells had detached from the surface. The cells were sedimented by 
centrifuging at 80g (5 minutes) and diluted into warmed medium to give 2x10  ^
cells/ml.
(ii) Suspension cells (MOLT-4)
Molt-4 cells were grown in RPMI1640 medium (section 2.4.2) containing FCS (10%) 
at 37°C (5% CO2). When the cells reached a density of 1-3x10'’ cells/ml they were 
reseeded to a density of 2x10  ^ cells/ml by centrifuging cells (80g, 5 minutes), 
washing the cell pellet gently in sterile PBS and resuspending in the appropiate 
volume of warmed medium.
2.17.2 FROZEN CELL STOCKS.
Growing suspension cells were centrifuged (80g, 5 minutes) and resuspended in 
growth medium containing 20% FCS (v/v) and 10% DMSO (v/v) to a final
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concentration of 1x10  ^ cells/ml. Growing anchorage dependent cells were first 
treated with trypsin before centrifuging as above. The cells were dispensed into 1ml 
aliquots and frozen overnight at -70°C before removing to liquid nitrogen for storage. 
To recover cells from liquid nitrogen storage, an aliquot was thawed at 37°C and the 
cells were diluted with 10ml growth medium. Cells were sedimented by centrifugation 
(80g, 5 minutes) and the supernatant discarded. The cell pellet was resuspended in 
10ml of fresh growth medium (containing 10% (v/v) FCS), transferred to a tissue 
culture flask, and incubated at 37°C in air containing 5 % COg.
2.17.3 CELL COUNTING AND VIABILITY.
Cell counts were determined by diluting aliquots of cells in Erythromycin B and 
counting using a Fuchs-Rosenthal Haemocytometer. Exclusion of the dye was taken 
as an indication of cell viability. Cells with an intact cell membrane were 
impermeable to the dye and were considered to be viable. Cells, however, with a 
"leaky" cell membrane incorporated the dye and were considered to be non-viable. 
The cell viability was calculated from the following equation;
% VIABILITY = (V/T) x 100 
V = viable cells/ml 
T = total cells/ml
2.18 BIOCHEMICAL METHODS
2.18.1 Assay of serine hydroxymethyltransferse activity
Serine hydroxymethyltransferase (SHMT) activity was assayed by an adaptation (Snell 
et ah, 1987) of the radiometric method of Taylor and Weissbach (1965). The cells 
were preincubated at 37°C with potassium phosphate (30/tl, 0.2M), pyridoxal 
phosphate (lO/il, 2mM) and tetrahydrofolate (20/d, lOmM) for 5 minutes before the 
reaction was started by the addition of 3-[^^C]-L-serine mix (section 2.5.8). The 
incubation was continued for 20 minutes before the addition of cold sodium acetate 
pH 4.5 (60/tl, IM) to stop the reaction. Formaldehyde (40/d, O.IM) and dimedone 
(60/d, 0.4M) were then added. The solution was mixed and then boiled for 5 minutes
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to accelerate the formation of a complex between the radiolabelled formaldehyde and 
the dimedone. After cooling on ice, toluene (1ml) was added and the tubes were 
mixed for 1 hour by rotation. After centrifugation the toluene layer (0.8ml) was 
removed to a scintillation vial containing 5 ml scintillant and counted on a LKB 
Wallac liquid scintillation counter. Activity was expressed as nmol of 
[ '^*C]formaldehyde trapped per hour per 10^  cells.
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CHAPTER 3
DEVELOPMENT OF SHMT PROBE
3.1 SUMMARY
This chapter describes the development of a probe suitable for detecting sequences 
coding for SHMT. At the beginning of the project, the only sequences available were 
the nucleotide and derived amino acid sequence of the gly A gene from E. coli 
(Plamann et aZ., 1983) and the amino acid sequences of the cytosolic and 
mitochondrial proteins purified from rabbit liver (Martini et a l , 1987; Martini et al. , 
1989). The protein sequence of the rabbit cytosolic SHMT was used as the basis for 
probe design. Oligonucleotides were designed based on the published amino acid 
sequence of rabbit cytosolic SHMT and used to amplify a 528 bp fragment of DNA, 
using RNA extracted from rabbit liver tissue as the template. The amplified fragment 
was cloned into pUC13 to form pUS1201, and subsequent sequencing of the fragment 
revealed that it contained the expected DNA sequences coding for cytoplasmic SHMT 
between amino acids 244 and 420. The fragment was later used as a probe in 
Northern blot analysis of RNA extracted from rabbit liver tissue and from a human 
leukaemic cell line, MOLT-4. The 528bp SHMT cDNA insert in pUS1201 was also 
used to screen a rabbit liver cDNA library to isolate a full length clone.
3.2 RESULTS
3.2.1 Primer Design
The only nucleotide sequence available to which primers could be designed was the 
sequence of the gly A gene from E. coli (Plamann et al. , 1983). Since the diversity 
between this species and rabbit is great, it was decided to use the published amino 
acid sequence of rabbit SHMT as a base on which to develop primers. The protein 
sequences of the cytosolic and mitochondrial rabbit SHMT (Martini et a l,  1987; 
Martini et a l , 1989) were reverse translated by inspection and examined for regions 
that would distingush between the coding sequences for each isozyme. These regions, 
amino acids 3-14, 20-25, 33-39, 86-89, 155-160, 246-249, 379-384, 396-399, 412- 
416, 429-438 and 456-464 (for location see figure 3.1), were further studied to give 
sequences that would show the least degeneracy of the genetic code and final 
oligonucleotide sequences were designed, which were biased to the codon usage table
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cy MA mi KA . *
TAVNGAPRDAALAQTQTGEASRG- WSSHEQMLAQ WTGQE PLKDSDAESLSDTDPE VYDIIKKMWELLQR SSNRQRVGLELIASENFASRAEKDRQCRGLELIASENFCSRA * . . * *  * * * * * * * * * *  * * *
cy VLEALGSCLNNKYSEGYPGQRYYGG|riHl|DELETLCQKRALQAYGLDPQCWGVNVQPySGmi alealgsclnnkysegypgkryygg|aew|deiellcqrraleafdldpaqwgvnvqpysg 
* * * * * * * * * * * * * * * * * * . * * * * * . *  , * * , *  * * * , * * * , * , , * * * ,  * * * * * * * * * *
cy s p a n f a v y t a l v e p h g r i m g l d l p d g g h l t h g f wItdkkkimi SPANLAAYTALLQPHDRIMGLDLPDGGHLTHGYMISDVKRViSAT SIFFESMPYKLNPQTGLSATSIFFESMAYKVNPDTGY
* * * * , * , * * * * , , * * , * * * * * * * * * * * * * * * * , * . *  * . , * * * * * * * * * * , * * . * * , * *
cy IDYDRLEENARLFHPKLIIAGTSCYSRNLDYGRLRKIADENGAYLMADMAHISGLWAGV mi IDYEQLALTARLFRPRLIIAGTSAYARLIDYARMREVCDEVKAHLLADMAHISGLVAAKV ***..*. .****.*.******* *.* .**.*.*.. ** *.*.**********.* *
cy VPSPF EHCHWTTTTHKTLRGCRAGMIFYRRGVRSVDPKTGKEILYNLESLINSAVFPGLmi ipspeikhad|w t t t t h k t l r g a r s g l i f y r k g v r t v d p k t g q e i p y t f e d r i n f a v f p s l ,****,* ,************ *,*.****,***,******.** *,,*, ** ****,*
cy q g g p h n h a i a g v a v a l k q a m t p e f k e y q r q w a n c r a l s a a l v e l g y k i v t g g s d n h l i l mi q g g p h n h a i a a v a v a l k q a c t p m f r e y s l q v l k n a r a m a d a l l e r g y s l v s g g t d n h l v l **********,******** ** *,** **, * **,,,**.* **.,*.**.****,*
cy v d l r s k g t d g g r a e k v l e mi v dl rp k g l d g a r a e r v l e ACSIACLVSITANKNTCPGDKSANKNTCPGDRSALRPSITPGGLRLGTPALTSRGLRLGAPALTSE GLLEKQFREDDFQKdfrr
cy VAHFIHRG:g 
*
TELTVQIQDDmi WDFIDEG 7NTGLEVKRK T AKLQDFKSFLLKD
*  .  * *
rGPRATLKEFKEKLAGD
* *.*..**. * *
EKHQRAVRAPETSQRLAD
****** . * , * * , .
LRQEVESFAALFPLPG LRRRVQQFARAFPMPG **. *. ** **.**
cy LPGF mi FPEH . *.
Figure 3.1: Alignment of amino acid sequences of rabbit cytosolic and
mitochondrial SHMT. Regions of dissimilarity are boxed, 
cy-cytosolic; mi-mitochondrial
. indicates conservative substitution; * indicates conserved amino acid
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for rabbit proteins (Maruyama et ah, 1986). The sequences of the two primers 
chosen, oligo 1 and oligo 3, to amplify SHMT are shown below and indicated in 
figure 3.4. These two primers span a region of 175 amino acids in the central part 
of the protein that includes residues which contribute to the proposed active site of 
the enzyme. The primers were synthesised, as described (section 2.7.8), on an 
Applied Biosystems 381A DNA synthesiser.
Oligo 1: 5’
aa244 phe
C G C C C UUU/ GAA/ CAU/ UGU/ CAU/ :GU 3’
glu his cys his val
Oligonucleotide
synthesised:
Oligo 3:
Oligonucleotide
synthesised:
C G C C C 5, YTT/ GAA/ CAT/ TGT/ CAT/ GT 3’
5’
aa420 glu
G G C C f\ G GAA/ AAA/ GAU/ UUU/ CAG/ AAA/ GU 3’
lys asp phe gin lys val
5’ T  C A A T T  ACC/ TTT/ TGG/ AAG/ TCCt TTC/ TC 3’
A minimum and maximum temperature of annealing was calculated for each 
oligonucleotide so that the annealing step of the amplification reaction could be 
carried out at a temperature that would allow binding of both primers. The formula 
for calculating annealing temperature is based on the number of individual bases 
present and is as follows:
(No. of A+T)*2 + (No. of G+C)*4
T •
Oligo 1 
Oligo 3
46"C
52“C
54“C
60"C
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3.2.2 Amplification of SHMT cDNA fragment
Total RNA extracted from rabbit liver tissue using the RNAzol™ method (section 
2.6.1) was used as a template for specific cDNA synthesis using oligo 3 (figure 3.4) 
to prime synthesis. Reverse transcription was carried out as described in section
2.15.1 using RAV-2 reverse transcriptase. The polymerase chain reaction was used 
directly to amplify the newly synthesised cDNA by the addition of the 5’ primer, 
oligo 1 (figure 3.4) and Taq polymerase (section 2.15.1). The samples underwent 25 
repeated cycles of denaturing the DNA, annealing the primers and extending synthesis 
from the primers. A negative control reaction containing no cDNA was also included 
to check for contamination. The products of the PCR reactions were electrophoresed 
through a 1.5% agarose gel.
Amplification of cDNA from the region between oligo 1 and oligo 3 should 
result in a fragment that is 528 nucleotides long. Figure 3.2 shows a band of less 
than 600 nucleotides amplified in the test reaction that is not present in the negative 
control. The minimum temperature of annealing for oligo 1 (46'^ C) was used as the 
annealing temperature of the PCR reaction. Since no non-specific bands were 
amplified at this temperature it was used for all subsequent amplifications.
3.2.3 Cloning the Amplified SHMT cDNA Fragment
The amplified cDNA fragment was extracted from the gel using NA45 paper as 
described in section 2.7.4 (i). Following precipitation and resuspension of the DNA 
pellet, the ends of the PCR product were modified with Klenow enzyme and 
phosphorylated using T4 polynucleotide kinase (sections 2.13.4 and 2.13.5). A 
phenol/chloroform extraction was carried out and, prior to ethanol precipitation, 
pUC13 (lOOng) that had been digested with Smal and dephosphorylated using CIP, 
was added. The precipitated DNA was ligated overnight at 10°C.
The ligation products were used to transform E. coli DH5a cells to ampicillin 
resistance. Recombinant clones were identified using the blue/white X-gal colour
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Figure 3.2: Amplification of a region of SHMT using RNA extracted from rabbit
liver as a template and oligo 1 and oligo 3 to prime synthesis (figure
3.4).
Lane 1: phiX174/HaeIII markers
Lane 2; negative control reaction, no DNA
Lane 3: Amplification reaction with rabbit RNA*
Lane 4: phiX174/HaeIII markers
Lane 5: negative control reaction, no DNA
For marker sizes, see appendix i
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MW(kb) 1 2  3 4 5
135— 
107—  
087—
0 6 0 —
Figure 3.2; Amplification of a region of SHMT using RNA extracted from rabbit 
liver as a template and oligo 1 and oligo 3 to prime synthesis (figure
3.4).
Lane 1: phiX174/HaeIII markers
Lane 2: negative control reaction, no DNA
Lane 3: Amplification reaction with rabbit RNA*
Lane 4: phiX174/HaeIII markers
Lane 5: negative control reaction, no DNA
For marker sizes, see appendix i
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selection system. This selection system uses the fact that the host strain DH5oi has 
a deletion mutation in the lac Z  gene, /acZAMlS, which renders the B-galactosidase 
inactive. Nonrecombinant plasmids produce a functional lac a-peptide which can 
complement the tocZAMlS deletion in host cells, thus producing a functional J5- 
galactosidase capable of producing a blue colour when plated on indicator medium 
containing X-gal and IPTG. Recombinant plasmids have a disrupted lac a-peptide 
due to the presence of insert and therefore have no il-galactosidase activity giving rise 
to the white colour when plated on indicator medium containing X-gal and IPTG.
DNA was extracted from transformants according to the method described in 
section 2.7.l(i). The presence of inserts was detected by carrying out a double 
digestion using restriction endonucleases EcoRI and Hindlll, which lie on either side 
of the Smal site in the multiple cloning site. Figure 3.3 shows the released insert of 
the expected size following electrophoresis of the digested plasmid DNA. The cDNA 
insert in the recombinant plasmid was then sequenced.
3.2.4 Sequencing of SHMT cDNA Insert in dTJS1201
Double stranded sequencing of the cDNA insert in pUS1201 was carried out 
according to the method of Lim and Pene (1988) as described in section 2.9.3. Both 
strands of the insert were sequenced in triplicate using specific and universal primers. 
The universal and reverse primers were used to prime sequencing from just outside 
the multiple cloning site, while oligos 1, 2 and 3 (figure 3.4) were used to prime 
sequencing internally. The resulting sequence is shown in figure 3.4. The 
recombinant pUC13 plasmid containing the 528bp SHMT cDNA insert was named 
PÜS1201.
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1 2 3
— 135 (kb)
—  087
^—0'60
— 031
F igu re  3 .3 : Recombinant pUC13 plasmids containing SH M T  cD N A
I^ n e  I 
l^nc 2 
I^ n e  3
Plasmid no. l/HcoRI and Hindlll 
Plasmid no. 2/FcoRI and Hindlll 
phiX 174/Haelll markers
I or marker sizes, see appendix i
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1 0 2 0 3 0 4 0 5 0 6 0
TTTGA6CACT GCCACGTGGT GACCACCACG ACCCACAAGA CGCTGCGAGG CTGCCGGGCC
O l i g o 1
7 0 8 0 9 0 1 0 0 1 1 0 1 2 0
GGCATGATCT TCTACAGGAG AGGAGTGCGC AGCGTGGACC CCAAGACTGG CAAAGAGATC
1 3 0 1 4 0 1 5 0 1 6 0 1 7 0 1 8 0
CTGTACAACC TGGAGTCGCT CATCAACTCT GCCGTGTTCC CGGGCCTGCA GGGAGGCCCC
1 9 0 2 0 0 2 1 0 2 2 0 2 3 0 2 4 0
CACAACCACG CCATCGCAGG GGTCGCCGTG GCCCTGAAGC AGGCCATGAC TCCGGAGTTC
2 5 0 2 6 0 2 7 0 2 8 0 2 9 0 3 0 0
AAGGAGTACC AGCGCCAGGT GGTGGCCAAC TGCAGGGCCC TGTCCGCAGC CCTCGTGGAG
O l i g o  2
3 1 0 3 2 0 3 3 0 3 4 0 3 5 0 3 6 0
CTGGGATACA AGATTGTCAC AGGTGGTTCT GACAACCATT TGATCCTCGT GGATCTCCGT
3 7 0 3 8 0 3 9 0 4 0 0 4 1 0 4 2 0
TCCAAAGGCA CAGATGGCGG GAGGGCGGAG AAGGTGCTGG AAGCCTGCTC TATCGCTTGC
4 3 0 4 4 0 4 5 0 4 6 0 4 7 0 4 8 0
AACAAGAACA CCTGCCCAGG TGACAAGAGT GCACTGCGTC CTAGCGGCCT GCGCCTGGGT
4 9 0 5 0 0 5 1 0 5 2 0 5 3 0
ACCCCAGCGC TGACATCCCG GGGCCTCCTG GAAAAAGACT TCCAGAAAGT
O l i g o  3
Figure 3.4: Sequence of the SHMT cDNA insert in pUS 1201. Oligonucleotides
used to amplify and sequence this region are underlined.
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3.2.5 Northern Blot Analysis of SHMT Expression
An equal amount of RNA extracted from rabbit liver tissue (section 2.6.1) and 
MOLT-4 cells (section 2.6.3) was electrophoresed through a denaturing formaldehyde 
gel (section 2.8.1 (ii)). The RNA was transferred to nylon (section 2.11.2) and the 
resulting filter was hybridised with radiolabelled SHMT cDNA from pUS1201 
(section 2.11.5). The filter was washed at 45®C at a low stringency using 
2xSSC/0.1 % SDS before exposing to X-ray film. A series of discrete bands were 
observed as shown in figure 3.5. The bands ranged in size from 1.4kb to 3.2kb for 
the rabbit RNA and from 1.5kb to 3.7kb for the human RNA. The intensity of the 
signal observed following exposure of the Northern blot differs between the species. 
The bands observed in the rabbit RNA could be seen on an overnight exposure of the 
filter to an autoradiograph. However, a signal was not seen in the MOLT-4 RNA 
until the filter had been exposed for 5 days. Possible explanations for the difference 
in signal intensity could include a homology difference between the human and rabbit 
sequences, or a cell cycle related effect, where perhaps the amount of SHMT RNA 
being synthesised varies at different stages of the cell cycle.
3.3 DISCUSSION
Based on the published protein sequence of the SHMT protein from rabbit liver, 
synthetic oligonucleotides have been designed to amplify a section of the mRNA 
coding for rabbit cytosolic SHMT. The portion of sequences amplified span the 
central region of the protein. In an alignment of the rabbit cytosolic and 
mitochondrial amino acid sequences with the derived amino acid sequence of the E. 
coli SHMT enzyme, the amplified region is well conserved, compared to the highly 
variable terminal regions which differ between cytosolic and mitochondrial enzymes 
and are to some extent absent in the bacterial sequence. Located within this region 
is the highly conserved VVTTTTHK sequence which contains at least two amino 
acids implicated in the active site of the enzyme. The lysine has been shown to bind 
the co-enzyme PLP (Bossa et ah, 1976), while the preceding histidine is implicated 
in binding the substrate serine (Stover et ah, 1992).
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1-3  2 kb
-22kb
—T7kb
"T5kb
-14kb
F ig u re  3 .5 :  Northern blot analysis o f  total RNA extracted from rabbit liver and
human M OLT-4 cells, using as a probe, radiolabelled cD N A  from 
pUS1201.
Lane 1: RNA extracted from M OLT-4 cells 
I ^ n e  2: RNA extracted from rabbit liver
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Using the polymerase chain reaction on RNA extracted from rabbit liver, the 
SHMT cDNA was specifically amplified. The protein sequence derived from this 
segment of cDNA was 100% identical to the published sequence of rabbit cytosolic 
SHMT (Martini et ah, 1987). The cDNA obtained was subsequently used to probe 
RNA that had been extracted from rabbit liver tissue and from the human leukaemic 
MOLT-4 cell line.
The pattern of banding observed in the rabbit RNA suggests a number of 
different species of RNA exist in the liver tissue. The bands range in size from 
approximately 1.4kb to 3.2kb. The full length cytosolic protein is 484 amino acids 
long and therefore requires a minimum of 1452 nucleotides to code for it, whereas 
the mitochondrial sequence is reported to be 475 amino acids long (Martini et ah , 
1989) and thus it would require a minimum of 1425 nucleotides to code for it. The 
possibility of cross-reactivity between the coding sequences for mitochondrial and 
cytosolic SHMT cannot be ruled out, since no data is available on the nucleotide 
sequence coding for the mitochondrial protein, however at the amino acid level the 
two enzymes share 67.2% identity (Martini et ah, 1989). The low stringency wash 
used may allow the cytosolic SHMT cDNA probe used, to detect mitochondrial 
sequences. The different sizes of bands may thus represent different stages of 
processing of the cytosolic mRNA or reflect cross hybridisation to mitochondrial 
SHMT.
The hybridisation pattern seen when the SHMT cDNA probe in pUS1201 is 
hybridised to rabbit and human (MOLT-4) RNA differs in that the bands detected in 
MOLT-4 RNA are slightly larger than in the rabbit RNA. This could simply be due 
to the human enzyme being larger than the 53kDA size reported for the rabbit SHMT 
(Martini et ah, 1987), since the size of human SHMT has never been determined.
As noted above, the difference in intensity could have been due to a low 
homology between rabbit and human or to a difference in expression of SHMT during 
the cell cycle. As is now known the identity between rabbit and human over the 
region from amino acids 244-420 is 95.6% (chapter 7), and so it is unlikely that
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cDNA from pUS1201 would not have hybridised to human RNA. A cell cycle 
dependent level of SHMT activity has been reported for rat hepatoma 3924 cells in 
culture where the activity of SHMT increased rapidly to a peak during the early 
exponential phase of growth and then declined in stationary phase (Snell et al. , 1987). 
Such an effect could be the result of rapidly altering SHMT mRNA levels. 
Preliminary experimental estimates of SHMT activity during the cell cycle of MOLT- 
4 cells did not show such a marked increase during the proliferative phase (Bolton et 
al. , 1989). It was suggested that this could be due to the growth of MOLT-4 cells 
in suspension rather than the anchorage dependent growth of 3924A cells. The RNA 
used in Northern blot hybridisation was extracted from confluent cells, when the rate 
of cell divison is slow, and it is possible that decreased levels of SHMT mRNA are 
synthesised at this time.
Growth-dependent increases have been observed in genes involved in DNA 
synthesis. The activity of thymidylate synthase (TS), one of the other enzymes 
involved in thymidylate synthesis, shows a cell cycle dependent pattern. In human 
diploid fibroblasts grown in culture, TS activity was shown to be very low in 
stationary cells, but increased when cells were replated at a low cell density, to a 
level 20-fold greater than the level found when cells had reached a stationary phase 
(Ayusawa et al. , 1986). A similar growth dependent pattern of expression exists for 
the enzyme thymidylate kinase (TK), where enzyme activity is detected in 
proliferating cells, but not in resting cells. In this case, studies have indicated that 
changes in the binding of nuclear factors to the 5’ flanking region of the TK gene 
coincide with the increase of TK transcription (Knight et a l,  1987).
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CHAPTER 4
ISOLATION OF RABBIT CYTOSOLIC SHMT cDNA
Rabbit cDNA library
Cloning Vector : Lambda gt 10 
Cloning Site : Eco R 1
Selection C riteria  : Clear plaques from turbid plaques (uncut lambda gt 10)
% Clear Plaques : 76% when plated on 0600 strain  before amplification ob 0600 Hf!
Number of Independent .  ^ g x 10^Clear Plaques (clones]
Average Insert Size (Range] : 1*6 Kb ( range ; 0.7 to > 4.0 Kb )
4.1 SUMMARY
A cDNA library made using RNA extracted from rabbit liver tissue (Clontech) was 
screened using radiolabelled cDNA from pUS120I as a probe. Sixty seven positive 
clones were identified, including a clone containing the complete coding sequence for 
cytosolic SHMT, pUS1203. The cDNA insert from this clone was subsequently 
subcloned and characterised by restriction endonuclease digestion and sequence 
analysis. The nucleotide sequence obtained was translated to protein, and the derived 
protein sequence compared to the published protein sequence of rabbit cytosolic 
SHMT (Martini et al. 1987). The sequence showed the clone contained a 5’ 
untranslated region of 155 nucleotides. The main open reading frame that follows 
this untranslated region is 1452 nucleotides long and is followed by a 3’ untranslated 
region of 653bp. Located within this 3’ untranslated region are two sequences 
signalling for poly A tail addition although no poly A tail was present.
4.2 RESULTS
4.2.1 Library Screening
A rabbit liver cDNA library (Clontech) was screened in an attempt to isolate a full 
length cDNA for SHMT. The library was made from RNA extracted from the liver 
of male and female New Zealand White rabbits. cDNA synthesis had been primed 
with oligo-dT. The resulting cDNAs were cloned into lambda gtlO at the unique 
EcoRI site. A total of 300,000 plaques were plated using the host strain C600 and 
screened for SHMT (section 2.10). Duplicate filters of each plate were taken and 
each was hybridised with radiolabelled cDNA from pUS1201. The filters were 
hybridised at 65°C and washed at a medium stringency also at 65°C, in 2xSSC/0.1 % 
SDS. A higher stringency was not used so as not to exclude the possibility of 
detecting a cDNA coding for mitochondrial SHMT. The identity between the 
cytosolic and the mitochondrial enzyme at the protein level is 67.2% (Martini et al. , 
1989), and since the probe region spanned the active site of the enzyme it was 
thought that mitochondrial clones could be detected, since this region was more likely
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to be well conserved. Positive clones which appeared in duplicate were identified and 
picked. A total of 67 positive clones were identified on a first round screen out of 
a total of 300,000 plated, giving a frequency of 1 in 3000 being positive for SHMT. 
Twenty of these positive clones were taken through four subsequent rounds of plating 
and rescreening until each clone was in a homogenous population. An example of 
the signal obtained after hybridising filters to radiolabelled cDNA from pUS1201 on 
a third round of purification is seen in figure 4.1.
DNA was extracted from sixteen of the purified lambda clones (section 2.7.2 
(ii)). Digestion of the lambda clones with EcoRI releases the two lambda arms of 
32.7kb and 10.6kb and any inserted DNA. Figure 4.2 shows the pattern obtained 
following EcoRI digestion of the lambda DNA. The size of the inserts were 
estimated by comparison to standard markers. Inserts in the size range of 
approximately 1.4kb to 2.3kb were observed. Four of the clones appeared to have 
no insert. A Southern transfer was performed (section 2.11.1) and the resulting blot 
was probed with radiolabelled cDNA from pUS1201 (section 2.11.4). The pattern 
observed following exposure of the probed blot to an autoradiograph is seen in figure 
4.3. The largest insert to hybridise was from clone 24 which had an insert of 
approximately 2.3kb. Clone 33 had an insert of approximately 2.1 kb, while clones 
41, 46, 61 and 62 all had inserts of approximately 1.8kb. Each of these clones could 
potentially contain all of the sequence necessary to code for SHMT, since the 
cytosolic form is reported to be 483 amino acids long (Martini et al. 1987) and thus 
would require 1449 nucleotides. The clones containing inserts of less than 1.5kb 
were therefore no longer studied.
4.2,2 Subcloning and Preliminary Characterisation of Putative SHMT cDNAs
It was decided to analyse lambda clones 24, 33 and 61 further. Lambda DNA from 
each of these clones was digested to completion with EcoRI. Following 
electrophoresis of the digested products on a 0.8% agarose gel the inserts were 
purified from the gel using the Geneclean™ method (section 2.7.4 (i)). The inserts 
were ligated into M13mpl8 that had been digested with EcoRI and dephosphorylated
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Figure 4.1: Hybridisation signal obtained on a third round screen of lambda clone
33, when probed with radiolabelled cDNA insert from pUS1201. 
Signal seen was obtained following an overnight exposure of the filter 
to X-ray film at -70°C.
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Figure  4.2: Lambda DNA extracted t'rom puritled clones and digested with LeoKl
to release inserted cDNA. Lor s i/e markers,  see appendix i
Lane 1 : Clone 26/LcoR! Lane 10: ( ' lone 45 L.eoRl
Lane 2: Clone 4/LcoRI Lane II : ( ' lone 62 LeoRI
Lane 3; ( ' lone l /LcoRI 1 .ane 12: Clone 24/L.eoRI
I^me 4: Clone 5/I-coRI I.ane LV ( lone 65 LeoRI
Lane 5: Clone 40, LcoRI 1 ane 14: ( lone 55 LeoRI
Lane (r. ( lone 34/L.coRI I ane 15: ( ' lone 21 LeoRI
1 .ane 7; ( lone 4(VLcoRI 1 ane Itv ( ' lone 20 1 eoRI
I.ane H: ( lone 4 1 1 .eoRI 1 .me 17: lambda IItrailII
Lane ( lone 01 1 eoRI
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Figure 4.3: Pattern of hybridisation observed following probing of Southern blot
of the gel seen in figure 4.2,-with radiolabelled cDNA from pUS1201.
For markers sizes, see appendix i
Lane 1: Clone 26/EcoRI Lane 10: Clone 43/EcoRI
Lane 2: clone 4/EcoRI Lane 11 : Clone 62/EcoRI
Lane 3: Clone 1/EcoRI Lane 12: Clone 24/EcoRI
Lane 4; Clone 5/EcoRI Lane 13: Clone 63/EcoRI
Lane 5: Clone 40/EcoRI Lane 14: Clone 33/EcoRI
Lane 6: Clone 34/EcoRI Lane 15: Clone 21/EcoRI
Lane 7: Clone 46/EcoRl Lane 16: Clone 20/EcoRI
Lane 8: Clone 41/EcoRl Lane 17: lambda/Hindlll
Lane 9: Clone 61/EcoRl
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using CIP, at a molar ratio of 2:1 to form clones 24, 33, 61, and the inserts from 
clones 24 and 33 were ligated into EcoRI digested and dephosphorylated pUC18 to 
form pus 1203 and pUS1204 respectively.
The ligation products were then used to transform E. coli DH5oi and 
recombinant plaques and colonies were identified using the blue/white X-gal colour 
selection system. Replicative form (RE) DNA was extracted from recombinant phage 
and a preliminary restriction map was prepared by digestion of RF DNA with the 
following restriction enzymes, EcoRI, Kpnl, BamHI, PstI and Xbal.
Figure 4.4 shows the restriction pattern formed following digestion of two 
different subclones of 24, 24  ^and 24s, with these restriction enzymes. Digestion of 
both clones released the insert of 2.3kb as expected. Digestion of both 24^  and 24  ^
with BamHI linearised the phage DNA indicating that no BamHI sites were present 
in the insert. This was confirmed later by sequence analysis. Digestion of 24^  by 
EcoRI, Kpnl, PstI and Xbal resulted in fragments of approximately 2.3kb, 900bp, 
700bp and 700bp respectively. When PstI was used to digest 24 ,^ the digestion 
pattern obtained suggests multiple bands differing only in size by approximately 
lOObp thus indicating the presence of more than one PstI restriction site. The same 
enzymes, when used to digest 24  ^ gave bands of approximately 2.3kb for digestion 
with EcoRI, 1.3kb for Kpnl and 1.6kb following digestion with Xbal. Although PstI 
appeared to have digested clone 24g, no distinct band was apparent. The pattern 
observed from 24^  and 24  ^suggests the inserts were present in different orientations. 
The location of a Kpnl site was already known from the nucleotide sequence of the 
insert in pUS1201, and it seemed from the restriction pattern obtained following 
digestion with Kpnl, that this was a unique Kpnl site to the insert. The sites for 
restriction enzymes PstI and Xbal were placed relative to the Kpnl site where 
possible, assuming that the cDNA in clone 24 coded for a full length SHMT. 
Digestion of clone 61 with Kpnl suggested that the insert was not complete at the 5’ 
end. The PstI site was later used to subclone a smaller fragment for sequencing of 
the 3’ end. The derived restriction map of clone 24 is shown in figure 4.5.
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Figure 4.4: Restriction pattern obtained following digestion o f  clones 24j and 24,
with EcoRI, PstI, Xbal, Kpnl and BamHI. For marker sizes, see 
appendix i ^
Lane 1: phi & lambda markfers^kb) Lane 7: phi & lambda markers 
l ^ n e  2: 24^/EcoRI Lane 8: 24,/EcoRI
Lan^âT 24jtKpnI I^ n e  9: 2 4 , /Kpnl
^ 0 ^ n e  4: 2 4 / Bam HI L ine  10: 2 4 , /Bam HI
U n e  5: 2 4 /P s t l  Lane 11: 2 4 /P s i l
U n e  6: 2 4 ^ /\h a l  Lane 12: 2 4 /X b a l
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Figure 4.5: Preliminary restriction map of clone 24
K-Kpnl 
X-Xbal 
P - PstI
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4,2,3 Sequencing Strategy
DNA sequencing was performed using single stranded M13mpl8 containing the 
inserts from clones 24, 33 and 61 as templates. Preliminary sequencing of the ends 
of the inserts in clones 24, 33 and 61 using the -40 universal primer revealed that 
clone 24 contained all of the sequences necessary to code for the complete SHMT as 
well as containing upstream non-coding sequences and 3’ non-coding sequence. 
Clone 61 was shown to start 40 amino acids downstream from the initiation codon 
AUG. Clone 33 was only obtained in one orientation, that which gave the 3’ non­
coding sequences. All three clones had the same 3’ non-coding sequence and finished 
at the same position. The remainder of the sequencing was done on clone 24, using 
244 and 24  ^ as templates to sequence both strands. The strategy used is shown in 
figure 4.6. Sequence was obtained for both strands over the entire length of the clone 
using a combination of specific oligonucleotides designed according to the sequence 
as it was obtained and the subcloning of smaller fragments into M13mpl8. The 
complete nucleotide sequence determined for both strands in triplicate is shown in 
figure 4.7.
Specific oligonucleotides were synthesised to walk the length of the clone in 
both directions. The sequence of these primers, their position on the clone and the 
amount of sequence obtained using them is shown in figure 4.6. For the 3’ 
noncoding sequence, some of the sequence was obtained by subcloning a smaller 
fragment into M13mpl8. From the inital restriction map it was known that a PstI 
digestion of 24  ^ should result in a large band of DNA that represented M13 DNA 
containing approximately 400 nucleotides of the 3’ end of the clone. The remaining 
sequence should be released. The M l3 phage would not be disrupted since the PstI 
site is in the multiple cloning site. Clone 24^  was digested with PstI to release 
fragments of 700bp, 600bp, 500bp, and 6.7kb. Following electrophoresis of the 
digested products on 1% agarose gel the 6.7kb fragment which represents the M13 
phage DNA and part of the 3’ non-coding sequence was purified (section 2.7.4 (i)). 
The purified DNA was religated at 16^ C before being used to transform E, coli DH5a 
cells to ampicillin resistance. Recombinant plaques were identified and single 
stranded DNA prepared. These clones were then sequenced using universal primer.
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uni vin
vil
IX
XI
X < — —111
uni
11
Oligo VÜ: 5’ CGTGCGGTnTGGAGC
Oligo viii: 5’ATCATGGGTCTGGAC
Oligo 1: 5’ TTCGAA/GCAT/C TGT/CCAT/CGT
Oligo 2: 5’ GAA/GTTCAAA/GGAA/GTAT/CCAA/G
Oligo v: 5’GGCCTGCTGGAAAAAGACTTC
Oligo ix: 5’AGGAGGTCGAGAGCTTC
Oligo ii: 5’AGACCAGAGCTGTGGGAGCT 
Oligo 3: 5ACCyTTTCTGGAAA/GTCT/CTTT/CTC 
Oligo iii: 5TCGCAGCGTCITGTTGGGT 
Oligo x: 5’TTGTCCGTCATGAACCCGT
Oligo xi: 5’GAAGTTCTCCGAGGCAAT
Figure 4.6:
Sequencing strate^ used to sequence rabbit cytosolic SHMT in clones 244& 255 
Oligonucleotide sequences shown are as they were synthesised.
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4.2.4 Nucleotide and Derived Amino Acid Sequence of Rabbit SHMT
Figure 4.7 shows the entire sequence of clone 24, which contains the coding 
sequences for cytosolic serine hydroxymethyltransferase. The insert which is 2261 
nucleotides long, contains a 5’ untranslated region of 155 nucleotides, followed by 
an open reading frame (ORF) of 1452bp, encoding a 484 amino acid protein of Mw 
53kD, a termination codon, TAG and a 3’ untranslated region of 653bp. No poly A 
tail was present in the insert although two sequences signalling for polyadenylation 
were present. The overall GC content of the clone is 61.8%
(i) The 5’ untranslated region
The AUG which initiates translation of SHMT is located at position 156-158. The 
sequence surrounding the ATG is in good agreement with the consensus sequence for 
the initiation of eucaryotic translation as described by Kozak (see below, Kozak 
1984a; 1987b) with 5 out of 7 nucleotides matching. The two most important 
nucleotides of the consensus sequence, the G at position 4-4 and a purine at -3 are 
both present in clone 24. There is one stop codon in the same reading frame, TGA, 
just upstream of the ATG at position 144-146; the first in frame downstream stop 
codon is at position 1608-1610.
Within this untranslated region which is 68.8% GC rich, are an imperfect 
inverted repeat of 10 nucleotides and a perfect direct repeat also of 10 nucleotides. 
The inverted repeat is located at positions 61-71 and 128-137 (see figure 4.7). The 
formation of a stem between these inverted repeated sequences with a single 
mismatch, would expose a loop of 57 nucleotides. The direct repeats which are 
adjacent to each other on the sequence are located within the loop from positions 76- 
85 and 86-95. There is no evidence for the existence of such a stem and loop 
structure, however it is possible that the its formation could have a regulatory role 
by exposing sequences to proteins.
The 5’ untranslated region also contains an ATG initiation codon at position 
5 in a different reading frame, to the one at position 155, Translation from this 
upstream ATG would continue until the ribosome reached the termination codon at
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Figure 4.7a: Example of sequencing gel. Clone 24 was sequenced using oligo v and 
iii to prime sequencing.
AAAGATGAAGAAAAAGGAGCCAGTGGGTTCCGCTGACTCCGCGGGTCACGTGGCGGGCCTGCCGGaGCGCGCGAGTGGACGGTCGTGGAC 9 0  
GGTCGTGGAGCGGCGGCCGGACCGAGGCATACGTGTCCGCGTTCCGGTGGCCTTGAACCAGCGTGATGGCGACCGCAGTCAATGGGGCCC 1 8 0
M A T A V N G A
CCAGGGACGCTGCCCTGTGGTCCTCGCATGAACAGATGCTGGCCCAGCCCCTGAAGGACAGCGACGCAGAGGTTTACGACATCATCAAGA 2 7 0  
P R D A A L W S S H E Q M L A Q P L K D S D A E V Y D I I K
AGGAGAGCAACCGGCAGAGGGTCGGCCTGGAGCTGATTGCCTCGGAGAACTTCGCCAGCCGTGCGGTTTTGGAAGCCCTGGGCTCCTGCT 3 6 0  
K E S N R Q R V G L E L I A S E N F A S R A V L E A L G S C
TAAATAACAAATACTCAGAGGGCTACCCCGGCCAGAGGTATTATGGCGGCACTGAGCATATCGATGAGCTGGAGACGCTGTGTCAGAAGC 4 5 0  
L N N K Y S E G Y P G Q R Y Y G G T E H I D E L E T L C Q K
GGGCGCTGCAGGCCTACGGCCTGGACCCACAGTGCTGGGGCGTCAACGTGCAGCCCTACTCAGGCTCCCCCGCCAACTTCGCCGTGTACA 5 4 0  
R A L Q A Y G L D P Q C W G V N V Q P Y S G S P A N F A V Y
CGGCCCTGGTGGAGCCCCATGGGCGCATCATGGGTCTGGACCTGCCCGACGGGGGCCACCTGACCCACGGGTTCATGACGGACAAGAAGA 6 3 0  
T A L V E P H G R I M G L D L P D G G H L T H G F M T D K K
AGATCTCGGCTACGTCCATCTTCTTTGAATCCATGGCCTACAAGGTGAACCCAGACACTGGCTACATCGACTACGACCGGCTGGAGGAGA 7 2 0  
K I S A T S I F F E S M A Y K V N P D T G Y I D Y D R L E E
ACGCGCGCCTCTTCCACCCGAAGCTGATCATCGCAGGAACCAGCTGCTACTCCCGGAACTTGGACTACGGGCGGCTCAGGAAGATAGCGG 8 1 0  
N A R L F H P K L I I A G T S C Y S R N L D Y G R L R K I A
ACGAGAACGGGGCCTACCTCATGGCCGACATGGCACACATCAGTGGGCTGGTGGTGGCTGGCGTGGTGCCCTCCCCCTTTGAGCACTGCC 9 0 0  
D E N G A Y L M A D M A H I S G L V V A G V V P S P F E H C
ACGTGGTGACCACCACGACCCACAAGACGCTGCGAGGCTGCCGGGCCGGCATGATCTTCTACAGGAGAGGAGTGCGCAGCGTGGACCCCA 9 9 0  
H V V T T T T H K T L R G C R A G M I F Y R R G V R S V D P
AGACTGGCAAAGAGATCCTGTACAACCTGGAGTCGCTCATCAACTCTGCCGTGTTCCCGGGCCTGCAGGGAGGCCCCCACAACCACGCCA 1 0 8 0  
K T G K E I L Y N L E S L I N S A V F P G L Q G G P H N H A
TCGCAGGGGTCGCCGTGGCCCTGAAGCAGGCCATGACTCCGGAGTTCAAGGAGTACCAGCGCCAGGTGGTGGCCAACTGCAGGGCCCTGT 1 1 7 0
i a g v a v a l k q a m t p e f k e ’y q r q v v a n c r a l
CCGCAGCCCTCGTGGAGCTGGGATACAAGATTGTCACAGGTGGTTCTGACAACCATTTGATCCTCGTGGATCTCCGTTCCAAAGGCACAG 1 2 6 0  
S A A L V E L G Y K I V T G G S D N H L I L V D L R S K G T
ATGGCGGGAGGGCGGAGAAGGTGCTGGAAGCCTGCTCTATCGCTTGCAACAAGAACACCTGCCCAGGTGACAAGAGTGCACTGCGTCCTA 1 3 5 0  
D G G R A E K V L E A C S I A C N K N T C P G D K S A L R P
GCGGCCTGCGCCTGGGTACCCCAGCGCTGACATCCCGGGGCCTCCTGGAAAAAGACTTCCAGAAAGTGGCACACTTCATCCACAGAGGCA 1 4 4 0  
S G L R L G T P A L T S R G L L E K D F Q K V A H F I H R G
TAGAGCTCACCGTGCAGATCCAGGACGACACGGGCCCCAGGGCAACCCTGAAGGAGTTCAAGGAGAAGCTGGCAGGCGACGAGAAGCACC 1 5 3 0  
I E L T V Q I Q D D T G P R A T L K E F K E K L A G D E K H
AGAGGGCCGTGCGGGCCCTGCGCCAGGAGGTCGAGAGCTTCGCCGCCCTGTTCCCGCTGCCCGGCCTGCCCGGCTTCTAGAGGGGCCGGC 1 6 2 0  
Q R A V R A L R Q E V E S F A A L F P L P G L P G F U
GCCTGAGGCCGAGGGGACCCCGCTTCGAGCCCCCGCGGGAGTGCCTTCGGACTTCCCTCGTCTTCCTCCCACATCAAACCCTTGTCTGGG 1 7 1 0  
AGGAGTAAGGCTGGCCCGGGGCAGTAGGGACGTGGCGGTG2\ACCATGGAGGCTGGCCGGCCGGCTGTGCACCTCCCTTCTCTTAGCGCCC 1 8 0 0  
CTGGGCACTGGTCTGGCTTCCTGCAGCCGGCCGGGCCCCGTGCTCACGGCTGTGAGAGCTGCCCGCCGGGACGTGTCAGGGACGCAGAGC 1 8 9 0  
AGAATCAGGACGACCACAGCTGAGAGGCGATTCCCCGGAGCCAGAAGAGGCGTGCCCAGCCTGGCGGAGGTGCAGCTCCCCACAGCTCTG 1 9 8 0  
GGTCTCCTCCACGCCTGCCCCAGGAAGCGCCCAGTGCCAGCCGCCGGCCTTTGCCGCCACCCCACCCCCCCCCCCCCCCGCACTGTGACA 2 0 7 0  
GGAAGCCACATGTCACCTTCCCAAAGAGACTTTATTTTTCACATAGCTGAAGTGCAAAACATAGCTGACCGTTTTTAATAAGCACAATCA 2 1 6 0  
AGGTTTTAACCACAGAATGTCTACAAGAATTATAGCTTTAAAAAATACAACCAATTTTTATATTTCAAAAATATCTGAACTCAZ\ATAAAT 2 2 5 0  
TAATTTCTGAA 2 2 6 1
Figure 4.7: Nucleotide and derived amino acid sequence ofrabbit SHMT cDNA, Sequences signalling polyadenylation, direct and inverted repeated sequences are in bold.
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position 209-211, to form an ORF of 69 amino acids (called uORF). The sequence 
surrounding this ATG is also in good agreement with Kozak’s consensus sequence 
(see below). Although this ATG lacks a G at position -f-4, it has an A at position - 
3. The purine at position -3 is the most highly conserved nucleotide in eucaryotic 
mRNA initiation sequences, and is an A in 75% of mRNAs examined (Kozak, 1986). 
It is only in the absence of this purine that the G at position +4 becomes essential for 
efficient translation (Kozak, 1986; 1989).
consensus sequence: A/GCCATGG 
rshmt: G TGATGG
uORF: A AGATGA
Figure 4.8 shows the derived amino acid sequence of uORF. A hydrophobicity plot 
of the predicted protein reveals four small regions of hydrophobicity, from amino 
acids 14-18, 27-30, 43-48 and 56-60 (figure 4.9). The N terminus of the ORF is 
largely hydrophillic. A comparison of the open reading frame protein product with 
the "SWISS-PROT" database (Altschul et ah , 1990) reveals a weak similarity to the 
S3 ribosomal protein of E. coli. The significance of this, if any is not known.
(ii) Coding sequence
The protein sequence derived from the main ORF of clone 24 was compared to the 
published protein sequence for rabbit liver cytosolic SHMT obtained by 
characterisation of tryptic peptide and cyanogen bromide peptides of the protein 
(Martini et ah 1987). The sequences were identical with the exception of the 
methionine at the start of the sequence, which was not present in the published 
sequence, thus accounting for the extra amino acid in the derived protein sequence 
(484 amino acids) compared to the published sequence of 483 amino acids. It is 
possible that the initiating methionine is cleaved off following synthesis in the cell. 
The initiating methionine amino acid is also absent from the mitchondrial enzyme, 
which can also lack the second lysine residue (30% of proteins) and the alanine (10% 
of protein) adjacent to it. This may be due to proteolytic processing during 
purification, although it has been suggested that it could mean the post-translational
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10 20 30 40 50 60
AAAGATGAAGAAAAAGGAGCCAGTGGGTTCCGCTGACTCCGCGGGTCACGTGGCGGGCCT 
M K K K E P V G S A D S A G H V A G L
70 80 90 100 110 120
GCCGGAGCGCGCGAGTGGACGGTCGTGGACGGTCGTGGAGCGGCGGCCGGACCGAGGCAT 
P E R A S G R S W T V V E R R P D R G I
130 140 150 160 170 180
ACGTGTCCGCGTTCCGGTGGCCTTGAACCAGCGTGATGGCGACCGCAGTCAATGGGGCCC 
R V R V P V A L N Q R D G D R S Q W G P
190 200 210
CCAGGGACGCTGCCCTGTGGTCCTCGCATGA 
Q G R C P V V L A U
Figure 4.8: Nucleotide and derived amino acid sequence of uORF,
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- 1 0 -
Figure 4.9; Hydrophobicity plot of uORF. Above the line represents hydrophillic 
regions, while below the line represents the hydrophobic regions.
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cleavage of a signal peptide (Martini et al. 1989).
The coding sequence for SHMT is 62.5% GC rich. This is clearly reflected 
when codon usage is examined. There is a strong bias towards guanine or cytosine 
in the third position of codons, with a further bias between these two nucleotides 
towards the pyrimidine cytosine (see table 4.1). In fact when there is a choice for 
the third base between the four nucleotides, neither A nor T bases predominate at the 
third position.
A hydrophobicity plot of the protein (figure 4.10) shows the protein to be 
predominantly hydrophillic as expected for the cytoplasmic location of the protein. 
Within the central region of the protein there are four relatively extended regions of 
hydrophobicity from amino acids 100-135, 220-255, 280-320 and 330-360, which 
may be involved in forming a hydrophobic pocket for binding substrates.
(iii) 3’ untranslated region
The main ORF of 484 amino acids terminates with a TAG stop codon at position 
1608-1610. Located further downstream of this are two other stop codons in frame, 
a TAA at position 1716-1718 and a TGA at position 1749-1751. Although no poly 
A tail is found in the clone, two sites signalling for polyadenylation are found. The 
most common sequence, signalling polyadenylation, AATAAA, is found at position 
2244-2249. A related sequence that is used in approximately 5% of cases is the 
AATACA sequence located slightly upstream at position 2204-2209 (Proudfoot, 
1991). The clone ends 12 nucleotides downstream from the termination signal at 
position 2244 with the EcoRI adaptor sequence, CCGGAATTC. Cleavage of the 
mRNA and polyadenylation usually occurs between 20 and 30 nucleotides 
downstream from the consensus sequence (Proudfoot, 1991). The clone is thus 
incomplete in size due to the lack of a poly (A) tail.
The 3’ untranslated region, which is 653 nucleotides long is 58.8% GC rich. 
Located within this region is a stretch of cytosine nucleotides, from position 2034- 
2059, 23 out of 26 nucleotides are cytosine. That this sequence was not found later
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Figure 4,10; Hydrophobicity plot of rabbit SHMT. Above the line represents 
hydrophillic residues, while below the line represents hydrophobic 
residues.
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in the 3’ UTR of the human SHMT cDNA suggests that the cytosine rich sequence 
is not a general significant feature of mammalian SHMTs, but it may be of functional 
significance to rabbit SHMT. Whether the sequence is cytoplasmic specific or not 
remains to be determined, since the nucleotide sequence of the rabbit mitochondrial 
SHMT cDNA is not known.
This region also contains numerous pairs of direct repeats, the longest of 
which is a lObp repeat from positions 2111-2120 and 2129-2138. There are two 
different hexamers that are repeated three times each within the 3' untranslated 
region. They are both GC rich, the first, GCCGGC is repeated at positions 1615- 
1620, 1768-1774 and 2023-2028. The second sequence, CCCCGC, is repeated at 
positions 1638-1643, 1651-1656 and 2056-2061. Seventeen different hexamers are 
repeated twice throughout the region as well as five different heptamers and one 
octamer. A search for inverted repeats of 6 nucleotides or more revealed a possibility 
of 11 different inverted repeats, which at any one time could form seven different 
stem and loop structures, with the size of the loop varying from 11 nucleotides to 68 
nucleotides long.
4.3 DISCUSSION
This chapter has described the successful isolation, characterisation and sequencing 
of a cDNA encoding cytosolic serine hydroxymethyltransferase from rabbit. This is 
the first nucleotide sequence of the cDNA from a mammalian source. Recently the 
sequence of the for^ gene from N. crassa has been reported, providing the only other 
published eucaryotic sequence (Me Clung et al., 1992). A thorough comparison of 
these two eucaryotic sequences is provided in chapter 7, where the sequence of part 
of human SHMT is compared to the rabbit sequence.
The rabbit cDNA isolated is 2.261kb long. This corresponds to the size of 
the major band seen in figure 3.5 of chapter 3. This was the largest clone among the 
clones that had been studied by restriction and sequence analysis. The clone consists
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of an ORF of 1.452kb coding for cytosolic SHMT that is flanked on the 5’ end by
155 nucleotides, and on the 3’ end by 653 nucleotides. The preliminary sequencing 
that was carried out on clones 24, 33 and 61 showed that they all had the same 3’ 
non-coding tail and finished in the same position. Although no poly (A) tail was 
found in the clone, two consensus sequences were present to signal for 
polyadenylation. The possibility exists that either of these two sequences could be 
used as the signal for cleavage and polyadenylation. Since these sequences are 
separated by 40 nucleotides, preferential cleavage at one or the other could generate 
mRNAs differing in size.
An analysis of the coding potential of clone 24 revealed that the sequence 
contained two ORF, one of which coded for cytosolic SHMT, and another which 
coded for a smaller protein of 69 amino acids. The smaller protein showed a weak 
homology with the S3 ribosomal protein of E. coli. The 3’ ORF starts at position
156 and continues until position 1608 where translation terminates with an opal 
codon, TGA. The 5’ ORF starts at position 5 of the sequence and continues until 
position 209. The degree of overlap between the two ORF is 54 nucleotides. 
Comparison with Kozak’s consensus sequence for the initiation of translation, shows 
both AUGs are in good context and could be used for the initiation of translation 
(Kozak, 1984a). In eucaryotic mRNAs most AUGs which initiate translation are 
located between 20 and 100 nucleotides from the 5’ start of the mRNA (Kozak, 
1987). However AUGs as close to the 5’ end as position 4, have been reported to 
initiate translation (Kelley, 1982). In this case the 5’ end of the cDNA in clone 24 
may not be the true 5’ end of the mRNA in vivo, as none of the clones examined in 
detail finished at the same position in the 5’ end. Primer extension analysis was not 
carried out to determine the in vivo 5’ end of the mRNA. The possible regulatory 
significance of this uORF is investigated and discussed in chapter 5. •
The procaryotic sequences currently available that code for SHMT are the 
sequences of the gly A gene from E. coli (Plamann et al., 1983), C. jejuni (Chan & 
Bingham, 1990) and B. japonicum (Rossbach & Hennecke, 1991). A partial sequence 
of the gly A gene from S. typhimurium is also available (Urbanowski et a l ,  1984).
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A comparison of the coding sequences of these genes with the rabbit SHMT coding 
sequence reveals a 43.8% homology between rabbit and C. jejuni, 44.3% with E. coli 
and 54.1 % with B. japonicum. The presence of a direct repeat in the 5’ untranslated 
region as occurs in rabbit, is found to be a common feature among the procaryotic 
sequences. The procaryotic sequences however, have in general, more direct repeats 
than their eucaryotic counterparts. The 5’ untranslated region of C. jejuni contains 
a lObp sequence that is repeated twice, at position 141-150 and 219-228. As well as 
this sequence, the 5’ untranslated region also contains a 9bp sequence and seven 6bp 
sequences that are repeated twice in this region. The B. japonicum 5’untranslated 
region has numerous repeated sequences, including three different 9bp sequences, five 
8bp sequences, sixteen 7bp sequences and seventy two 6bp sequences that are 
repeated. The propensity of repeats in this region of B. japonicum can in part be 
attributed to the size of the 5’ untranslated region, which is reported to be 1034 
nucleotides long, compared to the 443 nucleotides in C. jejuni and 357 nucleotides 
in E. coli. A scan for the presence of inverted repeats in this region shows the 
largest repeat to be a 7bp sequence in C. jejuni at position 225-231 and 246-252, and 
an 8bp sequence in B. japonicum at position 443-450 and 501-509. In neither case 
would the formation of a stem and loop structure expose both direct repeats as is the 
case for the rabbit SHMT.
The function of these sequences in the procaryotes is not known (Chan & 
Bingham, 1990). It is reported that the regulation of the gly A genes in E. coli and 
S. typhimurium is complex and involves sequences upstream of the -35 region 
(Stauffer, 1987). It is possible that these direct and inverted repeats have a role to 
play in regulation. In eucaryotes the situation is more complex. Little is known 
about the regulation of SHMT. Studies in N. crassa have suggested that the 
regulation of the for"  ^ gene is linked to the cross-pathway control system (McClung 
et ah, 1992), which is a system of control of amino acid synthesis, where the 
starvation of any of several amino acids results in the induction of genes for the 
biosynthesis of all amino acids (Hinnebusch, 1988). The system that operates in 
mammals is not known, it is possible that the tandem repeat sequence in the 5’ 
untranslated region is involved in binding a regulatory protein and thus regulating the
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synthesis of SHMT.
Tandem repeat sequences have been reported in the promoters of the mouse 
DHFR gene (Crouse et al., 1982) and human TS gene (Kaneda et al., 1990). In the 
case of TS, the repeated sequences are retained in the 5’ UTR of TS mRNA and it 
has been postulated that these sequences affect translational efficiency by the 
formation of stable stem and loop structures (Kaneda et al., 1990). This is further 
supported by the finding that deletion of two of the triple tandem repeats from a 
functional cDNA clone resulted in an enhanced gene activity (Kaneda et ah, 1987). 
TS mRNA has also been shown to be subject to a form of autoregulation. Translation 
of TS mRNA is inhibited specifically by the presence of purified recombinant human 
TS protein by a mechanism involving direct interaction of the protein with the RNA 
(Chu et al., 1991). Another case of the involvement of the 5’ UTR of mRNA in 
regulation, is ferritin mRNA. A highly conserved 28bp sequence in the 5’ UTR, 
capable of forming a stable stem and loop structure was shown to be necessary for 
iron-dependent regulation of ferritin. The ability of this specific sequence to regulate 
translation of ferritin mRNA involves a specific interaction with an 87kDa 
cytoplasmic protein (Leibold & Munro, 1988; Rouault et al., 1988).
A long 3’ tail is reported in all genes isolated that code for SHMT. C. jejuni 
has the longest with 1062bp, followed by rabbit at 653bp, N. crassa at 581bp, E. coli 
at 290bp and the smallest being B. japonicum with 231bp. Located within these tails 
are many direct and inverted repeat sequences, the exception being B. japonicum 
which has only four 6bp repeats and a total of seven inverted repeats.
A comparison of the codon usage of the procaryotic and rabbit sequences 
reflects the GC content of the coding sequences, which is highest for B. japonicum 
at 65.1% (33.6% C, 31.5% G), followed by rabbit at 62.5% (31.2% C, 31.3% G), 
E. coli at 53.4% (26% C, 27.4% G) and C. jejuni at 33% (11.9% C, 21.1% G). 
The GC content of the sequence from clone 24 is not uniform. The 5’ non-coding 
sequences have the highest GC content at 67.7%, followed by the coding sequences 
at 62.5%, with the 3’ non-coding sequences having the lowest at 58.8%. As expected
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from the high GC content of the rabbit sequences, the codon usage is skewed 
compared to the sequences of lower GC content. For rabbit SHMT there is an 
extreme selection at the third position in the codon towards guanine or cytosine with 
a stronger bias towards the pyrimidine cytosine as mentioned, resulting in a 3'** codon 
position GC content of 83% compared with an average 3"* codon position GC content 
of 76% in a compilation of rabbit sequences (Maruyama et al., 1986). B. japonicum, 
which has the highest GC content in the coding sequences does not display such a 
strong bias. While there is a preference for guanine and cytosine, there are also some 
cases where thymidine dominates at the third position. There is a strong bias against 
adenine, as can be seen from the lack of a predominance of adenine in the third 
position for any of the codons. C. jejuni, which has the lowest GC content at 33%, 
has a strong preference for adenine or thymidine at the third position with a higher 
predominance of the pyrimidine, thymidine. Where there is a choice for all four 
nucleotides at the third position, neither guanine nor cytosine predominate. This 
difference in codon usage is clearly seen in the case of valine, where for B. 
japonicum 99%, rabbit 93% and C. jejuni 8% of the codons for valine end in either 
a G or C.
The deduced amino acid sequence of rabbit liver cytosolic SHMT is compared 
in figure 4.11 with deduced amino acid sequences of the gly a gene from E. coli 
(Plamann et al., 1983), C. jejuni (Chan & Bingham, 1990) and B. japonicum 
(Rossbach & Hinnecke, 1991) using the Clustal analysis (Higgins & Sharp, 1988; 
1989). The rabbit cytosolic protein sequence is the largest at 484 amino acids, with 
the bacterial proteins being somewhat smaller (419, E. coli', 414, C. jejuni', 433, B. 
japonicum).
As can be seen from figure 4.11, the proteins are highly conserved indicating 
a high degree of evolutionary constraint. The homology between all species is 
highest in the central regions of the protein, with the N and C terminals showing little 
similarity except for a few conservative amino acid substitutions, perhaps indicating 
that these regions do not contain sequences necessary for the catalytic activity of the 
protein and function more in species specificity. There is a 28% identity between all
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Ra MATAVNGAPRDAALWSSHEQMLAQPLKDSDAEVYDIIKKESNRQRVGLELIASENFASRA
Eg MLKREM--------------------------------------NIADYDAELWQAMEQEKVRQEEHIELIASENYTSPR
Cj M-------------------------------------------------SLEMFDKEIFDLTNKELEGECERLEMIPSENFTLPE
B j MTSAKTASAPDS-----------------FFTASLDQADPEIAAAIKGELGRQRHEVELIASENIVSRA* .* .* ,* * *  , ,
Ra VLEALGSCLNNKYSEGYPGQRYYGGTEHIDELETLCQKRALQAYGLDPQCWGVNVQPYSG
EC VMQAQGSQLTNKYAEGYPGKRYYGGCEYVDIVEQLAIDRAKELFGADYA NVQPHSG
Cj VMELMGSILTNKYAEGYPGKRYYGGCEFVDHIETLAIERCKKLFNCKFA NVQPNSG
B j VLEAQGSVMTNKYAEGYPGALYYGGCEWVDVAENLAIDRAKKLFGAGFA NVQPNSG** ..***.***** **** * .* * * .* . . .  . **** **
Ra SPANFAVYTALVEPHGRIMGLDLPDGGHLTHGFMTDKKKISATSIFFESMAYKVNPDTGY
EC SQANFAVYTALLEPGDTVLGMNLAHGGHLTHG---------SPVNFSGKLYNIVPYGIDATGHI
Cj SQANQGVYAALINPGDKILGMDLSHGPHLTHG---------AKVSSSGKMYESCFYGVELDGRI
B j SQMNQAVFLALLQPGDTFMGLDLAAGGHLTHG---------SPVNMSGKWFKAAHYTVRREDQI*. * . *. ** . . *  . * *****   * .
Ra IDYDRLEENARLFHPKLIIAGTSCYSRNLDYGRLRKIADENGAYLMADMAHISGLWAGV 
EC -DYADLEKQAKEHKPKMIIGGFSAYSGWDWAKMREIADSIGAYLFVDMAHVAGLVAAGV 
Cj -DYEKVREIAKKEKPKLIVCGASAYATVIDFAKFREIADELPPYLFADIAHIAGLWAGE 
B j IDMDAVQKQAEEIKPKLIVAGGSAYSRAWDFKRFREIADSVGAYLLVDMAHFAGLVAGGV 
* . . . * , * * . * .  * * * .  * .  . . * . * * * .  . * * . . * . * *  , * * * , , *
Ra VPSPFEHCHWTTTTHKTLRGCRAGMIFYRRGVRSVDPKTGKEILYNLESLINSAVFPGL
EC YPNPVPHAHWTTTTHKTLAGPRGGLIL----------------- AKGGSEELYK KLNSAVFPGG
Cj HPSPFPHAHWSSTTHKTLRGPRGGIIM-----------------TND— EELAK K INSAIFPGI
B j HASPVPYAHVTTTTTHKSLRGPRGGLIL-----------------SND— ETLAK KLNSAIFPGL
. . *  . * *  * * * * _ *  *  * , * . * .  . . .  * * .  . * * * . * * *
Ra QGGPHNHAIAGVAVALKQAMTPEFKEYQRQWANCRALSAALVELGYKIVTGGSDNHLIL 
EC QGGPLMHVIAGKAVALKEAMEPEFKTYQQQVAKNAKAMVEVFLERGYKWSGGTDNHLFL 
Cj QGGPLMDVIAAKAVGFKFNLSDEWKVYAKQVRTNAQVLANVLMDTKFKLVSDGTHNHLVL 
B j QGGPLMHVIAAKAVAFGEALRPDFKVYAKNWENAKALAEAMKSHGFDIVSGGTDNHLML 
* * * *  . . * * .  * *  * * . . . *  *  * . . * . . * * *  *
Ra VDLRSKGTDGGRAEKVLEACSIACNKNTCP GDKSALRPSGLRLGTPALTSRGLLEKD
EC VDLVDKNLTGKEADAALGRANITVNKNSVPNGDDPKSPFVTSGIRVGTPAITRRGFKEAE 
Cj MSFLDREFSGKDADLALGNAGITPNKNTVP— GEIRSPFITSGLRLGTPALTARGFKEKE 
B j VDLRPKGLKGNVSEKALVRAAITCNKNGIPF— DPEKPFVTSGLRLGTPAATTRGFGVAE 
 * . .  . *  . * .  * * * .  *  * * . * . * * * *  * * * .
Ra FQKVAHFIHRGIELTVQIQDDTGPRATLKEFKEKLAGDEKHQRAVRALRQEVESFAALFP
E c AKELAGWMCDVLD SINDEA— V I ——--------—----------------- ERIKGKVLDICARYP
Cj MEIVSNYIADILD DINNEK----------—LQ———————————————ENIKQELKKLASNFI
B j FQQVGGMIAEVLN AIAQSDDGKAPLVE------------------------------- AAIKERVKALTDRFP. . . .  . .  ^. . .  . . . . . .
Ra LPGLPGF 
Ec VYA———
Cj lYERAMF 
B j lY Q --------
Figure 4.11: Alignment of derived amino acid sequence of rabbit SHMT (Ra) with the derived amino 
acid sequences of SHMT from E. coli (Ec), C jejuni (Cj) and B. japonicum (Bj) using CLUSTAL 
(Higgins & Sharp, 1988, 1989). * represents conserved amino acids . represents conservative changes
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four sequences, with a further 29% of conservative substitutions, while the identity 
between the bacterial proteins is 42.3% with a further 32% of conservative changes.
In the rabbit protein, there are two extended insertions from amino acid 7-24 
and 448-462 as well as five smaller insertions throughout the protein from amino 
acids 110-113, 153-158, 268-276 and 440-445 that are not present in the bacterial 
proteins. These sequences account for a lot of the dissimilarity between the rabbit 
protein and the bacterial counterparts and also the larger size of the rabbit enzyme. 
The larger size of SHMT from B. japonicum relative to the other bacterial proteins 
is also due in part to extra sequences at the N and C terminals, from amino acids 7- 
12 and 440-445.
Worthy of mention are the regions from amino acid 49-55, 69-79, 114-117, 
146-152,222-225,301-304, 355-358 and 399-407, where sequences are either exactly 
conserved, or substituted for by conservative amino acids between all proteins. The 
lysine residue at position 257, which is implicated in the attachment of the pyridoxal 
5’-phosphate coenzyme (Bossa et al. , 1976; Plamann et al. , 1983) and the conserved 
histidine residue at 256, adjacent to this lysine also implicated in the active site of the 
enzyme, are both conserved throughout the species. The region surrounding this 
lysine and histidine are also exactly conserved, the exception being C. jejuni which 
has two serine residues substituted for threonine.
A sulphydryl group reported as essential in the mammalian cytosolic 
isoenzyme (cysteine, 204; Schirch & Peterson, 1980) must be a unique feature of that 
protein since it is substituted for by alanine in the bacterial protein sequences. There 
are five other instances where a cysteine residue is a unique feature of the mammalian 
enzyme. A cysteine residue is substituted for an alanine residue at positions 105, 
248, 335 and 381, and for a proline residue at position 261. There are nine other 
non-conservative substitutions in the mammalian enzyme for amino acids that are 
conserved across the bacterial species; alanine for leucine (112), histidine for glycine 
(145), isoleucine for lysine (164), glutamic acid for proline (246), leucine for lysine 
(290), histidine for leucine (305), asparagine for methionine (306), valine for lysine
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(312) and a proline for tyrosine (479).
Two of the unique insertions in rabbit SHMT contain motifs with the potential 
for phosphorylating serine/threonine residues at positions 161 and 275. Insertion 
region 154-158 includes a lysine residue producing a basic doublet (KK, KR) on the 
N-terminal side of ser-161, similarly insertion region 269-277 contains a basic doublet 
(RR, RK) on the N-terminal side of either serine or threonine at position 275 (Figure 
4.11). Such a sequence motif is known to determine phosphorylation of eucaryotic 
proteins by cyclic AMP-dependent and other kinases (Kemp & Pearson, 1990; Roach, 
1991). Since the rabbit liver cytosolic enzyme can be phosphorylated in vitro using 
the catalytic subunit of a cyclic AMP-dependent protein kinase (K. Snell, unpublished 
work) it is possible that the two insertion regions therefore have a unique role to play 
in the phosphorylation of SHMT. At present the regulatory significance of 
phosphorylation of SHMT is not known.
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CHAPTER 5
EXPRESSION OF RABBIT CYTOSOLIC SHMT cDNA
5.1 SUMMARY
The cloned rabbit cytosolic SHMT cDNA insert from pUS1203 was expressed in 
COS-1 cells using the hcmv promoter in the vector, pUSlOOO. A 33% increase in 
SHMT activity was observed in cells transfected with the expression vector, 
p u s 1202, compared to control COS-1 cells transfected with pUSlOOO. In an attempt 
to increase the level of expression of SHMT, site specific mutagenesis to remove the 
upstream ATG codon (see chapter 4) was carried out to generate plasmid pUS1208, 
and the effect of the mutation on SHMT expression was studied. Expression of the 
SHMT cDNA in pUS1208, in COS-1 cells resulted in a dramatic increase in SHMT 
activity. The level of SHMT activity in COS-1 cells transfected with the mutated 
SHMT cDNA was 50-fold greater than pUS1202 transfected cells and 100-fold 
greater than control pUSlOOO transfected cells. Thus the upstream ATG codon that 
could initiate translation of a 69 amino acid protein overlapping the amino terminus 
of SHMT, has a significant regulatory role in controlling the expression of SHMT 
when transfected into COS-1 cells. The observed increase in expression of SHMT 
following removal of this ATG supports the scanning model of translation as proposed 
by Kozak (1989).
5.2 RESULTS
5.2.1 Subcloning the rabbit SHMT cDNA into the expression vector. dUSIOQO
The expression vector pUSlOOO (Jackson et ah, 1992), drives transcription of the 
inserted cDNA using a human cytomegalovirus promoter located upstream of the 
EcoRI restriction site, into which the cDNA was cloned. Other features of the 
plasmid are detailed in section 2.3.4.
Vector DNA was isolated (section 2.7.1(ii)) and digested with restriction 
enzymes to confirm the presence of the hcmv promoter and the selectable marker, 
gpt. Digestion of pUSlOOO with EcoRI should linearise the plasmid, since it is a 
unique site used for cloning. Digestion of pUSlOOO with Hindlll should release the
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promoter element of 600bp, while digestion with BamHI should release an insert of 
2.2kb, which represents the gpt gene. Figure 5.1 shows the products obtained 
following electrophoresis of digested plasmid on a 0.8% agarose gel. As can be seen, 
the bands obtained are as expected from the known restriction map of the plasmid.
pus 1203 was digested to completion using EcoRI to release the complete 
rabbit SHMT cDNA, before electrophoresis on a 0.8% agarose gel. The released 
fragment of 2.3kb was purified using Geneclean™ (section 2.7.4(i)) and ligated into 
p u s 1000 that had been digested with EcoRI and dephosphorylated using CIP as 
described (section 2.13.3). After ligation, the DNA was used to transform DHSol 
cells to ampicillin resistance (section 2.14.1) and transformants were picked, grown 
overnight and plasmid DNA extracted for analysis (section 2.7. l(i)). Since no colour 
selection scheme could be used, the presence of an insert was detected by EcoRI 
digestion. Those plasmids that contained inserts were further digested using Kpnl to 
orientate the inserted cDNA relative to the promoter. Digestion of inserts with Kpnl 
should release an insert of approximately 1.8kb if the cDNA has been inserted in the 
correct orientation relative to the promoter, whereas those transformants which had 
the cDNA inserted in a 3' to 5’ orientation should release a band of approximately 
2.2kb when digested with Kpnl. Figure 5.2 shows that plasmid number 9 contains 
the insert in the correct orientation for expression and was subsequently renamed 
pUS1202.
5.2.2 Transfection of dUS1202 into COS-1 cells
pUS1202 and control vector pUSlOOO were transfected into COS-1 cells as described 
(section 2.12.1). Six flasks of cells were independently transfected, 3 with pUS1202 
and 3 control transfections with pUSlOOO. The success of the transfection was 
monitored by Northern blot analysis, SHMT activity assay and polyacrylamide gel 
electrophoresis of proteins extracted from transfected cells.
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(kb) 2 3 1 —-
1 2 3 4
F ig u re '5 . 1 : Digestion ot 'pUSlOOO with HcoRl, Hindl ll  and BaniHI to cont'irm the 
presence o f  promoter  and gpt gene.
Uane 1: lambda DNA/Hindl l l  markers (see ap;iendi\  i)
Uine 2: pUS 1(KX)/Hindlll 
I^me 3: pUSl(KK)/BamHl 
I .ane 4: pi JS1 (MM), i:coKi
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Figure 5.2: Orientation o f  rabbit SH M T in pU Sl202 with respect to promoter.
U n e  I: lambda DN A/Hindlll  markers (appendix i)
U n e  2: plasmid no. 7/Kpnl 
U n e  3: plasmid no. 8 /Kpnl 
U n e  4: plasmid no. 9 / Kpnl 
U n e  5: plasmid no. 10/Kpnl 
U n e  6: plasmid no. 11/Kpnl
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(i) Northern blot analysis of expressed SHMT mRNA
Northern blot analysis was carried out on RNA extracted from transfected cells to 
demonstrate that the rabbit SHMT cDNA insert was transcribed from the hcmv 
promoter. RNA extracted from cells transfected with pUSlOOO and pUS1202 (section 
2.6.2), was electrophoresed (in duplicate) through a 1.2% denaturing formaldehyde 
gel as described in section 2.8. l(ii). One set of duplicate samples and marker RNAs 
were stained with ethidium bromide and the other set of samples were transferred to 
a nylon filter. The resulting filter was hybridised at 45°C using radiolabelled cDNA 
from pus 1201 as a probe (section 2.11.5). Figure 5.3 shows an autoradiograph of 
the filter after washing at 45®C in 2xSSC/0.1 % SDS and exposing to an X-ray film 
at -70°C overnight. Two bands are observed in the pUS1202 transfected cells that are 
not present in control transfected cells, thus indicating that the cells had taken up the 
exogenous DNA and the inserted SHMT cDNA was transcribed from the hcmv 
promoter. The size of bands observed following transfection of COS-1 cells (2.2kb 
and 1.5kb) corresponds to that seen in the Northern blot analysis of RNA extracted 
from rabbit liver tissue (chapter 3, figure 3.5). The presence of a 1.5 kb band in 
both the transfected cells and rabbit liver tissue may indicate processing of the 2.2kb 
transcript to a smaller 1.5kb message. Figure 5.4 shows the result of the ethidium 
bromide staining of the RNA and shows that the same amount of RNA was present 
in both pUSlOOO and pUS1202 samples.
(ii) PAGE analysis of proteins
The Northern blot analysis of RNA extracted from transfected cells confirmed that 
the transfected cDNA was being transcribed. To demonstrate translation of this 
mRNA into SHMT, two approaches were taken. The first was SDS-PAGE of 
proteins extracted from transfected cells to see if the expressed SHMT could be seen 
on a gel. The second approach was to assay the transfected cells for SHMT activity.
Proteins were extracted from the COS-1 cells following labelling with ^^ S- 
methionine as described in section 2.12.1, denatured by boiling with SDS/2- 
mercaptoethanol (section 2.8.2(ii)) and electrophoresed through a 9% SDS-
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Figure 5.3: Northern blot analysis of total RNA extracted from pUSlOOO and
pUS1202 transfected cells. The filter was probed with radiolabelled 
cDNA from pUS1201.
Lane 1: RNA extracted from pUSlOOO transfected cells 
Lane 2: RNA extracted from pUS1202 transfected cells
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Figure 5.4: Electrophoresis o f RNA extracted from pUSlOOO and pUS1202
transfected cells.
Lane 1: RNA extracted from pUSlOOO transfected cells 
Lane 2: RNA size standard markers (appendix i)
Lane 3: RNA extracted from pUS1202 transfected cells
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polyacrylamide gel as described (section 2.8.2(ii); Laemmli et al. , 1970). Following 
treatment of the gel to amplify the signal, the gel was exposed to X-ray film. Figure 
5.5 shows the resulting fluorograph. The predicted size of the cytoplasmic protein 
is 53kDa. A faint band is present in the proteins extracted from pUS1202 transfected 
cells at approximately 53kDa, that is not visible in the control pUS 1000 transfected 
cells.
(iii) SHMT activity assay
Antibodies to SHMT were not available, therefore a Western blot could not be carried 
out to unequivocally prove that the observed protein band was indeed SHMT. To 
determine if SHMT levels were elevated in pUS1202 transfected cells an assay 
specific for SHMT was carried out. The method for assaying the activity is based on 
a method devised by Taylor and Weissbach (1965). This assay measures the *^*0 
transferred from "^^ C-serine to methylene-THF, by equilibrating methylene-THF with 
a carrier, formaldehyde, and complexing the formaldehyde to dimedone which can 
then be measured.
The cells were harvested following treatment with trypsin (section 2.17.1(i)), 
counted (section 2.17.3) and resuspended to a density of 5x10® cells/ml before 
sonication. The SHMT assay was carried out as described using 1x10® cells in the 
assay (section 2.18.1). For pUSlOOO transfected control cells an activity of 33nmole 
formaldehyde formed/10® cells/hr was observed. In the pUS1202 transfected cells, 
an activity of 49nmole formaldehyde formed/10® cells/hr was detected, giving a 33% 
increase in SHMT activity in cells transfected with rabbit SHMT over cells 
transfected with pUSlOOO.
5.2.3 Mutagenesis to remove the upstream ATG in rabbit SHMT cDNA
The scanning model of translation in eucaryotes predicts that the distal most 5’ AUG 
codon on the mRNA is used as the initiating AUG, provided it is in good sequence 
context (Kozak, 1989). An examination of the 5’ UTR sequence of the rabbit SHMT
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Figure 5.5: PAGE analysis of proteins extracted from pUSlOOO and pUS1202
transfected ceils. * indicates expressed protein 
Lane 1: Proteins extracted from pUSlOOO transfected cells 
Lane 2: Proteins extracted from pUS1202 transfected cells 
Lane 3: radiolabelled size standards (appendix i)
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cDNA revealed the presence of an ATG codon (position 5, figure 4.7) upstream of 
the ATG used to initiate translation of the SHMT enzyme (see chapter 4). The 
sequence surrounding this ATG indicates that the ATG is in good context as described 
by Kozak (1987), and thus could act as a barrier to a scanning 40S ribosomal subunit. 
In order to examine the effect of this upstream ATG codon on SHMT expression, and 
to attempt to optimise expression of rabbit SHMT in COS-1 cells, mutagenesis was 
carried out on the cDNA insert in pUS1202 to remove the upstream ATG. The effect 
of this on SHMT expression was then determined by transfecting the mutated rabbit 
SHMT cDNA (pUS1208) and the original rabbit SHMT (pUS1202) into COS-1 cells 
and looking at the levels of SHMT produced.
Site specific mutagenesis of the cDNA insert in pUS1203 was carried out 
using two synthetic oligonucleotides, one of which contained the desired mutation, to 
amplify a fragment of the cDNA insert in pUS1203. This mutated fragment was then 
used to replace the same region of pUS1202 to generate a new plasmid pUS1208, 
which contained a cDNA insert identical to that in pUS 1202 except it lacked the 
upstream ATG codon at position 5 of the insert in pUS1203. The downstream 
primer, oligo 2-ATG (see below), was designed around a unique Clal restriction site 
located at position 420 of the rabbit cDNA which would allow replacement of the 
original sequence by the mutated fragment. The upstream primer containing the 
mutation, oligo 1-ATG, was synthesised, to modify the ATG codon to a sequence that 
would result in the generation of a new Clal restriction site. The exact nucleotides 
that were altered are shown below, the ATG to be mutated is shown in bold, and the 
new Clal restriction site is underlined. Cloning of the mutated DNA into pUS1202 
was then facilitated by the presence of the Clal site in the insert and the presence of 
a unique Clal restriction site in pUSlOOO, located 20 nucleotides upstream of the 
EcoRI restriction site and 30 nucleotides downstream of the hcmv promoter. The
ü ^ d  S  bix.strategy used in the generation of plasmid pUS1208 is outlined in figure 5.6,^and the 
difference between pUS1202 and pUS1208 is depicted in figure 5.7.
pUS 1202 sequence: 5’ AAAGATGAAGAAAAAGGAGCCAGTGG 3’ 
Oligo 1-ATG: 5’ AAAGATCGATAAAAAGGAGCCAGTGG 3’
Oligo 2-ATG: 5’ CCACTCATCGATATGCTCAGT 3’
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o l ig o  I -A TG o l i g o 2 - A T G
 ATCGAT
AAAGATGAAG
p u s  1203
r e m a in i n g  SHMT 
sequence
a m p l i f i c a t i o n  b y  PCR
A A AG A T C G A T A A
Clone i n t o  pCR v e c t o r  t o  g e n e r a t e  
p u s  1207
p u s  1207
Figure 5.6a; A m p l i f i c a t i o n  o f  5' r e g i o n  o f  SHMT cDNA 
f r o m  p U S I 2 0 3  t o  g e n e r a t e  m u t a t e d  f r a g m e n t  wh ich  
when c lo n e d  i n t o  pCR r e s u l t s  in g e n e r a t i o n  o f  p U S I 207.
pUS1202
C C
A d
promoter
promoter
pUS1207
Clal digestion and purification 
of fragments
C C
t d
promoter
pUS1208
Figure 5.6 Construction of pUS1208 
E-EcoRI,ClaI,H-HindIII
176
EcoRI ATG
Clal
hcmv
promoter 5’UTR SHMT
TAG
ATG
3’UTR
p u s  1202
promoter
ATG
clal
11
5’UTR SHMT
TAG
3’UTR
pUS 1208
Figure 5.7: Differences in the 5’ UTR of the cDNA inserts in 
pUS1202 and pUS1208
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Amplification was carried out as described in section 2.15.2 using pUS1203 
as a template and oligo 1-ATG and oligo 2-ATG to amplify a region of 420 
nucleotides, at an annealing temperature of 48®C. An aliquot of the amplification 
reaction (20/xl) was electrophoresed on a 1% agarose gel to examine the product. 
Figure 5.8 shows a band of the expected size in the reaction containing pUS1203 
DNA, whereas no band was observed in the negative control reaction containing no 
DNA. Without further purification, an aliquot of the PCR reaction was diluted to a 
concentration of 12.5ng/jnl and this was used directly for ligating into pCR™II 
(section 2.3.3). This vector is specifically designed for cloning PCR products by 
having a deoxythymidine overhang at the insertion site, which takes advantage of the 
non-template dependent activity of Taq polymerase to add a deoxyadenosine 
nucleotide to the 3’ end of the amplified DNA.
The ligation reactions were used to transform darn JMllO  to ampicillin 
resistance. Transformants were picked and grown overnight. Plasmid DNAs were 
extracted (section 2.7. l(i)) and digested with Clal to check for the presence of the 
required insert. Plasmids that contained inserts of the correct size were transformed 
into DH5ol cells and DNA was extracted from transformants. Double stranded 
sequencing was carried out on these plasmids using the universal and reverse primers 
(section 2.9.3 and 2.9.1). The sequence obtained confirmed that the desired mutation 
had taken place, and this was the only change that had occurred. Figure 5.9 shows 
sequence of the mutated region with the new Clal restriction site in the place of the 
upstream ATG codon. The pCR™II plasmid containing this mutated upstream region 
and part of the coding sequences for SHMT was renamed pUS1207.
5 .2 .4  Constnictîon o f dUS1208 containing rabbit SHMT cDNA without the 
upstream ATG
pus 1202 was transformed into dam' JMllO to generate unmethylated DNA. Plasmid 
DNA was extracted from transformants and digested to completion with Clal to 
release two bands of 440bp and 7.2kb. The 440bp band represents 420 nucleotides 
of rabbit SHMT cDNA and 20 nucleotides of pUSlOOO sequence, and the larger band
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Figure 5.8; Amplification o f  a 420bp region o f  the cDN A insert in pUS1203 to 
generate a mutated rabbit SH M T clone.
Lane 1: negative control reaction, no DNA 
Lane 2: phiX174/HaellI  markers (appendix i)
Lane 3: amplification reaction using pUS1203 as template 
Lane 4: amplification reaction using pUS1203 as template
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Figure 5.9: Sequence of the mutation in the cDNA insert in pUS1207
1 2 0
Lane 1: lambda Hindlll markersLane 2; pUS 1208 digested with Clal
I
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Figure 5.9a; Digestion of pUS1208 with Clal
represents the pUSlOOO vector, the remaining coding sequences for SHMT and the 
3’ UTR. The 7.2kb band was purified from the gel using Glassmax™ as described 
(section 2.7.4(iii)) and was dephosphorylated using GIF (section 2.13.2).
pus 1207 DNA was also digested to completion using CM and the products 
of the digestion were electrophoresed on a 1.2% agarose gel. The 420bp fragment 
released was purified from the gel using Glassmax™ (section 2.7.4(iii)) and ligated 
into pus 1202 that had been digested with CM and dephosphorylated using GIF 
(section 2.13.3). DNA from the ligation reaction was used to transform DH5a cells 
and transformants were picked and grown overnight. Flasmids containing the insert 
in the correct orientation were identified by digestion with Sstll. Digestion with Sstll 
releases a 1.6kb insert if the cDNA insert from pUS1207 has inserted in the correct 
orientation, or a 1.2kb fragment if the insert was in the incorrect orientation with 
respect to the remainder of the coding sequences. Figure 5.10 shows that plasmids 
number 8 an 10 have a digestion pattern that demonstrates the insert is in the correct 
orientation. These plasmids were then used to transform JMllO cells, and DNA 
extracted from the transformants was digested with CM to ensure that the reading 
frame was intact at the site of insertion of the cDNA insert from pUS 1207. ([fig 
Following digestion with CM and electrophoresis of the digested products on an 
agarose gel, a band of the expected size was observed thus showing that the CM 
restriction sites were still intact and the reading frame for SHMT had not been 
altered. This new vector containing rabbit SHMT cDNA without the upstream ATG, 
in the expression vector pUSlOOO, was named pUS1208.
5.2.5 Transfection of pUS1208 into COS-1 cells
Transfection of COS-1 cells with pUSlOOO, pUS1202 and pUS1208 was carried out 
as described in section 2.12.1. A total of nine flasks of cells were transfected, three 
with each of the expression vectors. As before the success of transfection was 
monitored by RNA analysis, the assay of SHMT activity and SDS-FAGE of 
radiolabelled proteins.
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Figure 5.10: Orientation o f rabbit SHMT cDNA in pUS1208.
Lane 1: lambda/Hindlll Lane 6: pUS1202/KpnI
Lane 2: pUSlOOO/Hindlll Lane 7: pUS1208/KpnI
Lane 3: pUS1202/HindIII Lane 8: pUSlOOO/Sstll
Lane 4: pUS1208/HindIII Lane 9: pUS1202/SslII
Lane 5: pUSlOOO/Kpnl Lane 10: pUS1208/SstII
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(i) Production of SHMT RNA
RNA was extracted from transfected cells as before (section 2.6.2). To demonstrate 
SHMT transcription from the hcmv promoter in both pUS1202 and pUS1208, and to 
determine whether the specific mutation engineered in pUS1208 had affected the 
levels of transcription of the SHMT cDNA, extracted RNA was hybridised with 
labelled cDNA from pUS1203. RNA extracted from each of the three transfections 
was dotted onto nylon filters as described in section 2.11.2(i), and hybridised with 
radiolabelled SHMT cDNA from pUS1203 (section 2.11.5). The filter was then 
washed first with 2xSSC/0.1%SDS at 45®C, followed by lxSSC/0.1%SDS also at 
45°C, before exposing to X-ray film at -70°C. The resulting autoradiograph can be 
seen in figure 5.11 and shows that the levels of transcription of SHMT in both 
pus 1202 and pUS1208 is the same, suggesting that any increase in SHMT activity 
in the pUS1208 transfected cells is a direct result of the introduced mutation 
enhancing translation. RNA extracted from control pUSlOOO transfected COS-1 cells 
did not hybridise to the probe.
(ii) SDS-PAGE analysis of proteins
Transfected cells were radiolabelled with ^^S-methionine as before and the proteins 
were subsequently electrophoresed through a 9% SDS-polyacrylamide gel as 
described (section 2.8.2(ii)). The gel was treated to amplify the signal before 
exposing to X-ray film. The fluorograph obtained after a 24 hour exposure of the X- 
ray film to the gel is seen in figure 5.12. Lane 4, which contains proteins extracted 
from pUS1208 transfected cells, has an intense band that is clearly amplified 
compared (o the corresponding region in lanes 2 and 3, which represent proteins 
extracted from pUSlOOO and pUS1202 transfected cells respectively. This band 
represents a protein of approximately 53kDa, the expected size of rabbit cytosolic 
SHMT (Martini et a l , 1987).
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Figure 5.11: Dot blot analysis of RNA extracted from pUSlOOO, pUS1202 and 
pUS1208 transfected cells. Filter was hybridised with radiolabelled 
cDNA from pUS1206.
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Figure 5.12: PAGE analysis o f proteins extracted from transfected cells. 
Lane 1: '^C-radiolabelled size standards (appendix i)
Lane 2: Proteins extracted from pUSKXX) transfected cells
Lane 3: Proteins extracted from pUS1202 transfected cells
Lane 4: Proteins extracted from pUS1208 transfected cells
* indicates expressed protein
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(iii) SHMT activity assay
The protein band seen in figure 5.12 indicates that a protein in pUS1208 transfected 
cells is being expressed at a much higher level than in pUS1202 and pUSlOOO 
transfected cells. The size of the protein being expressed is that expected for rabbit 
cytosolic SHMT. To determine if SHMT enzyme activity was correspondingly 
elevated a specific assay for SHMT activity was carried out according to section
2.18.1.
The cells from each transfection were treated with trypsin, counted and 
resuspended to a density of 10^  cells/ml. Triton was added to a final concentration 
of 0.05% before sonicating the cells. The assay was carried out as before using 
2x10  ^ cells in each assay. In pUSlOOO transfected cells, an activity of 20.7 nmole 
formaldehyde formed/hr/2xl0^ cells was obtained. The activity found in pUS1202 
transfected cells was approximately double that found in pUSlOOO transfected cells 
at 44.9 nmole formaldehyde formed/hr/2xl0^ cells. In cells transfected with pUS1208 
a dramatic increase in SHMT activity was observed. The level of activity found in 
these cells was approximately 100-fold the level found in control pUSlOOO transfected 
cells and 50-fold the level in pUS1202 transfected cells, at 2246.3 nmole 
formaldehyde formed/hr/2xl0^ cells. This high level of SHMT activity found in cells 
transfected with the mutated SHMT cDNA indicates that the intense band seen in 
figure 5.11 is likely to be SHMT, and indicates that removal of the upstream ATG 
codon has greatly increased expression of SHMT in COS-1 cells.
SHMT a c t iv i t y  in  u n its  o f nm ole  fo rm a ld e h yd e  fo rm e d  p e rh o u r /2 x 1 0 ^  ce lls :
cpm  sam ple  cprn b lank
s p e c if i cac ti v i ty o f  se rine  
(cp m /n m o le )5.3 DISCUSSION
X 3 X 50 X 1.25
Having isolated the complete coding sequence for rabbit cytosolic SHMT as well as 
the 5’ and the 3’ untranslated regions, it was possible to express SHMT in COS-1 
cells. The low level of expression initally obtained was not suitable for purification 
of SHMT from transfected mammalian cells and prompted a search for ways of 
increasing this expression. The role of the upstream ORF in regulating SHMT 
expression was therefore analysed.
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The scanning model for initiation of translation in eucaryotes predicts that a 
40S ribosomal subunit binds to the capped 5’ end of the mRNA and migrates along 
the mRNA until it finds an AUG codon that is in a favourable context for initiating 
translation (Kozak, 1978). Factors affecting this process are potential mechanisms 
for regulating translation and hence expression of a particular protein. Two factors 
which can affect initiation of translation are the presence of upstream AUG codons 
within the sequence and secondary structures within the 5’ UTR that might slow down 
movement of the ribosomal subunit along the mRNA. Examination of the sequence 
of the 5’ UTR in the SHMT cDNA insert in pUS1203 has revealed the presence of 
both an upstream ATG and a potential stem and loop structure.
The 5’ UTR of rabbit SHMT contains an imperfect GC rich indirect repeat 
sequence of ten nucleotides located at positions 62-71 and 128-137 (see chapter 4, 
figure 4.7) which has the potential to form a stem-loop structure. There is a single 
mismatch within the sequence, a G at position 67 is replaced by an T at position 132. 
Whether such a stem and loop structure is formed is not known, however it could act 
as a barrier to movement of the 40S ribosomal subunit along the mRNA to the AUG 
initiating SHMT translation which lies 18 nucleotides downstream of the stem.
A number of cases have now been established where insertion of sequences 
that could form secondary structures in the 5’ UTR of an mRNA, have decreased the 
efficiency of downstream translation. Insertion of oligonucleotides, which had the 
potential to form a secondary structure, into the 5’ UTR of the thymidylate kinase 
gene decreased translational efficiency of thymidylate kinase mRNA in rabbit 
reticulocyte lysates (Pelletier & Sonnenberg, 1985). Similar experiments carried out 
by inserting oligonucleotides, designed to create hairpin structures, upstream of the 
ATG initiating codon for preproinsulin, have also indicated that secondary structures 
upstream of ATG codons decreases the efficiency of downstream translation (Kozak, 
1986). Kozak also established that the strength of the secondary structure was 
important in determining its influence on downstream translation (1986). Naturally 
occurring secondary structure in the 5’ UTR of bovine aldehyde dehydrogenase 
mRNA has been implicated in regulating translation of this enzyme in rabbit 
reticulocyte systems, whereas with rat aldehyde dehydrogenase, which was predicted
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to have a less stable secondary structure in the 5’ UTR than the bovine clone, higher 
levels of translation were obtained (Guan & Weiner, 1989). Further investigations 
into the regulatory role, if any, of the inverted repeated sequence in SHMT 5’ UTR 
have not been carried out to date, however, as previous examples have indicated, the 
presence of such a sequence, particularly a GC rich one like this, could act as a 
barrier to a moving 40S ribosomal subunit and thus decrease the rate of translational 
efficiency downstream.
The influence of the upstream AUG codon on downstream translation of 
SHMT mRNA has been more clearly defined. Removal of this AUG codon has 
caused a dramatic increase in SHMT activity. The increased levels of SHMT activity 
are not due to an increased level of transcription or to an increased transfection 
efficiency in pUS1208 transfected cells, as seen in figure 5.11, supporting the 
scanning model for translation which predicts that upstream AUG codons in good 
sequence context have an effect on downstream initiation of translation from 
subsequent AUGs. The upstream ATG codon mutated in pUS1208 lies in good 
sequence context and agrees with the consensus sequence proposed by Kozak of 
ACCATGG (1987). This ATG codon could initiate translation of the 69 amino acid 
protein described in chapter 4, however no evidence for the production of such a 
protein has been found. Upstream AUG codons are relatively rare in vertebrate 
mRNAs occurring in less than 5% of cases (Kozak, 1987).
AUG codons introduced upstream of the AUG initiating translation of the main 
downstream ORF, have decreased translation from the downstream AUG (Kozak, 
1984). The insertion of an AUG codon upstream of the AUG initiating translation 
of preproinsulin was reported to reduce the yield of proinsulin following transfection 
into COS cells (Kozak, 1984). A naturally occurring single base mutation that results 
in the formation of an upstream AUG codon in the 5’ UTR of pigtail macaque 
erythrocyte carbonic anhydrase mRNA causes a 5000-fold reduction in the levels of 
carbonic anhydrase (Bergenhem et al. , 1992). However the presence of an upstream 
AUG does not always imply regulation of the initiation of translation from the 
downstream AUG. Mutagenesis of an ATG codon located in the 5' UTR of CBSl
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gene of yeast, which is required for expression of components of the respiratory 
chain, was found to have no effect on translation of the CBS 1 protein (Krummeck et 
a l , 1991),
The mechanism of regulation of SHMT by this upstream AUG is not known. 
It is possible that removal of the AUG has simply removed a barrier to the scanning 
40S ribosomal subunit and thus the first ATG codon in pUS1208 that the scanning 
40S subunit reaches, is the ATG codon initiating translation of SHMT. This case 
supports the current scanning model of translation (Kozak, 1989). It is also possible 
that the small ORF protein product which would result if translation was initiated 
from the upstream AUG, has a regulatory effect on SHMT translation and removal 
of the ATG and hence the ORF, removes this effect. As already mentioned there is 
no evidence for the presence of such a protein and the increased level of SHMT 
expression in pUS1208 transfected cells most likely results from removing a block to 
the scanning ribosomal subunit.
With the vastly increased levels of protein being produced in the COS-1 cells, 
it should now be possible to purify the protein from these cells. It would be 
interesting to examine the effect of mutations in the inverted repeated sequence to see 
if this would also increase levels of SHMT expression. Another way of maximising 
the amount of SHMT produced is to use a more efficient method of transfection. The 
DEAE-dextran method used here to transfect COS-1 cells has a transfection efficiency 
of approximately 10%. Commercial methods now available, such as lipofectin 
(BRL), which uses a lipid based mechanism, have a much higher transfection 
efficiency (90%). By using a combination of a method such as lipofectin and the 
rabbit SHMT cDNA in pUS1208, it should be possible to achieve even higher levels 
of SHMT activity, which would allow the purification of larger amounts of SHMT.
Isolation of the 5’ UTRs for other SHMTs will enable comparative studies to 
ascertain whether upstream ATGs and short ORF overlapping the SHMT initiation 
codon are a common feature, which will reinforce the premise that they have a 
regulatory function.
129
CHAPTER 6
ISOLATION OF HUMAN SHMT cDNA
6.1 SUMMARY
The rabbit liver SHMT cDNA sequence from clone pUS1203 was used to screen a 
human cDNA library made using mRNA isolated from a breast cancer cell line, ZR- 
75-1. Twenty positive clones were isolated, purified further and characterised by 
Southern blot analysis. Sequencing was carried out on two clones, pUS1205 and 
p u s 1206, which had inserts of 1.78kb and 2.68kb respectively. The derived protein 
sequence obtained was compared to that of rabbit SHMT derived from the nucleotide 
sequence of the cDNA insert in pUS1203. The largest clone isolated from the human 
library contained 930bp of SHMT coding sequences, 890bp of 3’ non-coding 
sequence and 850bp of 5’ sequence unrelated to rabbit SHMT. Located within the 
3’ region are four sequences for poly A tail addition, and possibly the start of a poly 
A tail. The SHMT coding sequences are 92% homologous to rabbit SHMT at the 
amino acid level and 85.7% identical at the nucleotide level. Further analysis of the 
unrelated sequence 5’ to the coding sequences revealed a potential mRNA splice 
acceptor site. Contained within this sequence is a region showing very high 
homology to Alu sequences from both humans and chimpanzees.
6.2 RESULTS
6.2.1 LIBRARY SCREENING
Prior to the isolation of the cDNA in pUS1203, the portion of rabbit SHMT coding 
sequences contained in pUS1201 was used as a probe, to screen two different human 
cDNA libraries on the basis of its hybridisation to human RNA in Northern blot 
analysis (chapter 3, figure 3.5). The first cDNA library to be screened was made 
using mRNA isolated from foetal brain tissue (courtesy of K. Davies, Oxford). The 
cDNA inserts were cloned into the lambda ZAP II cloning vector at the EcoRI site. 
A total of 10® plaques were plated using host strain XLl~Blue, and screened using the 
method described in section 2.11.3. Duplicate filters from each plate were hybridised 
with radiolabelled cDNA from pUS1201 at 55°C and subsequently washed at 55°C in 
2xSSC/0.1% SDS. Filters were then exposed to autoradiographs at -70°C for up to
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4 days. No positive clones were identified.
The second cDNA library to be screened was made using mRNA extracted 
from breast cancer cell line, ZR-75-1 (courtesy of D. Reynolds, University of 
Surrey). The cloning vector used was lambda gtlO and the inserts were cloned in at 
the EcoRI site. Again 10® plaques were plated using host strain C600 (section 2.10) 
and screened with radiolabelled cDNA from pUS1201 (section 2.11.3). Duplicate 
filters of each plate were taken and treated as previously described for the foetal brain 
library. No positive clones were identified. Following the isolation of the complete 
coding sequences for rabbit cytosolic SHMT, the breast cancer cell line library was 
rescreened using the complete cDNA from pUS1203 as a probe. Plaques (2x10®) 
were again plated and duplicate lifts from each plate were taken as described. The 
filters were hybridised overnight with radiolabelled cDNA from pUS1203 at 65°C,
before washing at 65°C in 2xSSC/0.1%SDS and exposing to autoradiographs.
/Positive clones that appeared in duplicate were picked and subjected to a second 
round of purification (section 2.10.4). A total of 20 positive clones were identified 
from a first round screen. These clones went through four rounds of purification 
until each was in a homogenous population. During the subsequent rounds of 
purification only 10 clones continued to give a positive signal.
DNA was extracted from each of these clones (section 2.7.2(iii)) and digested 
with EcoRI to release the two lambda aims of 32,7kb and 10.6kb as well as any 
inserted cDNA. Figure 6.1 shows the products of digestion following electrophoresis 
on a 0.8% agarose gel. Although an insert was only clearly visible in clone 13, a 
Southern transfer was performed (section 2.11.1) and the resulting blot probed with 
radiolabelled cDNA from pUS 1203 (section 2.11.4). The pattern observed following 
exposure of the blot to an autoradiograph is seen in figure 6.2. Six of the clones had 
inserts ranging from approximately 1.8kb to 2.7kb. The largest insert was from clone 
7 at 2.68kb, and further studies concentrated on this clone and also clone 1, which 
contained a 1.78kb insert.
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Figure 6.1: Lam bda D N A  extracted from  purified , putative hum an SH M T clones,
was d igested w ith EcoRI to release inserted cD N A  and electrophoresed
through a 0 .8%  agarose gel. 
Lane 1: phiX 174/H aeIII 
Lane 2: C lone 1/EcoR I 
Lane 3: C lone 8/EcoRI 
Lane 4: C lone 4/EcoR I 
Lane 5: C lone 7/EcoRI 
Lane 6: C lone 9/EcoR I
Lane 7: C lone 10/EcoRI 
Lane 8: C lone 13/EcoRI 
Lane 9: C lone 14/EcoRI 
Lane 10: C lone 15/EcoRI 
Lane 11: C lone 19/EcoRI 
Lane 12: lam bda/H ind lll
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Figure 6.2: H ybridisation signal obtained follow ing probing a Southern blot o f  the
gel seen in figure 6.1 w ith radiolabelled cD N A  from  pU S1203. F or
m arker sizes, see appendix i 
Lane 1: ph iX 174/H aeIII 
Lane 2: C lone 1/E coR I 
Lane 3; C lone 8/EcoR I 
Lane 4: C lone 4 /E coR l 
Lane 5: C lone 7 /E coR l 
Lane 6: C lone 9 /E coR l
Lane 7: C lone 10/EcoRI 
Lane 8: C lone 13/EcoRI 
Lane 9: C lone 14/EcoRI 
Lane 10: C lone 15/EcoRl 
Lane 11: C lone 19/EcoRl 
Lane 12: lam bda/H ind lll
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6.2.2 CHARACTERISATION OF PUTATIVE HUMAN SHMT 
DNAs from lambda clones 1, 7, 9 13, 15 and 19, all of which had inserts that 
hybridised to the cDNA from pUS1203, were digested to completion with EcoRI. 
Following electrophoresis of the digested products on a 0.8% agarose gel, the inserts 
were purified using the Geneclean™ method (2.7.4(1)). The purified inserts were 
then ligated into M13mpl8 that had been digested with EcoRI and dephosphorylated 
with CIP (section 2.13.2 & 2.13.3). The ligation products were used to transform 
DH5a. cells to ampicillin resistance (section 2.14.2) and recombinant clones were 
identified using X-gal (chapter 3, section 3.2.3). White recombinant plaques were 
recovered only from ligations using the inserts of clones 1 and 7. The plaques were 
picked and used to prepare stocks (section 2.16.1(i)). Replicative form DNA was 
extracted from overnight cultures of the phage stock (section 2.7.2(i)), and digested 
with EcoRI to check for the presence of inserts.
Following electrophoresis of the digested products (figure 6.3) an insert could 
only be seen in clone lb. The size of the phage band seen in the other clones 
suggested that they also contained inserts. The phage band seen for clones la and Ic 
appeared to be the same size as the equivalent band in 7a and 7b, even though the 
insert in 7a and 7b should have been Ikb larger. Further digestions were carried out 
on these recombinant clones using Kpnl, PvuII, PstI and BamHI to try and confirm 
the presence of inserts in la, Ic, 7a and 7b. Figure 6.4 shows the resulting digestion 
products following electrophoresis of the reactions on a 0.8% agarose gel. In all 
clones, digestion with Kpnl linearises the phage thus indicating that no restriction sites 
for Kpnl are located within the inserts. Digestion with the remaining three enzymes 
although confirmatory for the presence of an insert, are confusing. BamHI and PstI 
release inserts of approximately 300bp each when used to digest lb, yet linearise la 
and 7b. Similarly digestion of lb with PvuII releases two bands of approximately Ikb 
and 800bp, but when used to digest la and 7b, a single band of approximately 300bp 
is released. The digestion pattern of la and 7b suggests that both clones are in the 
same orientation, yet these inserts have undergone a rearrangement and in the case 
of 7b, a deletion that results in the loss of restriction sites BamHI and PstI and a 
PvuII site.
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Figure 6.3: D igestion o f  M 13 clones la , Ib , le , 7b and 7c w ith EcoRI to release
inserted D N A . F or m arker sizes, see appendix i 
Lane 1: phiX 174/H aeIII m arkers 
Lane 2: la/E coR I 
Lane 3: Ib/EcoR I 
Lane 4: Ic/EcoR I 
Lane 5: 7b/EcoR I 
Lane 6: 7c/EcoR I 
L>ane 7: lam bda Hindi 11 m arkers
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Figure 6.4: R estriction enzym e analysis o f  cD N A  inserts in clones la , lb  and 7b
using K pnl, PvuII, PstI and Bam HI. For m arker sizes, see appendix 
i.
Lane 1; lam bda & phi m arkers Lane 8: Ib /PstI
Lane 2; la /K pn l Lane 9: Ib/B am H I
Lane 3: la/P vuII Lane 10: 7b/K pnI
l^ n e  4: la/P s tI I.ane 11: 7b/PvuII
l.ane 5: la/B am H I Lane 12: 7b/PstI
I.ane 6: lb /K pnl 1 ane 13: 7b/Bam  HI
I.ane 7: Ib /Pviill Um e 14: lam bda & phi
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The cDNA inserts from lambda clones 1 and 7 were also ligated into EcoRI 
digested and dephosphorylated pUC 18 to form pUS1205 and pUS1206 respectively. 
Following transformation of DH5ol with the ligation products (section 2.14.1) white 
colonies were selected. DNA extracted from overnight cultures of these colonies was 
digested with EcoRI to check for the presence of inserts. In both cases bands of the 
appropiate size (approximately 1.8kb and 2.7kb respectively) were observed.
6.2.3 SEQUENCING STRATEGY
A preliminary sequence analysis was carried out on single stranded M13mpl8 DNA 
from la, lb, Ic, 7a and 7b using the universal primer to determine the orientation of 
the inserts since the restriction data obtained (figure 6.4) could not be used to 
unequivocally establish orientation. The sequence analysis would also help to resolve 
the confusion surrounding 7a and 7b, which had a restriction map like that of la, yet 
should have contained an insert approximately Ikb larger than the insert in la. The 
results indicated that clone lb contained an insert in the 5’ to 3’ orientation with 
respect to the universal primer and the remaining clones were all in the 3’ to 5’ 
orientation.
Translation of sequence obtained from lb using the universal primer revealed 
the insert to be incomplete at the 5’ end, containing sequences that coded for SHMT 
from amino acid 199, relative to the rabbit numbering system. The sequence of the 
insert in the opposite direction (la and Ic) was identical to the sequence of the insert 
in 7a and 7b. Hence both clones appeared to have the same 3’ untranslated region, 
ending at the same point. Assuming the human protein to be approximately the same 
size as the rabbit enzyme, a further 600 nucleotides would be required to contain 
complete coding sequence for human SHMT. Since the insert from lambda clone 7 
was approximately 2.7kb, it seemed likely that this clone would have all the coding 
sequence as well as some 5’ untranslated region.
Figure 6.5 shows the extent of sequence data obtained from each clone and 
the position of the primers used to sequence them. The sequence of the insert in lb
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was completely determined in triplicate (section 2.9). Clone la was partially 
sequenced. Clone 7b was also partially sequenced when it became apparent that some 
rearrangement of the insert had taken place, thus confirming the previous restriction 
enzyme analysis. The sequence of the entire 2.68kb insert was finally determined for 
both strands in triplicate in pUS1206. The sequence obtained from this clone agreed 
completely with the sequence of the insert in lb. However the 3’ end of the clone 
when sequenced in la, although identical to the 3’ end of clones Ic, 7a and 7b, was 
totally different to the 3’ end of the inserts from both clone lb and pUS1206.
The nucleotide sequence was determined using synthetic oligonucleotides to 
walk the length of the insert in both directions. Some of the primers used to 
sequence the rabbit SHMT cDNA in pUS1203 were also used. The sequences of the 
primers used are shown in figure 6.6.
6.2.4 SEQUENCE OF INSERT IN dUS1206 AND M13/lb
The complete sequence of the insert contained in pUS1206 is shown in figure 6.7. 
The insert is 2.68kb long and contains sequences that code for part of human SHMT. 
The sequence can be divided into three sections. The central part of the cDNA insert 
is 930bp of sequence that codes for 310 amino acids of human SHMT. By analogy 
to the rabbit protein sequence of cytosolic SHMT (chapter 4), the sequence presented 
here is likely to be the cytosolic form of human SHMT. Downstream of the coding 
sequence for SHMT is a 3’ untranslated region of 890bp. Upstream of the coding 
sequence is an 850bp region that shows no similarity to SHMT.
(i) The upstream region
An oligonucleotide (Oligo H2; for postition see figure 6.5) was synthesised based on 
the initial sequence from clone lb, that should sequence further upstream on a longer 
clone.
amino acid: S C Y S R N L
coding seq: AGC TGC TAG TCC CGA AAC T -
Oligo H2: 5’ AGTTTCGGGAGTAGCT 3’
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pUS1206
intron SHMT 3' UTR
HIO 
4 "■ —  "4- H24— C2 Rev
H6 iii H12
uni
H4
H13 H ll HI H7
lb
Figure 6.5: Sequencing strategy used to sequence cDNA 
inserts in pUS1206 and clone lb
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Oligo HIO: 5’ GCCTGCTAATACTACTTC 3’
Oligo H6: 5’ AACAAATGTGACGGGACCAC 3’
Oligo H2: 5’ AGTTTCGGGAGTAGCA 3’
Oligo iii: 5’ TCGCAGCGTCTTGTGGGT 3’
Oligo 3: 5’ ACC/TTTCTGGAAA/GTCT/CTTT/CTC 3’
Oligo C2: 5’ GCCGCCTGGTACTTAT 3’
Oligo H12: 5’ TTGCTGTCAGTAGCTC 3’
Oligo H13: 5’ AAGTAGTATTAGCAGGC 3’
Oligo H ll: 5’ TTGGAGGAAGCAGCCTGAA 3’
Oligo 1: 5’ TTCGAA/GCAT/CTGTCCAT/CGT 3’
Oligo H4: 5’ TCTGTCTGAGGCCCTGA 3’
Oligo HI: 5’ ATAGAGCTGACCCGTCAGAT 3’
Oligo H5: 5’ AAGGGGAACTGTTGA 3’
Oligo H7: 5’ GTATGTTAGTCAAGAG 3’
Figure 6.6; Sequence of oligonucleotides used to sequence cDNA inserts in 
pUS 1206 and clone lb.
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1 0  2 0  3 0  4 0  5 0  6 0  7 0  8 0  9 0
GAATTCCGGTTTTTTTTCAGATGGAGTCTCGCTCTGTTGCCCAGGCTGGAGTGCTGGAGTGCAGTGGCACAATCTCGGCTCACTGCRRGC
1 0 0  1 1 0  1 2 0  1 3 0  1 4 0  1 5 0  1 6 0  1 7 0  1 8 0
TCCACCTCCCGGGTTCACGCCATTCTCCTGCCTCAGCCTCCCAAGTAGCTGGGATTACAGGCGCCCGCCACCATGTCTGGCTAATTTTTT
1 9 0  2 0 0  2 1 0  2 2 0  2 3 0  2 4 0  2 5 0  2 6 0  2 7 0
GCATTTTTAGTAGAGACGGGGTTTCACCATGTTAGCCAGGATGGTCTCGATCTCCTGACCTCATGATCTGCCCGTCTCAGCCTCCCAAAG
2 8 0  2 9 0  3 0 0  3 1 0  3 2 0  3 3 0  3 4 0  3 5 0  3 6 0
TGCTGGGATTACAGGTGTGAGCCACCGCGCCCAGCCCCTACTTCTTGTTTTTCAATGTTGTATCCAGTGACCTTGCTAAATTTGCTTATT
3 7 0  3 8 0  3 9 0  4 0 0  4 1 0  4 2 0  4 3 0  4 4 0  4 5 0
CTAACAGTTGGGCCCTAGCATCTTGATTTTCTAGGTATATTGTGTTGTCTGTGTGTAATGTCAGTTTTTAAATTTCTTCTTTCCTAATCG
4 6 0  4 7 0  4 8 0  4 9 0  5 0 0  5 1 0  5 2 0  5 3 0  5 4 0
t t a t g c c t t t t g t t t c t t t t t c t t g c c t c a t t a t a c t t g g a a t a g a a g t a g t a t t a g c a g g c a t t t t g g t c t t g t t c t t g a a g g t a a c c a
5 5 0  5 6 0  5 7 0  5 8 0  5 9 0  6 0 0  6 1 0  6 2 0  6 3 0
TTTTGGTTTCCATTGTGTGGTCCCGTCACATTTGTTTCATTCTGCAGGTGCTTTTTGGTTCCTTCTCAGCAGGTAGTGCCCCAGCAGCAG
6 4 0  6 5 0  6 6 0  6 7 0  6 8 0  6 9 0  7 0 0  7 1 0  7 2 0
GGCTCACTACAACCCTGGACTCCTCAGGACTCCTGGGTCTGTGAGCCATACTTGGTTGAGCAGGCTGAACACACCAGTATCCATCCTGTC
7 3 0  7 4 0  7 5 0  7 6 0  7 7 0  7 8 0  7 9 0  8 0 0  8 1 0
TCACCCTCAAGTCCTCATCTAGGACATCATTCCTCTTGTCATGGTGGGTGGAGCCAGTTCAAGTGGGAGGACAGGAGGCAGGTGTGGTTG
8 2 0  8 3 0  8 4 0  8 5 0  8 6 0  8 7 0  8 8 0  8 9 0  9 0 0
GAGGAAGCAGCCTGAACCTGCCTCCCTGACATTCCACAGGTGAACCCAGATACTGGCTACATCAACTATGACCAGCTGGAGGAGAACGCA
V N P D T G Y I N Y D Q L E E N A
9 1 0  9 2 0  9 3 0  9 4 0  9 5 0  9 6 0  9 7 0  9 8 0  9 9 0
CGCCTCTTCCACCCGAAGGTGATCATCGCAGGAACCAGCTGCTACTCCCGAAACCTGGAATATGCCCGGCTACGGAAGATTGCAGATGAG 
R L F H P K L I I A G T S G Y S R N L E Y A R L R K I A D E
1 0 0 0  1 0 1 0  1 0 2 0  1 0 3 0  1 0 4 0  1 0 5 0  1 0 6 0  1 0 7 0  1 0 8 0
AAGGGGGGGTATGTGATGGGGGAGATGGGTGAGATGAGGGGGGTGGTGGGGGGTGGGGTGGTGGGGTGGGGATTTGAAGAGTGGGATGTG 
N G A Y L M A D M A H I S G L V A A G V V P S P F E H C H V
1 0 9 0  1 1 0 0  1 1 1 0  1 1 2 0  1 1 3 0  1 1 4 0  1 1 5 0  1 1 6 0  1 1 7 0
GTGAGGAGGAGGAGTGAGAAGAGGGTGGGAGGGTGGGGAGGTGGGATGATGTTGTACAGGAAAGGAGTGAAAAGTGTGGATGGGAAGAGT 
V T T T T H K T L R G G R A G M I F Y R K G V K S V D P K T
1 1 8 0  1 1 9 0  1 2 0 0  1 2 1 0  1 2 2 0  1 2 3 0  1 2 4 0  1 2 5 0  1 2 6 0
GGCAAAGAGATTCTGTACAAGGTGGAGTCTGTTATGAATTGTGGTGTGTTGGGTGGGGTGGAGGGAGGTGGGGAGAAGGAGGGGATTGGT 
G K E I L Y N L E S L I N S A V F P G L Q G G P H N H A I A
1 2 7 0  1 2 8 0  1 2 9 0  1 3 0 0  1 3 1 0  1 3 2 0  1 3 3 0  1 3 4 0  1 3 5 0
GGGGTTGGTGTGGCAGTGAAGGAAGGTATGACTCTGGAATTTAAAGTTTATGAAGAGCAGGTGGTGGGGAAGTGGAGGGGTGTGTGTGAG 
G V A V A L K Q A M T L E F K V Y Q H Q V V A N G R A L S E
1 3 6 0  1 3 7 0  1 3 8 0  1 3 9 0  1 4 0 0  1 4 1 0  1 4 2 0  1 4 3 0  1 4 4 0
GGGGTGAGGGAGGTGGGGTAGAAAATAGTGAGAGGTGGTTCTGAGAAGCATTTGATGGTTGTGGATCTGGGTTGCAAAGGCAGAGATGGT 
A L T E L G Y K I V T G G S D N H L I L V D L R S K G T D G
1 4 5 0  1 4 6 0  1 4 7 0  1 4 8 0  1 4 9 0  1 5 0 0  1 5 1 0  1 5 2 0  1 5 3 0
GGAAGGGCTGAGAAGGTGGTAGAAGCCTGTTCTATTGCCTGGAACAAGAAGAGGTGTGGAGGTGAGAGAAGGGGTGTGGGGGGGAGTGGA 
G R A E K V L E A C S I A G N K N T G P G D R S A L R P S G
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1 5 4 0  1 5 5 0  1 5 6 0  1 5 7 0  1 5 8 0  1 5 9 0  1 6 0 0  1 6 1 0  1 6 2 0
CTGCGGCTGGGGACCCCAGCACTGACGTCCCGTGGACTTTTGGAAAAAGACTTCCAAAAAGTAGCCCACTTTATTCACAGAGGGATAGAG 
L R L G T P A L T S R G L L E K D F Q K V A H F I H R G I E
1 6 3 0  1 6 4 0  1 6 5 0  1 6 6 0  1 6 7 0  1 6 8 0  1 6 9 0  1 7 0 0  1 7 1 0
CTGACCCTGCAGATCCAGAGCGACACTGGTGTCAGAGCCACCCTGAAAGAGTTCAAGGAGAGACTGGCAGGGGATAAGTACCAGGCGGCC 
L T L Q I Q S D T G V R A T L K E F K E R L A G D K Y Q A A
1 7 2 0  1 7 3 0  1 7 4 0  1 7 5 0  1 7 6 0  1 7 7 0  1 7 8 0  1 7 9 0  1 8 0 0
GTGCAGGCTCTCCGGGAGGAGGTTGAGAGCTTCGCCTCTCTCTTCCCTCTGCCTGGCCTGCCTGACTTCTAAAGGAGCGGGCCCACTCTG 
V Q A L R E E V E S F A S L F P L P G L P D F U
1 8 1 0  1 8 2 0  1 8 3 0  1 8 4 0  1 8 5 0  1 8 6 0  1 8 7 0  1 8 8 0  1 8 9 0
GACCCACCTGGCGCCACAGAGGAAGCTGCCTGCCGGAGGACCCCCACCTGGAGAGATGGATGAGCTCGTCCAAAGGGGAACTGTTGACAC
1 9 0 0  1 9 1 0  1 9 2 0  1 9 3 0  1 9 4 0  1 9 5 0  1 9 6 0  1 9 7 0  1 9 8 0
TCGGGCCCTTTGAGGGGGTTTCTTTTGGACTTTTTTCATGTTTTCTTCACAAATCAAAATTTGTTTAAGTCTCATTGTTAGTAATTCTGG
1 9 9 0  2 0 0 0  2 0 1 0  2 0 2 0  2 0 3 0  2 0 4 0  2 0 5 0  2 0 6 0  2 0 7 0
GACAGGTTftTTAAAGGATTTAAATTTGAACCTGGCTTTCTCACAGCTGGACATAATTCTAGGAAAATAAAATACTATGTCGCCACTTGGT
2 0 8 0  2 0 9 0  2 1 0 0  2 1 1 0  2 1 2 0  2 1 3 0  2 1 4 0  2 1 5 0  2 1 6 0
CATAATCATTTAGATGGTGGTGTAGGGCAAAGCTGTTAGAAAGATTGTAGCGTTTTACTCTCCCTGGGCTTTCCTTCCGCCTTGCTGCAA
2 1 7 0  2 1 8 0  2 1 9 0  2 2 0 0  2 2 1 0  2 2 2 0  2 2 3 0  2 2 4 0  2 2 5 0
CAGAGAGGAAATGCCCATGTCCACAGCTTGTACACACTGCCCCCTCACTATCTTGTTATCCAGTGGCATGCCAAAGGAGAACTGAATTAG
2 2 6 0  2 2 7 0  2 2 8 0  2 2 9 0  2 3 0 0  2 3 1 0  2 3 2 0  2 3 3 0  2 3 4 0
CTTCTGAGGCTTCTGCTGTAAATCAGAAGTGTATGTTAGTCAAGAGTAAACAAGATGCACCAGTATGGTGGGAGGGTTGCTGTCAGTAGC
2 3 5 0  2 3 6 0  2 3 7 0  2 3 8 0  2 3 9 0  2 4 0 0  2 4 1 0  2 4 2 0  2 4 3 0
TCAAAGTATGGTGTAGATV^TGGCCTCCTCCCTCCATCCTGGGAAGTCCCAGTCCCATCCTGGTGTGAGAATCAACCAGGCTTTCCTGCTC
2 4 4 0  2 4 5 0  2 4 6 0  2 4 7 0  2 4 8 0  2 4 9 0  2 5 0 0  2 5 1 0  2 5 2 0
CACCTGAGATAACCAACTCCCTCCCGTAATCAGGAAGCCAAATGTCACCTTCCCAAAGAAATTTTATTTTCACGTAGCTGAAGTGCAAAA
2 5 3 0  2 5 4 0  2 5 5 0  2 5 6 0  2 5 7 0  2 5 8 0  2 5 9 0  2 6 0 0  2 6 1 0
CATAGATGACCATTTTTAATAAGCACAATCAAATTTTTAACCACAGAATGTCTACAAGAATTATAGCTTTAAAAAATACAACCAATTTTT
2 6 2 0  2 6 3 0  2 6 4 0  2 6 5 0  2 6 6 0  2 6 7 0
ATATTTCAAAAATATTTGAACTCAAATAAATTAATTTCTTAAAAAGTAAAAAAAAAAAACCGGAATTC
Figure 6.7: Nucleotide sequence of cDNA insert in pUS1206.Direct repeated sequence flanking Alu element are underlined; sequences similar to transcription factor binding sites are marked by dashed line; sequences signalling polyadeny1ation are shown in bold.
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When used to sequence the insert in clone 7b, it was hoped that oligo H2 would 
provide sequence information further upstream. Examination of the resulting 
sequence revealed that instead of continuing to give SHMT cDNA sequence as 
expected, the sequence continued into the M13mpl8 cloning vector at the EcoRI 
restriction site. Although the clone was repeatedly subcloned into M13mpl8 and 
M13mpl9, and sequenced again with oligo H2, the same result was achieved, thus 
showing a deletion from the original insert of 2.68kb when in the 3’ to 5’ orientation 
with respect to the universal primer in M13mpl8. No transformants isolated from 
a ligation of M13mpl8 and the cDNA insert from lambda clone 7 ever contained the 
insert in the opposite orientation. The deletion of approximately 800bp, and the 
rearranged sequence at the 3’ untranslated region meant that further sequencing of the 
2.68kb insert was carried out on pUS1206, where the insert remained stable.
The sequence derived from pUS1206 using oligonucleotide H2 revealed the 
presence of a further 16 amino acids of SHMT sequence upstream of the sequence 
contained in lb. The derived amino acid sequence then diverged completely from the 
sequence of rabbit cytosolic SHMT. When the DNA sequence was translated into all 
three reading frames, no sequence similar to SHMT protein sequence could be 
detected, thus ruling out the possibility of a simple frameshift.
Examination of the sequence at the junction of the SHMT sequence and the 
unidentified sequence revealed a potential mRNA splice acceptor site. The 
dinucleotide preceding the GTG codon for valine-198, is an AG, which is usually 
present at the 3’ end of an intron. Further examination of the sequence surrounding 
this dinucleotide supports the view that this is an mRNA splice acceptor site. The 
frequency of each nucleotide at a position relative to the splice site has been 
calculated for a set of 130 sequences (Mount et al. , 1982), where an AG is obligatory 
at this position, and is shown in table 6.1. Figure 6.8 shows an alignment of the 
sequence surrounding the splice site in pUS1206, with a sequence derived from table
6.1, where at each position the nucleotide of the highest frequency is shown.
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position: -9 -8 -7 -6 -5 -4 -3 -2-1 +1 +2 4-3
highest freq. T T T T T N C A G G T C  
pu s 1206: A T T C C A C A G G T G
Figure 6.8: Comparison o f the sequence surrounding the splice site in pUS1206 with the
nucleotides most frequently found at the splice site junction (Mount et al. , 1982). The nucleotides 
are numbered according to whether they are in the intron or exon, with 4-1 being the first 
nucleotide o f the exon and -1 being the last nucleotide of the intron.
The frequency of nucleotides presented in table 6.1 indicates that the nucleotides at 
position -3, -2 and -1 are the most highly conserved and are the exact nucleotides at 
those positions in pUS1206. The nucleotide at position -4 shows no strong 
preference, with 29%, 25%, 24% and 22% being T, A, G and C respectively, and 
although a T is present in 58% of the sequences examined at positions -5 and -6, the 
next most common nucleotide at these positions is a C, which occurs in 28% and 
35% at positions -5 and -6 respectively.
When the nucleotide sequence of this 850bp region was used in a database 
search, an extensive number of homologies were found. Closer inspection of these 
homologies, revealed that the same section of the sequence was continually being 
picked up. The nucleotide sequence from position 9-322 had a high degree of 
homology, 75-80%, to Alu repetitive sequences and to Alu-like repetitive sequences 
from African green monkey, chimpanzee, G. crassicaudatus, gorilla and humans. 
Homology to pseudogenes was also detected. The Alu containing region (nucleotides 
9-322) is 42.1% identical to a region of human 5S ribosomal RNA pseudogene as 
well as showing homology to chimpanzee B-globin and eta-globin pseudogenes. 
Figure 6.9 shows the alignment of this proposed Alu sequence with other Alu 
sequences isolated from the human genome. When this Alu sequence was removed 
from the database search, no homology with the remaining 540 nucleotides was 
detected.
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alu GTTTTTTTTCAGATGGAGTCTCGCTCT-GTTGCCCAGGCTGGAGTGCTGGAGTGCAGTGGcol -TTTTTTTTGAGATGGAGTCTCGCACT-GTTGCCCAGGCTG---------GAGTGCAGTGGade -TTATTTTTGAGATGCAGTTTCGCTCTTGTCGCCCAGGCTG---------GAGTGCAGTGGg l y -------------------- TCTTGCTCT-GTCACC-AGGCTG--------- GAGTGCAGTGGngf -TTTTTTTTGAGATGGAGTCTCGCTCT-GTCACCCAGGCTGA---------AGTGCAGTGG
*  *  * *  * *  * *  * *  * * * * * *  * * * * * * * * * *
alu CACAATCTCGGCTCACTGCAAGCTCCACCTCCCGGGTTCACGCCATTCTCCTGCCTCAGC col CGCGATCTCAGCTCACTGCAACCTCCACCTCCTGGGTTCATGCAATTCTCCTGCCTCAGC ade CGTAATCTCGGCTCACTGCAGCCTCTGCCTCCCAGGTTCAGGTGATTCTCCTGTCTCAGC gly CA-GATCTCGGCTAACTGCAAGCTCCACCTCCCAGGTTTGAGCGATTCTCCTGCCTCAGC ngf CTTGATCTCGGCTCACTGCAGCCTTTGCCTCCTGGGTTCAAACAAGTCTCCTGCCTCAGC 
*  * * * * *  * * *  * * * * * *  * *  * * * * *  * * * *  *  * * * * * * *  * * * * * *
alu CTCCCAAGTAGCTGG-GATTACAGG-CGCCCGCCACCATGTCT-GGCTAATTTTTTGCAT col CTCCTGACTAGCTGG-GGTTACAGGGTGCACACCACCACACCCAGGCTAATCTTTTGTAT ade CTCCCAAGTAGCTGG-GATTACAGG-TGTGCGCCACCACGCCT-GGCTAATTTTTTGCAT gly CTCCTGAGTAGCTGGTAGCTACAGG-CGCATGCCACCACACTCAG-CTAAT-TTTTGTAT ngf CTCCTGAGTAGCTGG-GACTACAGG-CACACGCCGCCACGCCT-GGCTAATTTTTC-TAT **** * ******* ****** ** *** * ***** * * *  * *
alu TTTTAGTAGAGACGGGGTTTCACCATGTTAGCCAGGATGGTCTCGATCTCCTGACCTCA- co1 TTTTAGTAGAGACGTGGTTTCACTATGTTGGCCCGACTGGTCTCAAACTCCTGACCTCAT ade TTTTAGTAGAGATGGGGTTTCACCATGTTGGCCAGGCTGGTCTCAAACTCCTGGCCTCA- gly TTTTAGTAGAGACGGAGTTTCTCCATGTTGGCCAGGCTTGTCTCGATCTCTTGACCTT—  ngf TTTTTGCAGAGGCGGGGTTTCACCATGTTGGCCAGGATGGTCTTGATCTC-TGATCTC—  
* * * *  *  * * * *  *  * * * * *  *  * * * * *  * * *  *  *  * * * *  *  * * *  * *  * *
alu — TGATCTGCCCGTCTCAGCCTCCCAAAGTGCTGGGATTACAGGTGTGAGCCACCGCGCC col GGTGATCCGCCCGCCTTGGCCTCCCAAAGTGCTGGGATTACAGGCATGAGCCACCGTGCC ade GGTGATCCACCCACCTCGGCCTCCCAAAGTGGCTGGATTACAGGGGTGAGCCCCCATGCCgly -GTGATCCGCCCACCTCGGCCTCCCAAAGTCCTGGGATTACAGGCGTGAGC----------ngf -GTGATCCGCCC-CCTCGGCCTCCCAAAGTGTTGGGATTATAGGCGTAAGCCACCACGCC ***** *** ** ************ ****** *** *  * * *
alu CAGCCCCTACTTCTTGTTTTTcol CCGCC------------------ade CAGCC------------------
ngf CTGCCCCT----------- TCT
Figure 6.9: Alignment of the nucleotide sequence of the Alu element in pUS1206
(alu) with the sequence of other Alu elements from different human genes, 
col- collagenase gene; ade- adenosine deaminase gene; gly- glycoprotein a subunit 
gene; ngf- nerve growth factor gene.
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The overall GC content of this region is 48.8%, significantly lower than the 
GC content of the coding sequences which is 55.5%. The GC nucleotides are not 
evenly distributed throughout the region. The Alu sequence has a higher GC content 
of 56.1%, while the remaining 540 nucleotides have a GC content of 47.5%.
(ii) Sequences coding for SHMT
The nucleotide sequence of the insert in pUS1206 from position 850 to 1779 contains 
930bp of DNA sequence that codes for human SHMT, Translation of this sequence 
(figure 6.7) results in an amino acid sequence that is 92% identical with the sequence 
of the rabbit SHMT derived from the cDNA insert in pUS1203, over the same 
region. The protein sequence is incomplete at the N terminus, and, when compared 
to the rabbit protein sequence, it lacks 173 amino acids (519 nucleotides of coding 
sequence), assuming the two proteins were the same size. The size of the human 
enzyme is not known, since it has never been purified from any human source. 
Mammalian SHMTs purified to date range from 61kDa for rat (Palekar et al. , 1973) 
to 53kDa for the enzyme purified from rabbit liver (Schirch & Peterson, 1980). This 
would suggest that the mammalian SHMT enzymes range from 549 amino acids to 
477 amino acids in length, based on a lOOkDa protein containing 900 amino acids 
(Promega Protcols and Applications guide, 2nd Edition).
A comparison of the amino acid sequence presented in figure 6.7 with the only 
other mammalian SHMT sequences available, that of rabbit cytosolic SHMT (chapter 
4) and rabbit mitochondrial SHMT (Martini et at. , 1989) suggests that the human 
sequence isolated in pUS1206 codes for part of the cytosolic isozyme of SHMT, The 
protein sequence is 92% identical to cytosolic SHMT and 60.9% to mitochondrial 
SHMT.
The coding sequence for human SHMT is 55.5% G-C rich, which is slightly 
lower/higher than the G-C content of the same region in the rabbit sequence.
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(üi) The 3’ untranslated region
The SHMT protein coding sequence terminates with a TA A stop codon located at 
position 1780-1782. The 3’ untranslated region that follows which is 890 nucleotides 
long, is 42.2% G-C rich. Two sequences signalling for polyadenylation are found 
at the end of this region. The first of these is the AATACA sequence found at 
position 2595-2600, which is used for polyadenylation in approximately 5% of 
mRNAs (Proudfoot, 1991). Located 35 nucleotides further downstream is the most 
common sequence signalling polyadenylation, A AT AAA, positions 2635-2640 (see 
figure 6.7). A similar situation of multiple polyadenylation sequences was found in 
the rabbit clone, where both sequences were found separated by 40 nucleotides, with 
the AATAAA sequence being the one furthest downstream. A string of 12 adenines 
are found 17 nucleotides further downstream of the AATAAA sequence. These 
adenines could form the start of a poly A tail, which is normally found 10-30 
nucleotides downstream of the polyadenylation sequence (Proudfoot, 1991). The 
clone ends at position 2670 with the EcoRI linker sequence, CCGGAATTC.
6,2.5 SOUTHERN BLOT ANALYSIS
Genomic DNA was isolated from both HeLa and MOLT-4 cells as described in 
section 2.7.3. Molt-4 DNA was digested with Kpnl, Hindlll and BamHI, and HeLa 
DNA with EcoRI, PvuII and Smal prior to electrophoresis on a 0.8% agarose gel 
(figure 6.10). As can be seen from figure 6.10 (lanes 4, 5 and 6) Smal, Kpnl and 
Hindlll did not digest the DNA. A Southern blot was carried out (section 2.11.1) 
and the blot was probed with radiolabelled SHMT cDNA insert from clone lb 
(section 2.11.6). The filter was washed at 65°C in 2xSSC/0.1 %SDS before exposure 
to autoradiograph at -70°C. Figure 6.11 shows the pattern of hybridisation following 
4 days exposure. Digestion of HeLa DNA with EcoRI and PvuII resulted in bands 
of llkb, 6kb, 3.2kb, and 2.3kb, 2.0kb, 0.7kb and 0.4kb respectively. Digestion of 
the MOLT-4 DNA with BamHI resulted in three bands of 5.2kb, 4.5kb and 1.4kb. 
Since no EcoRI restriction sites are located within the insert in clone lb, the genomic 
clone must contain introns within these coding sequenes that contain EcoRI restriction 
sites. An internal BamHI site located within the coding region at position 1160
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Figure 6.10: Electrophoresis of genomic DNA extracted from HeLa and MOLT-4 
cells that had been digested with EcoRI, PvuII, Smal and Kpnl, Hindlll 
and BamHI respectively. Marker DNA sizes are given in appendix i.
Lane 1: lambda/Hindlll
Lane 2: HeLa DNA/EcoRl
Lane 3: HeLa DNA/PvuII
Lane 4: HeLa DNA/Smal
Lane 5: MOLT-4 DNA/Kpnl
I^ne 6: MOLT-4 DNA/Hindlll
l^ne 7; MOLT-4 DNA/BamHl
Lane 8: lambda/Hindlll
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Figure 6.11: Pattern o f hybridisation obtained following probing of a Southern blot 
o f the gel in figure 6.10, with radiolabelled cDNA from pUS1206.
Lane 1: lambda DNA/Hindlll (appendix i)
Lane 2: HeLa DNA/EcoRI
Lane 3: HeLa DNA/PvuII
Lane 4: HeLa DN/Smal
Lane 5: MOLT-4 DNA/Kpnl
Lane 6: MOLT-4 DNA/Hindlll
Lane 7: MOLT-4 DNA/BamHl
Lane 8: lambda DNA/Hindlll (appendix i)
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contributes to the observed banding pattern when probed with insert from clone lb. 
The hybridisation pattern obtained following digestion with PvuII indicates five 
restriction sites must be located within a region that is at least partially spanned by 
the cDNA insert in clone lb. Three of these are within the cDNA insert of clone lb 
at positions 883, 936 and 2023. The overall pattern of banding and size of hybridised 
bands when compared to the cDNA insert in clone lb or the larger insert in pUS1206 
indicate the presence of more introns in the gene in addition to the one detected in 
pUS1206.
6.3 DISCUSSION
Six independent clones containing putative human SHMT sequence have been isolated 
from a breast cancer cell line cDNA library, using as a probe, rabbit SHMT cDNA 
contained in pUS1203. Of these six clones which had inserts ranging from 
approximately 1.8kb to 2.7kb- two were further studied and characterised: pUS 1205 
which had a 1.78kb insert; and pUS1206, which contained the largest cDNA insert 
isolated, at 2.68kb. The nucleotide sequence determined for the cDNA inserts in 
pus 1205 and pUS1206 revealed that neither clone contained the complete coding 
sequence for human SHMT and, although the insert in pUS1206 was approximately 
900bp larger, it contained only an extra 42 nucleotides of coding sequence.
Translation of the DNA sequence obtained showed that the insert in pUS1205 
contained DNA that coded for SHMT from amino acid 191, while the sequence in 
pus 1206 started coding for SHMT at amino acid 174, relative to the rabbit sequence. 
The nucleotide sequence and hence derived protein sequence from both clones was 
identical over the region in common to both.
Examination of codon usage for human SHMT as presented in table 6.2, 
shows an overall preference for either guanine or cytosine at the third position of the 
codon. The percentage of guanines or cytosines at the third position of the codon is 
63.8%, compared to 83.6% for the same region in rabbit SHMT. The level of
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guanine and cytosine nucleotides at the third position of a codon was determined to 
be 43.7% for human DHFR and 76.4% for thymidylate kinase based on a table of 
human codon usage published by Maruyama and co-workers (1986). The most 
obvious example of bias for guanine and cytosine nucleotides at this position is seen 
in the case of valine, where out of a total of 21 valine codons in this region of the 
protein, 17 have either a guanine or cytosine at the third position (86%). In contrast 
to this is the amino acid lysine where 50% of the codons have a guanine at the 3rd 
position and 50% have an adenine at the 3rd position.
The deduced amino acid sequence of part of human SHMT is compared in 
figure 6.12 to the amino acid sequences of the same region of the bacterial enzymes 
using the Clustal analysis programme (Higgins & Sharp, 1988; 1989). The protein 
sequence has been derived from the nucleotide sequence of the gly A gene from E. 
coli (Plamann et ah, 1983), C. jejuni (Chan & Bingham, 1990) and B. japonicum 
(Rossbach & Hennecke, 1991). As can be seen from figure 6.12, the human protein 
is the largest for that region of the protein, containing 309 amino acids compared to 
273 amino acids for E. coli and C. jejuni, and 275 amino acids for B. japonicum. 
As is the case for the rabbit protein, the larger size of the human protein is due 
primarily to extra amino acids at the carboxyl end of the protein. There are also 
extra amino acids located downstream of the lysine implicated in binding pyridoxal 
phosphate in human SHMT that are not present in the bacterial enzymes. The 
sequences at the N terminus of the region here, which corresponds to the central 
region of the complete protein sequence, are more highly conserved than the C 
terminal. At the amino acid level the highest level of identity between the human and 
the bacterial sequences is for E. coli at 44.3%, followed by B. japonicum at 44.1% 
and C. jejuni at 39.5%. The overall identity between the four protein sequences 
presented is 24.5%, with a further 32.9% of conservative substitutions.
There are nine cases where a non-conservative amino acid substitution has 
taken place in the human protein at positions where the three bacterial sequences 
share the same amino acid. Five of these substitutions represent the presence of extra 
sulphydryl groups in the human protein. The alanines at positions 32, 75, 162 and
153
Hu VNPDTGYINYDQLEENARLFHPKLIIAGTSCYSRNLEYARLRKIADENGAYLMADMAHIS 
EC IDAT-GHIDYADLEKQAKEHKPKMIIGGFSAYSGWDWAKMREIADSIGAYLFVDMAHVA 
Cj VELD-GRIDYEKVREIAKKEKPKLIVCGASAYATVIDFAKFREIADELPPYLFADIAHIA 
B j RRED-QIIDMDAVQKQAEEIKPKLIVAGGSAYSRAWDFKRFREIADSVGAYLLVDMAHFA* * *. . .  . . * . ***•  . ** . . * . **  .
Hu GLVAAGWPSPFEHCHWTTTTHKTLRGCRAGMIFYRKGVKSVDPKTGKEILYNLESLIN
EC GLVAAGVYPNPVPHAHWTTTTHKTLAGPRGGLILAKGGSEELYKK-------------------------LN
Cj GLWAGEHPSPFPHAHWSSTTHKTLRGPRGGIIMTND— EELAKK------------------------- IN
B j GLVAGGVHASPVPYAHVTTTTTHKSLRGPRGGLILSND— ETLAKK-------------------------LN***..* . **.. .****.* * *.*.*.  . . . .  * .*
Hu SAVFPGLQGGPHNHAIAGVAVALKQAMTLEFKVYQHQWANCRALSEALTELGYKIVTGG 
EC SAVFPGGQGGPLMHVIAGKAVALKEAMEPEFKTYQQQVAKNAKAMVEVFLERGYKWSGG 
Cj SAIFPGIQGGPLMDVIAAKAVGFKFNLSDEWKVYAKQVRTNAQVLANVLMDTKFKLVSDG 
B j SAIFPGLQGGPLMHVIAAKAVAFGEALRPDFKVYAKNWENAKALAEAMKSHGFDIVSGG 
* * . * * *  * * * *  * *  * . * . . . *  *  * . . *
Hu SDNHLILVDLRSKGTDGGRAEKVLEACSIACNKNTCP GDRSALRPSGLRLGTPALTS
EC TDNHLFLVDLVDKNLTGKEADAALGRANITVNKNSVPNGDDPKSPFVTSGIRVGTPAITR 
Cj THNHLVLMSFLDREFSGKDADLALGNAGITPNKNTVP— GEIRSPFITSGLRLGTPALTA 
B j TDNHLMLVDLRPKGLKGNVSEKALVRAAITCNKNGIPF— DPEKPFVTSGLRLGTPAATT 
. . * * *  *  * . .  . * * * * .  *  * * . * . * * * *  *
Hu RGLLEKDFQKVAHFIHRGIELTLQIQSDTGVRATLKEFKERLAGDKYQAAVQALREEVES
E c RGFKEAEAKELAGWMCDVLD S INDE A------------V I -------------------—--------ERIKGKVLD
Cj RGFKEKEMEIVSNYIADILD———DINNEK—*— ———LQ—————-----—— —ENIKQELKK
B j RGFGVAEFQQVGGMIAEVLN AIAQSDDGKAPLVE— -------------------------AAIKERVKA ^^. . . . . .  .. ^. . . . . .
Hu FASLFPLPGLPDF
Ec ICARYPVYA--------
Cj LASNFIIYERAMF 
B j LTDRFPIYQ--------
Figure 6.12: Alignment of available amino acid sequence of human SHMT (Hu) 
with the same region in bacterial enzymes, using CLUSTAL (Higgins & Sharp, 1988, 
1989). * indicates conserved amino acid; . indicates conservative substitution 
Ec- E. coli SHMT amino acid sequence derived from sequence of glyA gene 
(Plamann et al., 1983); Cj- C. jejuni SHMT amino acid sequence derived from 
sequence of glyA gene (Chan & Bingham, 1990); Bj- B. japonicum SHMT amino 
acid sequence derived from the sequence of glyA gene (Rossbach & Hennecke, 1991).
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207 are all substituted for by a cysteine residue, as is the proline at position 89. That 
a similar situation exists in the rabbit protein (chapter 4, figure 4.11) may indicate a 
difference in intra-Zinter-chain disulphide bonding of the mammalian enzyme. The 
five other non-conservative substitutions in the human enzyme are proline for lysine 
(105), histidine for leucine (132), asparagine for methionine (133), valine for lysine 
(139) and a glutamic acid for proline (113).
Close inspection of the aligned sequences from such divergent taxa as human 
and bacteria, points to localised regions of higher constraint where, for 10-12 amino 
acids, there is a high degree of conservation of the amino acids across all species. 
In cases where the amino acid is not completely conserved, there has been a 
conservative substitution. Three regions where this occurs are from amino acids 76- 
88, 119-131 and 225-236, as numbered in figure 6.12. The first of these regions 
contains the lysine residue implicated in binding pyridoxal 5’ phosphate (Bossa et al. , 
1976; Plamann et al., 1983). There is a complete conservation of the residues here 
except for the substitution of two serine residues for two threonines in C, jejuni and 
a serine for threonine in B. japonicum. No residues in the other two regions have yet 
been identified to be involved in directly binding either of the coenzymes, however 
the high degree of conservation would indicate either catalytical or stuctural 
constraints of these regions.
Recent studies using purified sheep liver SHMT, have reported the 
requirement of two arginine residues for interaction with THF (Usha et al., 1992). 
Figure 6.13 shows the alignment of the sequence of the peptides containing the 
arginine residues in sheep SHMT with the same regions of the protein in human 
SHMT. Arginine-269 is conserved between sheep and human sequences thus 
supporting it’s role in binding THF. In the bacterial enzymes this arginine is replaced 
by a lysine in E. coli and an asparagine in C. jejuni and B. japonicum, both of which 
are conservative substitutions, thus maintaining the same charge as the arginine in 
sheep SHMT. The second arginine implicated in binding THF, arg-462, is not 
conserved in human SHMT but is conservatively substituted for by a glutamine. 
However in the bacterial enzymes arg-462 is replaced by glutamic acid in E. coli and 
C. jejuni and by an alanine in B. japonicum none of which are conservative
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substitutions. Therefore, it is unlikely that this arginine residue is involved in binding 
THF in the bacterial enzymes.
sheep: CRAGMIFYRKG RAVRALR
human: CRAGMIFYRKG AAVQALR
Figure 6.13: Alignment of sequence of peptides that contain the arginines implicated in
binding THF (Usha et ah,  1992). * indicates the arginine implicated
Since no 5’ untranslated region was isolated in either pUS 1205 or pUS1206, 
a search for an upstream ORF or other potential regulatory sequences in common 
with the rabbit 5’UTR could not be performed. A search of the 3’ UTR reveals a 
number of directly repeated sequences as well as inverted repeat sequences, as is the 
case for the 3’UTR of rabbit and bacterial SHMT. The longest perfect direct repeat 
in the 3’ UTR, AGTATGGTG, is located at position 2312-2320 and again at position 
2345-2353. A 14bp direct repeat with a single mismatch is located at positions 1870- 
1883 and 2231-2244. The mismatch is at position 1877 and 2238, where an adenine 
is in the place of guanine. There also exists three octamers and two heptamers that 
are each repeated twice as well as numerous hexamers. There are potentially seven 
perfect inverted repeated sequences and two imperfect inverted repeated sequences, 
a 13-mer at positions 2015-2027 and 2101-2113 and a 16-mer at positions 2310-2325 
and 2366-2281, which at any one time could form seven different stem and loop 
structures with a loop size from 16 to 94 nucleotides.
Located within the 3’ UTR are four potential sequences signalling for 
polyadenylation. The most common sequence for polyadenylation is AATAAA, 
which is located at the end of the 3’ UTR at position 2635-2640 and also 600 
nucleotides further upstream at position 2045-2050. The lesser used sequences, 
AATACA and ATTAAA are located at positions 2595-2600 and 1989-1994 
respectively. Cleavage and polyadenylation could occur from any of these four
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sequences and would thus give rise to different sizes of transcript, two of which 
would be appoximately 600 nucleotides shorter. In rabbit the 3’ UTR of the cDNA 
insert isolated in pUS1203 has two sequences signalling poly A addition, each 
separated by 35 nucleotides.
The coding sequences for the human SHMT end abruptly at position 849 of 
the cDNA insert in pUS1206 at an AGGT sequence which matches the consensus 
sequence for the 5’ end of exons of nuclear genes (Ohshima et ah, 1987; Csank et 
ah, 1990). As already discussed the sequences surrounding this consensus sequence 
agree with the calculated frequency of nucleotides found adjacent to intron/exon 
boundaries. This intron is a "phase 0" type since it interrupts the reading frame 
between codons. An analysis of the frequency of the different phase types among 
nuclear introns demonstrate a non-uniform distribution of types, with a reduced 
frequency of "phase 2" type introns (20%), which interrupt the codon between the 
second and third nucleotides. An equal distribution of "phase 1" (40%) and "phase 
0" (41%) types was observed over 271 human introns examined (Fedorov et ah, 
1992).
Conservation of exon boundaries has been reported for the 
phosphofructokinase gene from human liver, rabbit muscle and mouse liver (Vaisanen 
et ah, 1992). Similarly for the thymidylate synthase (TS) gene, it has been shown 
that the splice junctions of the exons in human and mouse TS are identical (Deng et 
ah, 1986). Examination of the rabbit SHMT nucleotide sequence at the same region 
as the human exon boundary reveals the sequence AGGT. Of the seven exons coding 
for thymidylate synthase, six have AG as the last two nucleotides of the exon (Kaneda 
et ah, 1990). The nucleotide sequence most frequently flanking the 5’ exon side of 
a splice donor site is reported to be AG (Lear et ah, 1990). This indicates that the 
AG dinucleotide at position 673-674 in rabbit SHMT (chapter 4, figure 4.7) could 
represent the last two nucleotides of an exon at the 5’ splice site, thus conserving the 
exon/intron boundary for this intron between human and rabbit for cytoplasmic 
SHMT.
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The isolation of a clone containing an intron from a cDNA library synthesised 
using oligo dT as a primer, is unusual but not unprecedented. A cDNA isolated from 
a rat kidney cDNA library, using mouse preproepidermal growth factor (ppEGF) as 
a probe, was found to contain a single intron between exon 15 and 16 of the rat 
ppEGF gene, and was explained as a result of a high degree of alternative splicing 
(Saggi et ah, 1992). As is the case for the intron found in pUS1206, the intron 
retained in the ppEGF clone, contained multiple termination codons in all reading 
frames, thus not permitting readthrough to produce an altered protein. Regulatory 
roles for introns have been reported in the past for some genes. An example of this 
is the case of thymidylate synthase, where the presence of an intron is required for 
the accurate expression of the mRNA. Using mini-gene constructs containing the TS 
cDNA, the effect of including 5’ flanking region and intron 1 was examined when the 
contructs were transfected into thymidine auxotrophic rat fibroblast cells. 
Transfection with the construct containing only the cDNA resulted in constitutive 
expression of TS, however the inclusion of intron 1 and the 5’ flanking region were 
sufficient to confer a normal S-phase dependent pattern of expression of TS. The 
presence of both the intron and the 5’ flanking sequences were required for this 
normal pattern of TS expression (Takayanagi et ah, 1992). The presence of introns 
has also been shown to increase expression of mouse DHFR, another enzyme of the 
thymidylate synthesis pathway (Gasser et ah, 1982).
The only eucaryotic gene encoding SHMT to be isolated and sequenced to date 
is the/or gene of N. crassa. Increased mRNA levels in response to amino acid 
imbalance suggests that the gene is at least partially under the cross pathway control 
(CPC) system, a pathway whereby deprivation for any amino acid results in increased 
expression of all amino acid biosynthetic genes. Examination of the sequence of the 
for gene has revealed six potential sites responsive to CPC, one of which is a perfect 
match for CPC binding site consensus sequence. This sequence, TGACTCA, is 
located within the first short intron of the for  gene (McClung et ah, 1992). CPC-1, 
the product of the cpc-1 gene, is a DNA-binding protein that acts as a positive 
transcription factor of amino acid biosynthetic genes in N. crassa (Paluh et ah, 1988; 
Paluh & Yanofsky, 1991). Although studies remain to be done to confirm binding
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of CPC-1 to this site in the intron, the response offor mRNA to the amino acid status 
of the cell suggests that the gene is under control of CPC-1. Hence it appears 
possible that the intron of SHMT in N, crassa would be important for regulating the 
expression of the SHMT gene. Whether a similar situation exists in SHMT from 
higher eucaryotes remains to be explored.
Other examples of genes where introns contain specific sequences involved in 
regulating the expression of that gene include rat phosphofructokinase and human 
purine nucleoside phosphorylase (PNP, EC 2.4.2.1). A potent glucocorticoid 
response element (GRE), contained within intron 1 of the phosphofructokinase gene 
contributes to the hormonal regulation of the gene (Lange et al. , 1992). It has been 
suggested that formation of a glucocorticoid hormone receptor-DNA complex 
enhances gene transcription by placing the transactivating domain of the receptor in 
a position where it can interact with components of the transcription initiation 
complex (Godowski et ah, 1988; Yamamoto, 1985). In the case of PNP, the 
inclusion of all five introns of PNP into the minigene construct resulted in an increase 
in PNP expression, when transfected into mouse NIH 3T3 cells. Inclusion of intron 
1 had a disproportionate effect due to the presence of an enhancer-like element within 
the intron (Jonsson et ah, 1992).
A scan of the intron sequence in clone pUS1206 for specific sequences that 
could be involved in binding transcription factors or other regulatory sequences reveal 
two imperfect Ap3 binding sites. The Ap3 transcription factor binds to a degenerate 
consensus sequence of TGTGGA/TA/TA/T. The sequence at position 556-563, 
TGTGGTCC matches at six out of eight nucleotides of the consensus sequences, 
whereas the sequence at position 803-810, TGTGGTTG, differs only at the final 
nucleotide of the consensus sequence. Two potential binding sites for the 
transcription factor Inr are located at positions 477-484 and position 720-727 where 
the sequences, CTCATTAT and CTCACCCT, each differ by one nucleotide from the 
consensus sequence of CTCANTCT. Whether these sequences are involved in 
binding transcription factors or not remains to be determined. The possibility exists 
also that the some unidentified sequence responsible for regulating SHMT is also
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present. Since the intron is not complete within clone pUS1206, it is possible that 
sequences further upstream from the Alu sequence could be important.
Alu repeats are the most extensively studied family of retroposons in primates. 
There are 500,000 copies of the sequence in the genome, and thus it constitutes 
approximately 5% of the human genome. The typical member of the Alu family, 
approximately 300bp long, is composed of two related sequences, tandemly arranged, 
the right monomer is usually slightly longer at 170bp than the left monomer 
(Deininger et ah, 1981) . The 310 nucleotides at the 5’-end of pUS1206 as well as 
showing an extensive homology with members of the Alu family as seen in figure 
6.9, has many other features in common with these sequences. Figure 6,14 shows 
the alignment of the first 150 nucleotides of this Alu with the second monomer. 
Consistent with the view of two related monomers contributing to an Alu element, 
these two halves show nearly 50% homology. Another feature of the Alu element 
is duplication of the target sequence at the site of insertion. The sequence GTTTTT 
at position 9-14 is repeated again at the end of the Alu sequence at position 317-322. 
The short direct repeats found at the end of Alu elements range from 6-20 nucleotides 
in length. Whether the repeated sqeuence at the ends of this Alu are longer cannot 
be determined since the sequence then extends into the EcoRI linker sequence, 
GAATTCCG. Two sites exist within the Alu sequence for the restriction enzyme 
Alul, from which the element derived it’s name, at position 88-91 and 137-140.
Thus this chapter has described the isolation of cDNA sequences coding for 
human cytosolic SHMT. This is the first sequence available for the human enzyme 
and its extensive homolgy to the rabbit sequence (92% at amino acid level) indicates 
an extremely high degree of conservation among the higher eucaryotes for SHMT. 
The clone sequenced (pUS1206) does not contain the complete coding sequence for 
SHMT, since it has an incomplete intron at the 5’ end of the coding sequence. It 
appears that the sequence is complete at the 3’ end since a sequence indicating 
polyadenylation as well as the potential start of the poly A tail was found. A 
comparison of this human sequence with the other known eucaryotic sequences is 
provided in chapter 7.
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a l u  LIM ITS: 9 1 5 0
a l u  LIM ITS: 1 7 0  3 22
9 G T TTTTTTTCAGATGGAGTCTCG CTCTGTTGC CCAGGCTGGAGTGCTGGAGTGCAI I l l l l l l  I I  I I I I  I I  I I I  I I I I  I I I I I I1 7 0  GCTAATTTTTTGCATTTTTAGTAGAGACGGGGTTTCACCATGTTAGCCAGGATGGTCTCG 
64  GTGGCACAATCTCGGCTCACTGCAAG CTCCACCTCCCGGGTTCACGCCATTCTCCTGCCI I  I I I I  I N I  I I I I  l l l l l l  I I I I I  I I2 3 0  ATCTCCTGACCTC ATGATCTGCCCGTCTCAGCCTCCCAAAGTGCTGGGATT ACAGGTG 
1 2 3  TCAGCCTCC CAAGTAGCTGGGATTACAGI t i l l  I I I  I I I  I I I2 88 TGAGCCACCGCGCCCAGCCCCTACTTCTTGTTTTT
Figure 6.14: Alignment of left and right monomers of the Alu element in pUS1206.
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CHAPTER 7
COMPARISON OF HUMAN AND RABBIT SHMTs
7.1 SUMMARY
This chapter provides a comparison of the available eucaryotic SHMT nucleotide and 
amino acid sequences. To date, these include the sequence of the rabbit cytosolic 
SHMT cDNA and its derived protein sequence (chapter 4), the sequence of a partial 
human cytoplasmic SHMT cDNA and derived protein sequence (chapter 6), the 
protein sequence of the rabbit mitochondrial SHMT (Martini et al. , 1989) and the 
sequence of the for locus of N. crassa which encodes SHMT (McClung et al. , 1992). 
The comparison shows a high degree of conservation among the enzymes. Regions 
of complete conservation of amino acids across all species, indicates a particularly 
high degree of constraint, and in some cases these conserved amino acids have been 
implicated in the active site of the enzyme (Usha et al., 1992; Schirch, 1982). At the 
nucleotide level the coding sequences for rabbit and human SHMT are 87.5% 
identical. Of note is a region in the 3’ UTR that is extremely well conserved between 
human and rabbit.
7.2 RESULTS AND DISCUSSION
SHMT is an enzyme involved in the metabolism of serine in both procaryotes and 
eucaryotes. In plant green tissue the enzyme functions in the opposite direction to 
that normally used in mammals of glycine production, and is said to be the major 
source of photorespiratory CO2 release. The properties of SHMT purified from 
different eucaryotes are very similar. The enzymes are of similar sizes, 53kDa for 
both the rabbit mitochondrial and cytosolic SHMTs (Martini et al., 1987; 1989), 
53kDa for N. crassa cytosolic SHMT (McClung et al., 1992), 56kDa for sheep 
cytosolic SHMT (Ulevitch & Kallen, 1977) with the largest purified to date being the 
cytosolic enzyme from rat liver at 61kDa (Palekar et al., 1973).
Comparison of the protein sequences of the rabbit and human cytosolic SHMT 
to the published bacterial sequences shows a considerable degree of identity at 28 % 
and 24.5% respectively (chapter 4 and 6). The alignment of the known amino acid 
sequence of human and rabbit cytosolic SHMT in figure 7.1 shows an extremely high
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Hu VNPDTGYINYDQLEENARLFHPKLIIAGTSCYSRNLEYARLRKIADENGAYLMADMAHIS Ra VNPDTGYIDYDRLEENARLFHPKLIIAGTSCYSRNLDYGRLRKIADENGAYLMADMAHIS
Hu GLVAAGWPSPFEHCHWTTTTHKTLRGCRAGMIFYRKGVKSVDPKTGKEILYNLESLIN Ra GLWAGWPSPFEHCHWTTTTHKTLRGCRAGMIFYRRGVRSVDPKTGKEILYNLESLIN ***.*********************************.**.*******************
Hu SAVFPGLQGGPHNHAIAGVAVALKQAMTLEFKVYQHQWANCRALSEALTELGYKIVTGG Ra SAVFPGLQGGPHNHAIAGVAVALKQAMTPEFKEYQRQWANCRALSAALVELGYKIVTGG 
* * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * *  * * , * * * * * * * * * * . * * . * * * * * * * * * *
Hu SDNHLILVDLRSKGTDGGRAEKVLEACSIACNKNTCPGDRSALRPSGLRLGTPALTSRGL Ra SDNHLILVDLRSKGTDGGRAEKVLEACSlACNKNTCPGDKSALRPSGLRLGTPALTSRGL 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Hu LEKDFQKVAHFIHRGIELTLQIQSDTGVRATLKEFKERLAGD-KYQAAVQALREEVESFA Ra LEKDFQKVAHFIHRGIELTVQIQDDTGPRATLKEFKEKLAGDEKHQRAVRALRQEVESFA 
* * * * * * * * * * * * * * * * * * * , * * * . * * *  * * * * * * * * * * * * * *  * , *  * * * * * * * * * * * * *
Hu SLFPLPGLPDF Ra ALFPLPGLPGF .* * * * * * * * . *
Figure 7.1; Alignment of known human cytosolic SHMT amino acid sequence (Hu) 
with the corresponding region of the rabbit cytosolic SHMT (Ra). indicates 
conserved amino acids; . indicates conservative substitutions.
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level of residue conservation. The amino acid identity between the rabbit protein 
sequence from amino acids 174-484, to the corresponding region of human sequence, 
is 92% with a further 6% of conservative substitutions. The level of identity 
observed between human and rabbit for various other protein sequences is reported 
to be between 85-97%. For the enzyme paraoxonase, which is involved in the 
metabolism of toxic organophosphorus insecticides, the level of identity is reported 
to be 85% (Hassett et ah, 1991). The human phosphoglucomutase enzyme, which 
catalyses the interconversion of glucose-1-phosphate and glucose-6-phosphate, has an 
extremely high level of identity to the rabbit enzyme at 97 % (Whitehouse et ah, 
1992). At the nucleotide level these two sequences have 92% identity.
There are four non-conservative substitutions between human and rabbit 
SHMT throughout the 310 amino acids presented in figure 7.1. Leucine replaces 
proline in human SHMT at position 149, valine replaces glutamic acid at position 153 
and proline at position 268, and alanine takes the place of arginine at position 286. 
The glutamic acid at position 283 in the rabbit sequence is absent from the human 
enzyme. Particularly noteworthy is the marked region from amino acids 428-451 in 
the rabbit sequence which is well conserved between the human and rabbit cytosolic 
enzymes, yet was absent from the bacterial counterparts. The functional significance 
of this sequence is unknown. This region is hydrophillic and thus is likely to be on 
the surface of the protein and so possible functions of this sequence could include an 
interaction with other cellular proteins. The N terminus of the rabbit SHMT also has 
a hydrophillic sequence that is absent in the bacterial enzymes. An association 
between cytosolic SHMT and a multienzyme complex, involved in utilisation and 
production of tetrahydrofolate co-factors, has been reported (Caperelli et ah, 1980), 
however further studies have not been carried out.
At the nucleotide level, the coding sequences for rabbit and human SHMT are 
85.7% identical. Examination of the 3’ UTR of both the human and rabbit mRNA 
shows the human sequence to be longer at 898 nucleotides compared to the rabbit at 
653 nucleotides. Alignment of these two sequences over the whole 3’ UTR reveals 
a 54.2% identity, however when this alignment is limited to include only the final 200
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nucleotides the identity increases dramatically to 82.6%. Figure 7.2 shows the 
alignment of this region of the 3’UTR from human and rabbit SHMT cDNAs and 
shows the human clone to be slightly longer at the end due to the presence of the start 
of a poly A tail. There are only 10 mismatches between this region of the 3’ UTR 
in human and rabbit SHMT cDNA, excluding the poly A tail in the human clone. 
This extensive conservation of 3’UTR may indicate a regulatory role. Further 
upstream of this highly conserved region are localised areas where the sequences 
show good alignment. The region from position 1891-1958 in human is quite well 
conserved between the rabbit and human sequences, containing two different 
hexanucleotide sequences that are completely conserved. The larger size of the 
human 3’ UTR can be mainly attributed to the sequences towards the 5’ end of this 
UTR region. Two main regions, from positions 1823-1890 and 1997-2079 of the 
human clone are not present in the rabbit sequence.
Examination of all four known protein sequences for eucaryotic SHMT reveals 
a high level of conservation among such divergent species as man and neurospora. 
Figure 7.3 shows the alignment of the four protein sequences for the region of 
sequence available for human SHMT. The overall level of identity between all four 
species is 43.8% with a further 32.9% of conservative substitutions. When the rabbit 
mitochondrial enzyme is excluded the level of identity between the cytosolic proteins 
increases to 55% with a further 28% of conservative substitutions. As noted above 
the most closely related sequences are the human and rabbit sequences at 98% 
similarity between the cytosolic enzymes and 85.5% similarity between the rabbit 
mitochondrial and human cytosolic enzymes. The overall identity between the 
mammalian enzymes is 60% with a further 28.4% conservative substitutions. SHMT 
from human and N. crassa have 54.2% similarity.
There are localised regions within the sequence that show a higher degree of 
conservation. These include positions 55-62, 77-84, 128-134 and 140-147 (numbered 
as in figure 7.3). The region from position 77-84 contains the lysine that binds 
pyridoxal 5’ phosphate (Bossa et al., 1976; Plamann et al., 1983). Examination of 
the sequence surrounding this lysine residue in all known sequences for SHMT
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h sh m t LIM ITS; 2 4 6 2  2 6 7 8  
r s h m t  LIM ITS: 2 0 7 0  2 2 6 1
AGGAAGCCAAATGTCACCTTCCCAAAGAAATTTTA TTTTCACGTAGCTGAAGTGCAAAAI I I I M I I I  I M M I I I I I I I I I I I I I  I M i l  l l l l l l l  I I I I M I I I I I I M I IAGGAAGCCACATGTCACCTTCCCAAAGAGACTTTATTTTTCACATAGCTGAAGTGCAAAA
CATAGATGACCATTTTTAATAAGCACAATCAAATTTTTAACCACAGAATGTCTACAAGAAM i l l  M i l l  M M M M M M M M M M  I I I I I I I I I I I I I I  M  I I I I I I I I 1 1CATAGCTGACCGTTTTTAATAAGCACAATCAAGGTTTTAACCACAGAATGTCTACAAGAA
TTATAGCTTTAAAAAATACAACCAATTTTTATATTTCAAAAATATTTGAACTCAAATAAAM M M M M M M M M M M M M M M M M M M M M M I  M M M M M M MTTATAGCTTTAAAAAATACAACCAATTTTTATATTTCAAAAATATCTGAACTCAAATAAA
TTAATTTCTTAAAAAGTAAAAAAAAAAAACCGGAATTCI I I I M I I I  I ITTAATTTCTGAA
Figure 7.2: Alignment of the region in the 3’ UTR shared between human and
rabbit cytosolic SHMT cDNAs.
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Hu VNPDTGYINYDQLEENARLFHPKLIIAGTSCYSRNLEYARLRKIADENGAYLMADMAHIS Rc VNPDTGYIDYDRLEENARLFHPKLIIAGTSCYSRNLDYGRLRKIADENGAYLMADMAHIS Nc VNIDTGLIDYDTLEKNAQLFRPKVLVAGTSAYCRLIDYERMRKIADSVGAYLWDMAHIS Rm LNPQTGLIDYEQLALTARLFRPRLIIAGTSAYARLIDYARMREVCDEVKAHLLADMAHIS ,* ,** *.*. *. ,*,**.*,,,.**** * * *. *.*..****&*
Hu GLVAAGWPSPFEHCHWTTTTHKTLRGCRAGMIFYRKGVKSVDPKTGKEILYNLESLIN Rc GLWAGWPSPFEHCHWTTTTHKTLRGCRAGMIFYRRGVRSVDPKTGKEILYNLESLIN Nc GLIASEVIPSPFLYADWTTTTHKSLRGPRGAMIFFR-GVRSVDAKTGKETLYDLEDKIN Rm GLVAAKVIPSPFKHADWTTTTHKTLRGARSGLIFYRKGVRTVDPKTGQEIPYTFEDRIN ****** * ************* ******** **,,**,****** * * * * * **
Hu SAVFPGLQGGPHNHAIAGVAVALKQAMTLEFKVYQHQWANCRALSEALTELGYKIVTGG Rc SAVFPGLQGGPHNHAIAGVAVALKQAMTPEFKEYQRQWANCRALSAALVELGYKIVTGG Nc FSVFPGHQGGPHNHTITALAVALKQAASPEFKEYQQKWANAKALEKKLKELGYKLVSDG Rm FAVFPSLQGGPHNHAIAAVAVALKQACTPMFREYSLQVLKNARAMADALLERGYSLVSGG ***** ******************* * * * * * * * * * * * * * *
Hu SDNHLILVDLRSKGTDGGRAEKVLEACSIACNKNTCPGDRSALRPSGLRLGTPALTSRGL Rc SDNHLILVDLRSKGTDGGRAEKVLEACSIACNKNTCPGDKSALRPSGLRLGTPALTSRGL NC TDSHMVLVDLRPIGVDGARVEFLLEQINITCNKNAVPGDKSALTPGGLRIGTPAMTSRGF Rm TDNHLVLVDLRPKGLDGARAERVLELVSITANKNTCPGDRSAITPGGLRLGAPALTSRQF
*  * * , * , *  . * *  *  *  *  * * * ,  * * * * * * *  * * * * * * * * * * * * * *  *
Hu LEKDFQKVAHFIHRGIELTLQIQSDTGVRA-TLKEFKERLAGD-KYQAAVQALREEVESF Rc LEKDFQKVAHFIHRGIELTVQIQDDTGPRA-TLKEFKEKLAGDEKHQRAVRALRQEVESF Nc GEADFEKVAVFVDEAVKLCKEIQASLPKEANKQKDFKAKIATSD— IPRINELKQEIAAWRm REDDFRRWDFIDEGVNIGLEVKRKT A-KLQDFKSFLLKDPETSQRLADLRRRVQQF* ** * * * *   * . . . ** .  . . . . .  .
Hu ASLFPLP------ GLPDFRc AALFPLP——————GLPGFNc SNTFPLPVEGWRYDAGL-Rm ARAFPMP---- — GFPEH
* * . *
Figure 7.3: CLUSTAL alignment of eucaryotic SHMT sequences over the region
of known human sequence. Hu- human cytosolic SHMT; Rc- rabbit cytosolic SHMT; 
Nc- N. crassa cytosolic SHMT; Rm- rabbit mitochondrial SHMT. * indicates 
conserved amino acid; . conservative substitution
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reveals conservation across a diverse range of taxa, with the only changes being the 
conservative replacement of threonine by serine in C. jejuni and B. japonicum. This 
conservation complies with the consensus sequence proposed by Smith and co-workers 
for the Schiff s base forming region of PLP-dependent decarboxylases of S(N/T)XHK 
(Smith et al., 1991). When limited to include only the eucaryotic SHMT sequences 
this consensus sequence can be extended to a longer sequence of 
H/DVVTTTTHKT/SLRG. Shown below are the sequences that surround this lysine 
in all of the sequences known including plant sequences.
human: 
rabbit cyto: 
rabbit mito:
N. crassa:
E. coli:
B. japonicum:
HVVTTTTHKTLRG
HVVTTTTHKTLRG
DVVTTTTHKTLRG
DVVTTTTHKSLRG
HVVTTTTHKTLAG
HVTTTTTHKSLRG
(chapter 6)
(chapter 4)
(Martini et al., 1989) 
(McClung et al., 1992) 
(Plamann et al., 1983) 
(Rossbach & Hennecke, 
1991)
C. jejuni: 
pea mito:
HVVSSTTHKTLRG
DVVTTTTHKSLRG
(Chan & Bingham, 1990) 
(Turner et al., 1992)
This consensus sequence is extremely well conserved among all species. The 
functional role of the lysine and histidine residue of the consensus sequence has been 
elucidated. Mutagenesis of the histidine residue to an asparagine in the E. coli 
enzyme resulted in a 70% decrease in catalytic activity (Hopkins & Schirch, 1986) 
and it was thus suggested that this residue did not have a critical catalytic role 
(Hopkins & Schirch, 1986). Similarly, mutagenesis of this histidine in tryptophan 
synthase, another PLP dependent enzyme, showed that the enzyme was not required 
for catalytic activity (Miles et al., 1989). Further studies using the mutated E. coli 
SHMT suggests that this histidine plays an important role in the binding and reactivity 
of the hydroxymethyl group of serine and that it is also involved in blocking side 
reactions of the enzyme (Stover et al., 1992).
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Amino acid residues in the other conserved regions have not been identified 
as being involved in directly binding either the substrate or the co-enzymes, however 
the extensive conservation of these amino acids indicates either catalytical or 
structural constraint. The lack of cDNAs coding for SHMT up until now has 
prevented site specific mutagenesis of eucaryotic SHMT, to identify the importance 
of specific amino acids to catalytic activity or binding of the substrates or coenzymes. 
Studies to date that have identified important catalytic amino acids in eucaryotic 
SHMT have been carried out by modifying the enzyme chemically. One such 
experiment has been carried out using phenylglyoxal modified SHMT purified from 
sheep liver (Usha et ah, 1992). Phenylglyoxal specifically modifies arginine 
residues, and was shown to modify two arginine residues per subunit of SHMT. 
Incubation of the enzyme with THF prevented modification of these arginines thus 
implicating them in binding THF (Usha et ah, 1992). It was suggested that the 
interaction of the arginine residues with THF was probably due to the positively 
charged guanidinium side chain of arginine, binding the carboxyl group of THF. The 
peptides containing these arginine residues were sequenced to give the sequences 
AGMIFYRK and RAVRALR.
The comparison below of the same regions in human, rabbit and N. crassa 
shows good conservation of the first arginine, however the second arginine residue 
implicated in binding THF is not so well conserved. The second arginine residue is 
completely conserved in the sheep and rabbit cytosolic enzyme, conservatively 
substituted for in human by glutamine and non-conservatively substituted in rabbit 
mitochondrial SHMT by alanine and in N. crassa by asparagine. This non­
conservative substitution in mitochondrial SHMT may indicate a difference in the 
mitochondrial enzymes binding of THF, since in the pea mitochondrial enzyme this 
arginine is replaced by a serine, while the first arginine is conserved in pea.
sheep: AGMIFYRK AVRALR
human: AGMIFYRK AVQALR
rabbit cyto: AGMIFYRR AVRALR
rabbit mito: SGL IFYRK RLADLR
N. crassa: GAMIFFR-* RINELK*
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Schirch and co-workers have suggested that the polyglutamate-binding domain 
for the polyglutamyltetrahydrofolate coenzyme may be a series of positively charged 
lysyl residues in the E, coli enzyme at positions 191, 194 and 196, that could interact 
with the negatively charged gamma-carboxyls of the polyglutamates (Martini et al. , 
1987). The positive charge of these lysine residues is conserved in the eucaryotic 
enymes by arginine, histidine, lysine and glutamine. Site-directed mutagenesis would 
need to be carried out to positively identify these amino acids in a polyglutamate 
binding site.
A comparison of the N-terminal sequences of rabbit cytosolic and 
mitochondrial sequences with the N. crassa sequence shows the sequences to be well 
conserved from amino acids 49-173 (figure 7.4). The sequences further upstream 
from this position are not well conserved. Indeed this lack of conservation of 
sequence at the N-terminus of the protein is also seen at the C-terminus. These 
regions contain sequences that are absent in the bacterial enzymes and account for the 
larger size of the eucaryotic proteins. A hydrophobicity plot of these "insertion 
sequences" indicate they are primarily hydrophillic and are therefore more likely to 
be on the surface of the protein and so would not interfere with the catalytic centre. 
Tryptic digestion of the amino terminal 35 residues from cytosolic SHMT resulted in 
2-fold increase in thus supporting the idea that these sequences do not have a 
catalytic function in the enzyme (Schirch et ah, 1986,). As previously noted, it is 
possible that these sequences function in interacting with other proteins. Another 
possibility is that these sequences could function in compartmental specificity of the 
enzymes, since the human and rabbit cytoplasmic sequences are well conserved in this 
region, yet the rabbit cytosolic and mitochondrial SHMT are poorly conserved.
The hydrophobicity pattern of the four proteins in figure 7.5 shows they have 
very similar patterns. The N and C terminals are largely hydrophillic. The predicted 
patterns of alpha helices and beta turns are also similar for all four proteins thus 
indicating a similar pattern of folding. A slight difference is predicted at the C 
terminal of the mitochondrial protein, where the alpha helices are not as predominant 
as in the cytosolic enzymes. The high degree of conservation of glycine and proline
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Rc MATAVNGAPRDAALWSSHEQMLAQPLKDSDAEVYDIIKKESNRQRVGLELIASENFASRANo MSTY--------- SLSETHKAMLEHSLVESDPQVAEIMKKEVQRQRESIILIASENVTSRARm KAAQTQTGEASRG-WTGQE----- SLSDTDPEMWELLQREKDRQCRGLELIASENFCSRA
. . .    .  *  .  .  *  *  . * *  . .  * * * * * *  * * *
Rc VLEALGSCLNNKYSEGYPGQRYYGGTEHIDELETLCQKRALQAYGLDPQCWGVNVQPYSG NO VFDALGSPMSNKYSEGLPGARYYGGNQHIDEIEVLCQNRALEAFHLDPKQWGVNVQCLSG 
, , . * * * *  , , * * * * * *  * *  * * * * * , .  . * * . *  * * * , * * * . * .  * * *  * * * * * *  * *
Rc SPANFAVYTALVEPHGRIMGLDLPDGGHLTHGFMTDKKKISATSIFFESMAYKVNPDTGY Nc SPANLQVYQAIMPVHGRLMGLDLPHGGHLSHGYQTPQRKISAVSTYFETMPYRVNIDTGL Rm SPANLAAYTALLQPHDRIMGLDLPDGGHLTHGYMSDVKRVSATSIFFESMPYKLNPQTGL ****,,.* *.. *.*.******.****.** **.*..**.*,*..* .**
Rc IDYDRLEENARLFHPKLIIAGTSCYSRNLDYGRLRKIADENGAYLMADMAHISGLWAGV Nc IDYDTLEKNAQLFRPKVLVAGTSAYCRLIDYERMRKIADSVGAYLWDMAHISGLIASEV Rm IDYEQLALTARLFRPRLIIAGTSAYARLIDYARMREVCDEVKAHLLADMAHISGLVAAKV ***. *. .*.**.*....**** * * .**.*.*,. *. *.*.,********... *
Rc VPSPFEHCHWTTTTHKTLRGCRAGMIFYRRGVRSVDPKTGKEILYNLESLINSAVFPGL Nc IPSPFLYADWTTTTHKSLRGPRGAMIFFR-GVRSVDAKTGKETLYDLEDKINFSVFPGH Rm IPSPFKHADWTTTTHKTLRGARSGLIFYRKGVRTVDPKTGQEIPYTFEDRINFAVFPSL .**** . ,********.*** *...**.* ***,**.***.*. *..*. ** .***.
Rm QGGPHNHAIAGVAVALKQAMTPEFKEYQRQWANCRALSAALVELGYKIVTGGSDNHLIL Nc QGGPHNHTITALAVALKQAASPEFKEYQQKWANAKALEKKLKELGYKLVSDGTDSHMVL Rm QGGPHNHAIAAVAVALKQACTPMFREYSLQVLKNARAMADALLERGYSLVSGGTDNHLVL *******,*...******* .* *.** ,*. * .*.. * * **..*..*.*.*..*
Rc VDLRSKGTDGGRAEKVLEACSIACNKNTCPGDKSALRPSGLRLGTPALTSRGLLEKDFQK Nc VDLRPIGVDGARVEFLLEQINITCNKNAVPGDKSALTPGGLRIGTPAMTSRGFGEADFEK Rm VDLRPKGLDGARAERVLELVSITANKNTCPGDRSAITPGGLRLGAPALTSRQFREDDFRR ****. * **.*.* .** .*. ***. ***.**, *.***,*.**.*** , * ** ,
Rc VAHFIHRGIELTVQIQDDTGPRA-TLKEFKEKLAGDEKHQRAVRALRQEVESFAALFPLP Nc VAVFVDEAVKLCKEIQASLPKEANKQKDFKAKIATSD— IPRINELKQEIAAWSNTFPLPRm WDFIDEGVNIGLEVKRKT A-KLQDFKSFLLKDPETSQRLADLRRRVQQFARAFPMP*.    * . . . . . . *   **.*
Rc GL—————PGF Nc VEGWRYDAGL Rm GF PEH
Figure 7.4: Clustal alignment of the amino acid sequences of rabbit cytosolic (Rc)
and mitochondrial (Rm) SHMTs with the amino acid sequence of cytosolic SHMT 
from N. crassa (Nc). * indicates conserved amino acid; . indicates conservative 
substitution
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Figure 7.5; Hydrophobicity plot of eucaryotic cytoplasmic SHMTs. Above the line 
represents hydrophillic residues, while below the line represents hydrophobic 
residues.
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residues among the species could place constraint on protein folding.
Noteworthy among the rabbit and human cytosolic SHMTs are the number of 
cysteine residues that are unique to these proteins. There are five cases within the 
310 amino acids presented in figure 7.1 where a cysteine residue has replaced the 
amino acid in the mitochondrial and N. crassa enzyme. In four of these, the amino 
acid replaced is an alanine which is conserved in both the rabbit mitochondrial and 
N. crassa enzyme at positions 31, 75, 89 and 162. The cysteine at position 107 
replaces an isoleucine in N. crassa and a valine in the mitochondrial sequence. These 
unique cysteine residues may indicate mammalian specific intra/inter-chain disulphide 
bond formation in the cytosolic enzyme.
The mammalian SHMTs contain two sequence motifs with the potential for 
phosphorylating serine/threonine residues at position 161 and 275 of the rabbit 
protein. The serine at position 161 is conserved in both of the rabbit sequences and 
also in the N. crassa sequence. A basic doublet (KK rabbit cytosolic; KR rabbit 
mitochondrial; RK N. crassa cytosolic) is also conserved on the N terminal side of 
the serine (161). Such a sequence motif is known to determine phosphorylation of 
eucaryotic proteins by kinases (Kemp & Pearson, 1990; Roach, 1991). The serine 
at position 275 is conserved in the human sequence, but is substituted for by a 
threonine residue in the rabbit mitochondrial protein. The basic doublet that could 
signal for phosphorylation is also present (RR rabbit cytosolic; RK human cytosolic; 
RK rabbit mitochondrial). Phosphorylation of the rabbit cytosolic SHMT in vitro 
using the catalytic subunit of a cyclic AMP-dependent kinase has been demonstrated 
(K. Snell, pers. commun.). The exact residues that are phosphorylated by this kinase 
have not been identified. These potential phosphorylation sites are not present in the 
bacterial SHMTs and so could possibly function as mammalian specific targets for 
phosphorylation. The regulatory significance of phosphorylation of SHMT, if any, 
is not known at present.
The comparison of the available eucaryotic SHMT sequences has shown them 
to be highly conserved, thus indicating structural and catalytic constraints. The
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isolation of cDNAs coding for these eucaryotic enzymes will enable site specific 
mutagenesis to be carried out with a view to identifying the role of individual amino 
acids in the correct functioning of the enzyme.
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CHAPTER 8
CONCLUDING REMARKS 
AND FURTHER STUDIES
8.1 Concluding remarks and fuither studies
At the start of this study it was not possible to undertake molecular studies on 
eucaryotic SHMTs as no nucleotide sequence data was available. The successful 
isolation of mammalian SHMT cDNA clones now makes such studies possible. A 
probe designed (chapter 3) using the available amino acid sequence of the rabbit 
cytosolic SHMT (Martini et a t,  1987) was used to isolate the complete coding 
sequences for rabbit cytosolic SHMT (chapter 4). This was then used to isolate a 
clone coding for human cytosolic SHMT from amino acid 174, relative to the rabbit 
sequence (chapter 6). The clone contained an intron, within which, was an Alu 
element. Expression of the rabbit SHMT cDNA in COS-1 cells was achieved, albeit 
at low levels (chapter 5). Site specific mutagenesis to remove an upstream ATG 
codon witin the 5’ UTR was found to dramatically increase the levels of SHMT 
activity, when transfected into COS-1 cells.
The successful cloning and expression of mammalian SHMT cDNAs reported 
in this thesis opens the way for further molecular studies on mammalian SHMT to be 
performed. Site directed mutagenesis can now be carried out to mutate specific 
amino acids of mammalian SHMT, with a view to determining the role of such amino 
acids in the binding of substrates and coenzymes. The involvement of specific amino 
acids in the catalytic activity of the enzyme can also be determined using site directed 
mutagenesis. Site directed mutagenesis has previously been carried out on E. coli 
SHMT to attempt to elucidate the role of histidine 228 (position 256 in rabbit 
cytosolic SHMT) (Hopkins & Schirch, 1986; Stover et a t , 1992). Such studies have 
implicated this residue in binding the hydroxyl group of serine.
The use of site directed mutagenesis has previously helped identify amino 
acids involved in the catalytic activity of rat glutathionine transferase and human 
dihydrofolate reductase (Tamai et a t, 1991; Tan et a t,  1990). Site directed 
mutagenesis of four cysteine residues in rat glutathionine transferase to alanine 
residues have revealed that none of the cysteine residues were required for enzyme 
activity (Tamai et a t ,  1991). Mutagenesis to delete two residues of human DHFR
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(gly-45 and lys-46) has indicated that these residues may play a role in catalysis since 
the catalytic efficiency of the mutated enzyme was decreased relative to the wild type 
enzyme (Tan et ah, 1990). Site directed mutagenesis of residues conserved among 
the known SHMT sequences may elucidate the role of these residues. Potential sites 
to study include the sequence motifs conserved in the mammalian SHMTs that signal 
for phosphorylation, lysine residues that have been proposed to be involved in binding 
THF (Martini et al., 1987) and the two arginine residues recently implicated in 
binding THF (Usha et al., 1992).
The high levels of expression of rabbit SHMT obtained following mutagenesis 
to remove the upstream ATG codon can now allow purification of the enzyme. 
Crystallisation and X-ray crystallographic data of the purified wild type recombinant 
protein and mutated SHMT would enhance the mutagenesis studies in identifying the 
role of specific amino acids in catalysis or binding substrates. A comparison of the 
X-ray crystallographic data for the wild type and mutant SHMTs would enable 
differences in enzyme structure to be ascertained.
The isolation of the human SHMT cDNA clone in pUS1206, which 
contains part of an intron sequence poses questions as to why the mRNA retained this 
intron. As noted in chapter 6, retaining an intron sequence in mRNA has previously 
been reported (Saggi et al. , 1992) and introns have been reported to be required for 
correct cell cycle related expression of TS and an increased expression of DHFR 
(Kaneda et a l, 1990; Takayanagi et a l, 1992; Gasser et a l, 1982). The SHMT 
cDNA insert from pUS1206 can now be used to screen a human genomic library in 
an attempt to isolate the gene coding for cytoplasmic SHMT. The isolation of the 
genomic sequence would identify the remaining coding sequences for SHMT, the 
remaining intron sequences and also sequences in the 5’ flanking region of the gene.
Studies using the 5’ flanking region of the SHMT gene and a reporter gene 
can be carried out to identify sequences involved in regulating SHMT expression. 
The tissue specific expression of the serine dehydratase gene, an enzyme competing 
for serine in liver, has been shown to be associated with an altered pattern of
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DNasel-hypersensitive sites, therefore it would be interesting to see if any similar 
changes in DNasel hypersensitive sites occur in SHMT 5’ flanking regions during 
SHMT expression. The cell cycle specific pattern of expression of SHMT (Snell et 
al. , 1987) could be associated with changing DNasel hypersensitive sites.
Isolation of the SHMT gene would enable construction of a mini gene 
containing the complete cDNA sequence interrupted by the complete intron sequence 
of the intron in pUS1206. The effect of this intron on expression of SHMT could then 
be compared to the expression pattern of the uninterrupted cDNA sequences to 
determine the influence of this intron on SHMT expression. Similar experiments 
have been carried out using the human thymidylate synthase (Kaneda et al. , 1990) and 
purine nucleoside phosphorylase genes (Jonsson et al. , 1992) and in both cases the 
introns have been involved in directly regulating expresion of the cDNAs. In the case 
of purine nucleoside phosphorylase the presence of introns were required for 
expression of the gene, transfection of NIH 3T3 cells with an intronless purine 
nucleoside phosphorylase gene resulted in undetectable activity (Jonsson et al. , 1992). 
The inclusion of intron 1 into a thymidylate synthase minigene was sufficient to 
confer cell cycle dependent expression (Kaneda et al., 1990),
The increased levels of SHMT expression obtained in pUS1208 transfected 
COS-1 cells (chapter 5) will enable purification of the protein from these cells. By 
using a more efficient method of transfecting COS-1 cells, it should be also possible 
to achieve even higher levels of expression. Purified recombinant SHMT protein can 
then be used for inhibitor-binding studies, with the long term goal of identifying 
inhibitors that could be used therapeutically. Administration of an antifolate drug, 
NSC 127755, to mouse myeloma cells resulted in a block in thymidylate synthesis. 
Associated with this was inhibition of SHMT (Snell & Riches, 1989). It will then be 
of interest to study the interaction of this drug and other potential drugs, with SHMT 
to identify binding of the drug to SHMT. This may aid the design of a more 
effective inhibitor.
Another possible approach to inhibiting SHMT is the use of antisense
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oligonucleotides directed specifically against SHMT to block translation of the protein 
(Stein & Cohen, 1988). The nucleotide sequence (chapter 4 and 6) now makes this 
possible for the first time. Another potential use of antisense oligonucleotides 
synthesised specifically against SHMT would be to elucidate the individual roles of 
the cytoplasmic and mitochondrial SHMTs. The isolation and sequence of 
mitochondrial SHMT cDNA will be required before the full contribution of each of 
these isozymes to metabolism can be studied. Of all the clones analysed to date, none 
contained sequences that coded for mitochondrial SHMT, even though the stringency 
used to screen the libraries was not very high. The lack of mitochondrial clones 
could be due to a low homology between the cytosolic and mitochondrial sequences. 
It is possible that the mitochondrial SHMT gene is not a highly expressed gene and 
more clones would have to be screened to isolate mitochondrial SHMT coding 
sequences, however this conflicts with data showing that 90% of total SHMT activity 
in MOLT-4 cells is mitochondrial (M. Bolton, pers commun). The development of 
a mitochondrial specific SHMT probe should enable the isolation of cDNA coding for 
mitochondrial SHMT.
The isolation of the human SHMT cDNA has enabled chromosome mapping 
studies to be carried out. Preliminary mapping experiments have localised the gene 
coding for cytosolic SHMT to chromosome 7 (collaboration with K. Johnson & T. 
van Tongaren, Charring Cross and Westminster Medical School). More refined 
mapping will be used to localise the gene to a more specific region of the 
chromosome. The isolation of mitochondrial SHMT cDNA would also enable the 
mapping of the gene coding for this enzyme to be carried out. The location of this 
gene will be of great importance if it maps to a region where breakpoints have been 
noted in schizophrenic patients. Since no specific metabolic defiency is known to be 
a causative factor in schizophrenia, colocalisation of the gene for mitochondrial 
SHMT with a known chromosomal abnormality in schizophrenic patients, would 
identify the enzyme as a potential causal factor in schizophrenia. The rational for this 
is that the reaction catalysed by mitochondrial SHMT is the main source of glycine 
in the nervous system, where glycine functions as a neurotransmitter.
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The elevated levels of SHMT expression achieved when the upstream ATG 
codon was removed from the rabbit SHMT cDNA, indicates that the presence of this 
codon, or the protein product of the ORF that follows may be involved in regulating 
the expression of SHMT. Antibodies raised against this protein can be used to 
identify if the protein is expressed cultured cells, and if expressed, is there a cell 
cycle specific pattern of expression that is related to the pattern of SHMT expression. 
A way of determining whether the presence of the upstream ATG codon itself, or the 
protein product of the upstream ORF is involved in regulation is to carry out site 
specific mutagenesis further downstream from the ATG codon within the coding 
sequences for this small ORF but upstream of the ATG codon initiating translation 
of SHMT. An elevated level of SHMT expression in such a vector would identify 
the protein product as the regulatory factor.
The work presented in this thesis has provided a basis for further analysis to 
be carried out on mammalian SHMT. The isolation and expression of mammalian 
SHMT now allows studies on the regulation of SHMT to be carried out, the results 
of which could be very important to the understanding of the utilisation of serine for 
metabolic processes such as nucleotide and glycine synthesis.
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APPENDIX i
Lambda/Hindm markers PhiX174/Haein markers
23.130 kb 1.353 kb
9.416 kb 1.078 kb
6.557 kb 0.872 kb
4.361 kb 0.603 kb
2.322 kb 0.310 kb
2.027 kb 0.281 kb
0.564 kb 0.271 kb
0.125 kb 0.234 kb
0.194 kb
0.118 kb
0.072 kb
RNA markers 
9.49 kb 
7.46 kb 
4.40 kb 
2.37 kb 
1.35 kb 
0.24 kb
Protein Molecular Weight Standards
200 KDa (pg 125) 200 KDa (pg 114)
97.4 KDa 
68 KDa 
43 KDa 
29 KDa
18.4 KDa 
14.3 KDa
97 KDa 
69 KDa 
46 KDa 
30 KDa
